
<html lang="en"     class="pb-page"  data-request-id="bd36f9bb-af76-4445-b59a-5fb6761c5c24"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b01147;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-20;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Cyanine–Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells" /></meta><meta name="dc.Creator" content="Zhengyang  Jiang" /></meta><meta name="dc.Creator" content="Kathryn  Pflug" /></meta><meta name="dc.Creator" content="Syed Muhammad  Usama" /></meta><meta name="dc.Creator" content="Dacheng  Kuai" /></meta><meta name="dc.Creator" content="Xin  Yan" /></meta><meta name="dc.Creator" content="Raquel  Sitcheran" /></meta><meta name="dc.Creator" content="Kevin  Burgess" /></meta><meta name="dc.Description" content="A small subset of heptamethine dyes (cyanine-7 or Cy7) share an intriguing characteristic: preferential tumor accumulation and retention. These dyes absorb in the near-infrared (NIR) region (above ..." /></meta><meta name="Description" content="A small subset of heptamethine dyes (cyanine-7 or Cy7) share an intriguing characteristic: preferential tumor accumulation and retention. These dyes absorb in the near-infrared (NIR) region (above ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 30, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01147" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01147" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01147" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01147" /></link>
        
    
    

<title>Cyanine–Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01147" /></meta><meta property="og:title" content="Cyanine–Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0009.jpeg" /></meta><meta property="og:description" content="A small subset of heptamethine dyes (cyanine-7 or Cy7) share an intriguing characteristic: preferential tumor accumulation and retention. These dyes absorb in the near-infrared (NIR) region (above 750 nm) and perform active targeting to deliver therapeutic and toxic cargoes to various tumor models in vivo. In this work, four heptamethines 1 were synthesized, which have a gemcitabine fragment attached to the meso-position of the Cy7 core. Theranostic agent 1a was discovered that localized in glioblastoma tumor cells, has absorption maxima in NIR region, and showed similar therapeutic effect to gemcitabine but at one-third the molar dose." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01147"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01147">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01147&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01147&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01147&amp;href=/doi/10.1021/acs.jmedchem.9b01147" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9236-9245</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01099" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01187" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cyanine–Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zhengyang Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhengyang Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhengyang++Jiang">Zhengyang Jiang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1725-2883" title="Orcid link">http://orcid.org/0000-0002-1725-2883</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kathryn Pflug</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kathryn Pflug</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular & Cellular Medicine, Texas A&M University Health Science Center, College Station, Texas 77843, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kathryn++Pflug">Kathryn Pflug</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Syed Muhammad Usama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Syed Muhammad Usama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Syed+Muhammad++Usama">Syed Muhammad Usama</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7487-1568" title="Orcid link">http://orcid.org/0000-0002-7487-1568</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dacheng Kuai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dacheng Kuai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dacheng++Kuai">Dacheng Kuai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xin Yan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xin Yan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Yan">Xin Yan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Raquel Sitcheran</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raquel Sitcheran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular & Cellular Medicine, Texas A&M University Health Science Center, College Station, Texas 77843, United States</div></div><span class="conrtib-corresp"><strong>*</strong>R.S.: e-mail, <a href="/cdn-cgi/l/email-protection#36455f42555e534457587642575b4318535243"><span class="__cf_email__" data-cfemail="e192889582898493808fa195808c94cf848594">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raquel++Sitcheran">Raquel Sitcheran</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kevin Burgess</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin Burgess</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United States</div></div><span class="conrtib-corresp"><strong>*</strong>K.B.: e-mail, <a href="/cdn-cgi/l/email-protection#1c7e696e7b796f6f5c687d716932797869"><span class="__cf_email__" data-cfemail="dbb9aea9bcbea8a89bafbab6aef5bebfae">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Burgess">Kevin Burgess</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6597-1842" title="Orcid link">http://orcid.org/0000-0001-6597-1842</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01147&amp;href=/doi/10.1021%2Facs.jmedchem.9b01147" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9236–9245</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 30, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 July 2019</li><li><span class="item_label"><b>Published</b> online</span>30 August 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01147" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01147</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9236%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhengyang%2BJiang%252C%2BKathryn%2BPflug%252C%2BSyed%2BMuhammad%2BUsama%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D20%26contentID%3Dacs.jmedchem.9b01147%26title%3DCyanine%25E2%2580%2593Gemcitabine%2BConjugates%2Bas%2BTargeted%2BTheranostic%2BAgents%2Bfor%2BGlioblastoma%2BTumor%2BCells%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9245%26publicationDate%3DOctober%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01147"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1489</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01147" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cyanine–Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhengyang&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Kathryn&quot;,&quot;last_name&quot;:&quot;Pflug&quot;},{&quot;first_name&quot;:&quot;Syed&quot;,&quot;last_name&quot;:&quot;Muhammad Usama&quot;},{&quot;first_name&quot;:&quot;Dacheng&quot;,&quot;last_name&quot;:&quot;Kuai&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Raquel&quot;,&quot;last_name&quot;:&quot;Sitcheran&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Burgess&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9236-9245&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01147&quot;},&quot;abstract&quot;:&quot;A small subset of heptamethine dyes (cyanine-7 or Cy7) share an intriguing characteristic: preferential tumor accumulation and retention. These dyes absorb in the near-infrared (NIR) region (above 750 nm) and perform active targeting to deliver therapeutic and toxic cargoes to various tumor models in vivo. In this work, four heptamethines 1 were synthesized, which have a gemcitabine fragment attached to the meso-position of the Cy7 core. Theranostic agent 1a was discovered that localized in glioblastoma tumor cells, has absorption maxima in NIR region, and showed similar therapeutic effect to gemcitabine but at one-third the molar dose.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01147&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01147" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01147&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01147" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01147&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01147" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01147&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01147&amp;href=/doi/10.1021/acs.jmedchem.9b01147" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01147" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01147" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01147%26sid%3Dliteratum%253Aachs%26pmid%3D31469566%26genre%3Darticle%26aulast%3DJiang%26date%3D2019%26atitle%3DCyanine%25E2%2580%2593Gemcitabine%2BConjugates%2Bas%2BTargeted%2BTheranostic%2BAgents%2Bfor%2BGlioblastoma%2BTumor%2BCells%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D20%26spage%3D9236%26epage%3D9245%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291685" title="Dyes and pigments">Dyes and pigments</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/jmcmar.2019.62.issue-20/20191024/jmcmar.2019.62.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0009.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A small subset of heptamethine dyes (cyanine-7 or Cy7) share an intriguing characteristic: preferential tumor accumulation and retention. These dyes absorb in the near-infrared (NIR) region (above 750 nm) and perform active targeting to deliver therapeutic and toxic cargoes to various tumor models in vivo. In this work, four heptamethines <b>1</b> were synthesized, which have a gemcitabine fragment attached to the <i>meso</i>-position of the Cy7 core. Theranostic agent <b>1a</b> was discovered that localized in glioblastoma tumor cells, has absorption maxima in NIR region, and showed similar therapeutic effect to gemcitabine but at one-third the molar dose.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glioblastoma multiforme (GBM) forms aggressive malignant tumors, and patients with this disease have a 5-year survival rate of only 5.1%.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There are only four FDA approved drugs for brain tumor therapy: temozolomide (TMZ, 2005),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> lomustine, carmustine, and bevacizumab (2017).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Combination of TMZ and radiotherapy is the standard of care for GBM, but more effective therapies need to be established since the median survival is 14.6 months, and this requires new strategies to generate preclinical leads.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a></div><div class="NLM_p">Gemcitabine (dFdC, or <b>gem</b>) acts against a wide range of solid tumors (FDA approved for breast, non-small-cell lung, ovarian, and pancreatic).<a onclick="showRef(event, 'ref4 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref6">(4,6)</a> In cells, a triphosphate is formed from this nucleoside, i.e., dFdCTP, which is incorporated into DNA and hence acts as a chain-terminator. Simultaneously, the corresponding diphosphate (dFdCDP) inhibits ribonucleotide reductase (RNR) leading to more favorable gemcitabine/dCTP ratios in cells, improving gemcitabine’s efficacy. Nevertheless, the efficacy of gemcitabine could be improved, especially for GBM.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6−9)</a> Gemcitabine has been investigated in preclinical and clinical studies for GBM,<a onclick="showRef(event, 'ref4 ref9'); return false;" href="javascript:void(0);" class="ref ref4 ref9">(4,9)</a> but the therapeutic response tends to be relatively poor for several reasons.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> First, penetration through the blood–brain barrier (BBB) is low, even in the brain-tumor-bearing animals where the BBB may be leaky.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Second, gemcitabine has a short half-life due to enzyme metabolism.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Third, gemcitabine is not actively targeted<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> to tumors versus healthy tissue.</div><div class="NLM_p">A small set of heptamethine cyanine dyes localize in tumors (MHI-148, <b>A</b>; IR-783, <b>B</b>; DZ-1, <b>C</b>; and IR-780, <b>D</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18">(13−18)</a> The literature on actively targeted<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> small molecule gemcitabine derivatives<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> features an example of a conjugate to one of these tumor-seeking fluorophores (<b>C</b>) tested on GBM, i.e., NIRG, <b>E</b>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In mouse models, both <b>E</b> and its parent fluorophore <b>C</b> localized in intracranial GBM tissue and persisted there for over 24 h.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Background structures and compounds featured in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Conjugate <b>1a</b> comprises a Cy7 dye framework; a similar compound, <b>G</b>, but based on a Cy5 core, has been reported.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Conjugate <b>G</b> localized in tumors (from SGC7901 gastric carcinoma cells) and decreased their volume, but the decrease does not appear to have been compared to a gemcitabine control.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Conjugates such as these based on a Cy5 core (λ<sub>maxem</sub> ∼ 655 nm) are more difficult to observe in vivo than near-IR probes featured in this work. Overall, compound <b>G</b> is not especially relevant to the current study, though the structure is similar.</div><div class="NLM_p">Our work in this area began with an investigation of <i>meso</i>-Cl displacement in <b>A</b> with various nucleophiles,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> particularly albumin.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We found that a covalent adduct is formed between <b>A</b> and the free thiol of albumin Cys in PBS buffer at 37 °C. Albumin has a remarkably long half-life in vivo.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Thus, formation of an albumin adduct in serum after injection, and import of that via albumin receptors,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> which are overexpressed in cancer cells,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> explains persistence of <b>A</b> (and presumably <b>B</b>–<b>D</b>) in tumor tissue. These data are confirmed by the independent studies by Canovas et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> published simultaneously with ours. We estimate the in vivo half-life of <b>A</b> in the serum of a mouse is around 36 min.</div><div class="NLM_p last">All four fluorophores <b>A</b>–<b>D</b> that show the remarkable tumor-seeking effect described above have a <i>meso</i>-chloride. This led us to wonder if a gemcitabine conjugate formed by displacing this chloride, thereby rendering the conjugate unable to form a covalent complex with albumin, would also localize into tumors in vivo and, if so, if it would persist there. To test these ideas, the <i>meso</i>-gemcitabine adducts <b>1</b> were designed. We hypothesized these conjugates would localize in cultured glioblastoma cancer cells if the chloride was not important for short-term uptake, but unlike <b>A</b>, they would not persist in tumors in vivo for long periods because they cannot form covalent adducts with albumin. Consequently, we set out to test if these assertions were true and to simultaneously probe therapeutic effects of <b>1</b> in a mouse subcutaneous xenograft model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Syntheses, ex Vivo Stabilities, and Cellular Studies</h3><div class="NLM_p">Conjugates <b>1a</b>–<b>d</b> were prepared by substitution of the <i>meso</i>-Cl in their parent heptamethine cyanine dyes <b>A</b>–<b>D</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> using the gemcitabine derivative <b>F</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">S1</a>) as nucleophile. Parent dyes <b>A</b>–<b>D</b> and their corresponding conjugates <b>1a</b>–<b>d</b> showed similar fluorescence quantum yields and UV absorption characteristics (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Table S1 and Figure S1</a>); consequently, they have maximal absorbance at good wavelengths, around 795 nm, and sufficient brightness for in vivo diagnostic imaging.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Conjugates <b>1a</b>–<b>d</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Literature evidence indicates gemcitabine modifications at the exocyclic amine group do not adversely reduce its cytotoxicity.<a onclick="showRef(event, 'ref6 ref30'); return false;" href="javascript:void(0);" class="ref ref6 ref30">(6,30)</a> To verify this in the current study, we measured the cytotoxicities of gemcitabine and intermediate <b>F</b> with respect to U87 glioblastoma cells. The data obtained in these experiments were very similar (IC<sub>50</sub>: <b>gem</b>, 8.2 ± 1.7; <b>F</b>, 11.0 ± 1.4 nM; <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S7a</a>) indicating that formation of the conjugate did not significantly impact the efficacy of the gemcitabine component.</div><div class="NLM_p">Several experiments were undertaken to test the stabilities of an illustrative conjugate, <b>1a</b>, when incubated in physiological media. Thus, U87 tumor tissue from control mice (featured in the in vivo experiments described below) was cut into small pieces, homogenized (1 g of tumor per mL of RIPA buffer), then mixed with <b>1a</b>; the stability of <b>1a</b> was followed by analytical HPLC using detection at 780 nm corresponding to the fluorophore absorption maxima. Under these conditions the compound had a half-life of around 60 h at 37 °C (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). The half-life of <b>1a</b> was even longer when it was incubated with tumor cell lysate (4 million cells lysed with 1 mL RIPA buffer). These data imply <b>1a</b> in the tumor may persist in a conjugated form for several hours.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Conjugate stability of <b>1a</b> in physiological conditions. Tumor tissue or cultured U87 cells were homogenized with RIPA buffer on ice before centrifuging to collect supernatant. Conjugates were incubated at 50 μM at 37 °C for up to 72 h. The % compound remaining was calculated based on area under curve from the analytical HPLC trace through a C4 column (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S4</a>). (a) Conjugate stability of <b>1a</b> in U87 tumor homogenate and U87 cell lysate. (b) In serum in vitro at 37 °C, conjugate <b>1a</b> was metabolized to a new compound in ∼3 h. (c) The half-life of <b>1a</b> in mouse serum at 37 °C was determined to be ∼1 h. Compound <b>5</b> was identified as <b>1a</b> metabolite by mass spectrometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The connection between experiments featuring cell lysates and tumor homogenates to pharmacokinetics is tenuous, but in vitro stability tests in serum at 37 °C probably have more physiological relevance. These experiments show that the conjugate was metabolized to a new compound in 3 h with relatively high fidelity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b), via a process that was inhibited by a mixture of proteases and phosphatases (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S5b</a>) and was also inhibited at lower temperature (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S5c</a>). Mass spectrometric analyses (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S6b</a>) showed the metabolite had a molecular mass corresponding to the amide hydrolysis product <b>5</b>. That assertion was proven by HPLC analyses involving “spiking” the metabolite mixture with synthesized compound <b>5</b> and checking coelution (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S6c</a>). Thus, the amide bond in <b>1</b> that connects gemcitabine to the rest of the conjugate is vulnerable to proteolysis in serum in vitro giving it a half-life of approximately 1 h at 37 °C (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c).</div><div class="NLM_p">Overall, we concluded that short-term intracellular confocal imaging experiments featuring compounds <b>1a</b>–<b>d</b> would be indicative of intracellular localization of the conjugates and not simply track free fluorophore liberated from the nucleoside. Data collected from confocal imaging of <b>1a</b> is illustrative of that obtained for all the samples in the series <b>1a</b>–<b>d</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">S2</a>). Throughout, colocalization in the lysosome and mitochondria was uniformly observed (just as for the parent dyes <b>A</b>–<b>D</b>: <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S3</a>) except for <b>1c</b>, which gave no detectable accumulation in the mitochondria. Mitochondrial localization and, by inference, escape from the lysosome, probably enhances cytotoxicity, so conjugates <b>1a</b>, <b>1b</b>, and <b>1d</b> only were considered beyond this point, and <b>1c</b> was excluded because it did not appear to escape from the lysosome.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conjugate <b>1a</b> uptake and subcellular localization in U87 cells at 37 °C. Pearson’s correlation coefficient (PCC) for colocalization between red (<b>1a</b>) and green (organelle stain) fluorescence was 0.74 with mitochondria and 0.62 with lysosomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cytotoxicity data for <b>1a</b>, <b>1b</b>, and <b>1d</b> were measured, and comparisons were made with reference compounds <b>2a</b>, <b>2b</b>, and <b>2d</b> which were specifically prepared for this purpose (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Scheme S2</a>). Conjugates <b>2</b> feature the same dye as the key compounds <b>1</b>, but the nucleoside cargo, cytidine, is innocuous.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0010.gif" alt="" id="fx1" /></img></div><div class="NLM_p">Cytotoxicity data for the gemcitabine-derivative <b>1d</b> relative to its cytidine control <b>2d</b> led us to exclude this compound from further studies for the following reasons. Both the free dye <b>D</b> and the control <b>2d</b> are cytotoxic at <10 μM, whereas none of the other dyes <b>A</b>–<b>C</b> are at these levels (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figures S7b</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). Moreover, compounds <b>1a</b> and <b>1b</b> proved to be significantly more toxic than their parent dyes <b>A</b> and <b>B</b>, and their cytidine-based controls <b>2a</b> and <b>2b</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>c). Conjugates <b>1a</b> and <b>1b</b> were less cytotoxic than gemcitabine, but the difference was not great because all three of those compounds were observed to have IC<sub>50</sub> values in the 0.01–0.02 μM range. The cytotoxicity of gemcitabine on U87 cells has some variance (about 0.01–0.5 μM)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and often stabilizes at certain values before 100% apparent cell death;<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> consequently, for the purposes of this study, the IC<sub>50</sub> values quoted throughout are calibrated relative to the lowest concentration beyond which no further cell death appears to occur. On the basis of these data either compound <b>1a</b> or <b>1b</b> could have been selected for in vivo studies; conjugate <b>1a</b> was in fact chosen because there is literature<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> that indicates <b>A</b> has a superior tumor-to-muscle imaging contrast index relative to <b>B</b>. To further validate the therapeutic effect of conjugate <b>1a</b> in vitro, cytotoxicity measurements on other glioblastoma cells (LN18, LN229) as well as control cells (HEK293) were conducted (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S8</a>). The results indicate enhanced cytotoxicity of <b>1a</b> on glioblastoma cells compared to control cells.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cytotoxicity of conjugates <b>1</b>, their cytidine analogs <b>2</b>, and their parent dyes. (a) Compounds <b>2d</b> and <b>D</b> were shown to be significantly toxic below 10 μM (IC<sub>50</sub>: <b>2d</b>, 3.4 ± 0.4; <b>D</b>, 7.1 ± 1.7 μM). Conversely, in the sets <b>1a</b>, <b>2a</b>, and <b>A</b>, and <b>1b</b>, <b>2b</b>, and <b>B</b>, gemcitabine and compounds <b>1</b> are significantly more cytotoxic than the controls <b>2</b> and the free dyes (parts b and c, respectively). IC<sub>50</sub> values are the following: <b>gem</b>, 8.2 ± 1.7; <b>1a</b>, 20.9 ± 5.0; <b>1b</b>, 20.7 ± 3.2 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> In Vivo Studies</h3><div class="NLM_p">A xenograft mouse model was used to examine the effects of lead compound <b>1a</b> on tumor growth in vivo. U87 glioma cells stably expressing luciferase and RFP reporters (U87-luc-RFP) were injected subcutaneously into the flanks of Fox1<sup>nu</sup> mice. In the key experiments, the test compound (<b>1a</b> or <b>gem</b>, 10 mg/kg) or vehicle control was administered intravenously via retro-orbital vein at days 4 and 8 after tumor inoculation and then weekly for a total of six injections. No significant body weight loss was observed among mice in all treatment groups (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S11</a>). Tumor burden was evaluated using weekly bioluminescent imaging of mice 1–5 weeks after drug or vehicle administration. Administration of <b>1a</b> or <b>gem</b> significantly reduced tumor burden (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). There was no significant difference in tumor size in mice injected with <b>gem</b> or <b>1a</b> on mg/kg basis, but in terms of moles of drugs delivered, <b>1a</b> afforded the similar effect at under a third of the dose of <b>gem</b> (molecular weight of <b>1a</b>, 1034.6, is 3.45 greater than that of gemcitabine hydrochloride, 299.66).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Therapeutic effect of <b>1a</b>. (a) Luminescence images of mice harboring U87-RFP-Luc subcutaneuous tumors and treated with indicated compounds were acquired with an IVIS Spectrum in vivo imaging system (PerkinElmer) at 2 and 5 weeks after drug administration. (b) Mean tumor size (cm<sup>2</sup>) with SEM over a 5-week period after drug administration (<i>n</i> = 3). Two-way ANOVA with Bonferroni posttest shows statistically significant differences between <b>1a</b> or <b>gem</b> compared with vehicle control group at 4 weeks (**<i>p</i> < 0.01) and 5 weeks (***<i>p</i> < 0.001). (c) Mean tumor luminescence (photons per second, p/s) with SEM over a week period (<i>n</i> = 3). Two-way ANOVA with Bonferroni posttest shows statistically significant differences between <b>1a</b> or <b>gem</b> and the vehicle group at 5 weeks (<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Localization of <b>1a</b> in vivo was monitored by fluorescence imaging of tumor-bearing mice at different times postinjection. Cyanine fluorescence was observed throughout the mice 30 min after drug injection, with maximal signal in the liver and tumor, and at the site of injection (retro-orbital vein; <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a, mice 1–4). Conjugate <b>1a</b> mostly cleared from the mouse after 24 h (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a); imaging at 48 h after drug injection revealed residual <b>1a</b> fluorescence signal that was ∼10-fold lower than the signal observed at 30 min postinjection and ∼100-fold lower at 144 h (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Localization/clearance of <b>1a</b> in vivo. (a) Mice were injected with 10 mg/kg <b>1a</b> with an uninjected control (last mouse in each view). Images were taken at 0.5, 1, 2, 24, 48, and 144 h after intravenous injection, and their fluorescence intensities are normalized to be on the same scale. (b) Images at 10× lower scale show persistence of fluorescence in <b>1a</b>-treated mice, indicating residual drug localization over extended periods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Tumor tissue and organs of the mice injected with <b>1a</b> were dissected and imaged to further visualize the localization of the drug conjugated to the fluorescent dye. One of the <b>1a</b>-treated mice was analyzed 2 h after intravenous injection; the fluorophore had localized to the tumor as well as the intestines, kidneys, liver, and lungs (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a). Two days after injecting <b>1a</b>, some signal was still detected in the tumor, and significant signal was also observed in the liver and kidneys (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">S10c</a>).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Localization of <b>1a</b> post-mortem via fluorescence imaging on tissues: (a) dissected 2 h after intravenous injection of <b>1a</b>; (b) removed from <b>1a</b>-, <b>gem</b>-, and vehicle-injected mice 2 d after intravenous injection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Data presented above indicate that the conjugate <b>1a</b> hydrolyzes with a half-life of approximately 1 h in serum at 37 °C to give free gemcitabine and fluorophore <b>5</b>. However, fluorescence in the tumor implant is near maximal around 30 min after intravenous injection, indicating that some of conjugate <b>1a</b> is imported into tumor cells in vivo. This assertion is consistent with the observation that the molar efficacy of the conjugate is significantly greater than gemcitabine with respect to reduction of tumor burden in these models. Conjugate <b>1a</b> is cleared from the tumor more quickly than <b>E</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and other fluorophores like MHI-148 that feature a <i>meso</i>-Cl,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> consistent with our original hypothesis.</div><div class="NLM_p">In related studies, we<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and others<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> have found Cy7 dyes with a <i>meso</i>-chloride react with albumin (<i>t</i><sub>1/2</sub> ∼ 30 min at 37 °C) to give a covalent adduct. Displacement of <i>meso</i>-chloride is impossible for conjugates <b>1</b> and <b>G</b> (no <i>meso</i>-Cl). In previous work we have shown that dyes in this series that have a <i>meso</i>-chloride can form conjugates with serum albumin, and the albumin adducts persist in tumors for extended periods.<a onclick="showRef(event, 'ref24 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref29">(24,29)</a> Thus, the presence of a <i>meso</i>-Cl, covalent albumin binding or not, manifests itself in this study by the residence time of the fluorophore in the tumor.</div><div class="NLM_p last">Overall, it is advantageous to conjugate gemcitabine with tumor seeking dyes like <b>A</b> at <i>meso</i>-position if relatively quick clearance is important to reduce the off-target effect and toxicity to normal organs, and this approach was shown here to give greater molar efficacy of <b>1a</b> relative to gemcitabine. Alternatively, if the goal is to increase the residency time in tumors, then a better strategy might be via conjugates like <b>E</b> that we suggest form covalent adducts with albumin in serum.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General Experimental Procedure</h3><div class="NLM_p">All reactions were carried out under an inert atmosphere (nitrogen, or argon where stated) with dry solvents under anhydrous conditions. Glassware for anhydrous reactions was dried in an oven at 140 °C for minimum 6 h prior to use. Dry solvents were obtained by passing the previously degassed solvents through activated alumina columns. Reagents were purchased at a high commercial quality (typically 97% or higher) and used without further purification unless otherwise stated.</div><div class="NLM_p">Flash chromatography was performed using silica gel (230–400 mesh). Analytical thin layer chromatography (TLC) was carried out on Silicycle silica gel plates and visualized by UV, ninhydrin, <i>para</i>-methoxybenzaldehyde, and/or potassium permanganate stain. A reversed phase column on preparation high performance liquid chromatography (prepHPLC) was also applied to purify compounds in 10–90% MeCN/water gradient with 0.1% trifluoroacetic acid over 20 min. The purity of the compounds <b>1a</b>–<b>d</b> and <b>2a</b>,<b>c</b>,<b>d</b> were confirmed by LC/MS, in 10–90% MeCN/water gradient with 0.1% formic acid over 10 min. LC traces at 254 nm are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Supporting Information.</a> All the compounds had ≥95% purity.</div><div class="NLM_p">High field NMR spectra were recorded with Bruker Avance III at 400 MHz for <sup>1</sup>H and at 101 MHz for <sup>13</sup>C for all compounds except for compound <b>5</b>. NMR spectra of <b>5</b> were taken with Bruker Avance 500 at 500 MHz for <sup>1</sup>H and 126 MHz for <sup>13</sup>C. All spectra were calibrated using residual nondeuterated solvent as an internal reference (CDCl<sub>3</sub>, <sup>1</sup>H NMR = 7.24, <sup>13</sup>C NMR = 77.0; MeOD-<i>d</i><sub>4</sub>, <sup>1</sup>H NMR = 3.30, <sup>13</sup>C NMR = 49.0; DMSO-<i>d</i><sub>6</sub>, <sup>1</sup>H NMR = 2.50, <sup>13</sup>C NMR = 39.5). The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, dd = double doublet, dt = double triplet, dq = double quartet, m = multiplet, br = broad. All statistical analyses were carried out by GraphPad Prism 6.0 (GraphPad Software). Results are represented as the mean ± SD.</div><div class="NLM_p last">Electrospray ionization mass spectrometry (ESI-MS) data were collected on triple-stage quadrupole instrument in a positive mode. Paper spray mass spectrometry data were obtained with LTQ XL mass spectrometer (Thermo Fisher Scientific, San Jose, CA). Instrumental conditions used for the positive-mode mass spectrometry is specified as the following: paper spray voltage, 3.5 kV; heated-capillary temperature, 275 °C; heated-capillary voltage, 33 V; tube lens voltage, 65 V. Both the full-scan and tandem mass spectra were acquired, and the corresponding <i>m</i>/<i>z</i> values confirmed the structure of each species. The qualitative filter paper was purchased from VWR (catalog no. 28310-026). Paper was cut into an isosceles triangle shape with 10 mm height and 5 mm base. A copper clip was employed as both the paper holder and the spray voltage conductor. The distance from the paper tip to the mass spectrometer inlet was kept to be 5 mm.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cell Culture</h3><div class="NLM_p last">LN18 and LN229 cells were cultured on 75 cm<sup>2</sup> tissue culture flasks in Dulbecco’s modified Eagle medium (DMEM, ATCC) supplement with 5% fetal bovine serum (FBS). HEK293 and U87 cells were cultured on 75 cm<sup>2</sup> tissue culture flasks in Dulbecco’s modified Eagle medium/nutrient mixture F-12 Ham (DMEM/F12, Millipore Sigma) supplement with 10% fetal bovine serum (FBS). All cells were cultured in a humidified incubator at 37 °C with 5% CO<sub>2</sub> and 95% air.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound Syntheses and Characterization. <i>N</i>-(1-((2<i>R</i>,4<i>R</i>,5<i>R</i>)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-3-mercaptopropanamide (<b>F</b>)</h3><div class="NLM_p last">Compound <b>F</b> was prepared via the protocol previously published.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Briefly, 2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate (TBTU, 1.2 g, 1.2 equiv) and compound <b>H</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (1.1 g, 3.0 mmol, 1.0 equiv) were dissolved in <i>N</i>,<i>N</i>-dimethylformamide (DMF, 0.3 M) in an ice bath, and gemcitabine hydrochloride (0.90 g, 3.0 mmol, 1.0 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (<sup><i>i</i></sup>Pr<sub>2</sub>NEt, 1.1 mL, 2.0 equiv) were then added to the reaction mixture. The mixture was stirred at room temperature for 18 h. Product was purified via flash chromatography (2–5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) with 63% yield (1.1 g). Protecting group of the thiol in the product (0.59 g, 1.0 mmol) was then removed under acidic conditions in 1:3 (v/v) trifluoroacetic acid (TFA)/CH<sub>2</sub>Cl<sub>2</sub> (0.2 M) on ice for 1 h, with triethylsilane (Et<sub>3</sub>SiH, 0.39 mL, 2.4 equiv) as scavenger. After removal of the solvents, the mixture was washed with diethyl ether 5 mL × 2 to get compound <b>F</b> (0.36 g as 1.0 equiv TFA salt, 80% yield). <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.17 (d, <i>J</i> = 7.9 Hz, 1H), 6.28 (t, <i>J</i> = 8.1 Hz, 1H), 6.16 (d, <i>J</i> = 7.9 Hz, 1H), 5.50 (dt, <i>J</i> = 13.5, 6.9 Hz, 1H), 4.27 (dd, <i>J</i> = 6.7, 3.1 Hz, 1H), 3.95 (d, <i>J</i> = 11.1 Hz, 1H), 3.80 (dd, <i>J</i> = 12.8, 3.2 Hz, 1H), 2.85–2.72 (m, 4H). <sup>13</sup>C NMR (101 MHz, MeOD) δ 171.66, 145.40, 130.47, 129.25, 127.29, 122.73, 95.82, 81.80, 71.07 (dd, <i>J</i> = 31.8, 16.8 Hz), 60.57, 38.94, 20.00. 162.29, 85.88 (dd, <i>J</i> = 40.0, 22.0 Hz) from TFA, 66.87, 15.41 from Et<sub>2</sub>O.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Syntheses of <b>1a</b>–<b>d</b></h3><div class="NLM_p last">Compounds <b>B</b> (no. 543292, Sigma-Aldrich) and <b>D</b> (no. AB332015, abcr GmbH) were commercially available, and compounds <b>A</b> and <b>C</b> were prepared by the protocol previously described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> As shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, equal equivalents of compound <b>F</b> and representative free heptamethine dyes <b>A</b>–<b>D</b> were dissolved in DMF (0.06 M), followed by 2.0 equiv of triethylamine (Et<sub>3</sub>N) and stirred at 25 °C for 6 h. Solvent was removed in vacuum, and compound was purified via prepHPLC and lyophilized to get <b>1a</b>–<b>d</b> (30–40% yield).</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 1-(5-Carboxypentyl)-2-((<i>E</i>)-2-((<i>E</i>)-3-(2-((<i>E</i>)-1-(5-carboxypentyl)-3,3-dimethylindolin-2-ylidene)ethylidene)-2-((3-((1-((2<i>R</i>,4<i>R</i>,5<i>R</i>)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-3-oxopropyl)thio)cyclohex-1-en-1-yl)vinyl)-3,3-dimethyl-3<i>H</i>-indol-1-ium (<b>1a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.66 (s, 2H), 8.24 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (d, <i>J</i> = 7.4 Hz, 2H), 7.46–7.37 (m, 6H), 7.30–7.20 (m, 3H), 6.34–6.23 (m, 1H), 6.19–6.08 (m, 1H), 4.23–4.10 (m, 6H), 3.95–3.85 (m, 1H), 3.85–3.71 (m, 1H), 3.71–3.59 (m, 1H), 3.10–3.02 (m, 2H), 2.78 (t, <i>J</i> = 6.5 Hz, 2H), 2.70–2.59 (m, 4H), 2.30 (t, <i>J</i> = 7.3 Hz, 1H), 2.21 (t, <i>J</i> = 7.3 Hz, 4H), 1.92–1.80 (m, 2H), 1.77–1.51 (m, 22H), 1.46–1.35 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 174.22, 171.69, 171.64, 162.65, 154.87, 154.01, 144.53, 142.13, 140.83, 132.92, 128.51, 124.80, 122.34, 111.16, 95.93, 94.56, 81.09, 58.87, 58.78, 48.70, 43.48, 36.70, 33.45, 33.05, 31.72, 27.41, 27.36, 27.33, 26.58, 25.66, 24.12, 24.06, 20.37. Measured M<sup>+</sup> (C<sub>54</sub>H<sub>66</sub>F<sub>2</sub>N<sub>5</sub>O<sub>9</sub>S<sup>+</sup>) (<i>m</i>/<i>z</i>): 998.4531. Calculated M<sup>+</sup>: 998.4544 (1.3 ppm).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 2-((<i>E</i>)-2-((<i>E</i>)-2-(3-(1-((2<i>R</i>,4<i>R</i>,5<i>R</i>)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-ylamino)-3-oxopropylthio)-3-((<i>E</i>)-2-(3,3-dimethyl-1-(4-sulfobutyl)indolin-2-ylidene)ethylidene)cyclohex-1-enyl)vinyl)-3,3-dimethyl-1-(4-sulfobutyl)-3<i>H</i>-indolium (<b>1b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 9.99 (s, 1H), 8.99 (s, 1H), 8.74–8.62 (m, 2H), 8.26 (d, <i>J</i> = 7.6 Hz, 1H), 8.16 (d, <i>J</i> = 7.9 Hz, 1H), 7.72–7.61 (m, 1H), 7.57 (dd, <i>J</i> = 15.2, 7.3 Hz, 2H), 7.47–7.35 (m, 3H), 7.32–7.20 (m, 2H), 6.34 (dd, <i>J</i> = 14.2, 6.2 Hz, 2H), 6.26 (d, <i>J</i> = 7.9 Hz, 1H), 6.18–6.03 (m, 1H), 4.27–4.12 (m, 5H), 3.96–3.85 (m, 1H), 3.80 (d, <i>J</i> = 12.7 Hz, 1H), 3.65 (dd, <i>J</i> = 12.8, 3.3 Hz, 1H), 3.17 (s, 1H), 3.08 (t, <i>J</i> = 6.4 Hz, 1H), 2.99 (t, <i>J</i> = 6.8 Hz, 1H), 2.78 (t, <i>J</i> = 6.5 Hz, 1H), 2.72–2.52 (m, 8H), 1.89–1.71 (m, 12H), 1.71–1.55 (m, 12H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 172.22, 171.72, 171.65, 162.66, 159.27, 154.89, 154.00, 146.77, 144.78, 142.18, 140.91, 140.85, 133.09, 128.51, 124.74, 122.28, 111.29, 101.32, 95.99, 94.76, 58.78, 58.71, 50.68, 48.74, 48.71, 48.56, 43.58, 27.42, 25.97, 25.75, 22.38. Measured M<sup>+</sup> (C<sub>50</sub>H<sub>62</sub>F<sub>2</sub>N<sub>5</sub>O<sub>11</sub>S<sub>3</sub><sup>+</sup>) (<i>m</i>/<i>z</i>): 1042.3564. Calculated M<sup>+</sup>: 1042.3571 (0.7 ppm).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-((<i>E</i>)-2-((<i>E</i>)-3-((<i>E</i>)-2-(1-(5-Carboxypentyl)-3,3-dimethylindolin-2-ylidene)ethylidene)-2-(3-(1-((2<i>R</i>,4<i>R</i>,5<i>R</i>)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-ylamino)-3-oxopropylthio)cyclohex-1-enyl)vinyl)-3,3-dimethyl-1-(4-sulfobutyl)-3<i>H</i>-indolium (<b>1c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.70 (d, <i>J</i> = 14.2 Hz, 1H), 8.63 (d, <i>J</i> = 14.0 Hz, 1H), 8.24 (d, <i>J</i> = 7.6 Hz, 1H), 7.55 (dd, <i>J</i> = 10.2, 7.6 Hz, 2H), 7.49–7.33 (m, 5H), 7.29–7.20 (m, 4H), 6.38 (d, <i>J</i> = 14.3 Hz, 1H), 6.25 (d, <i>J</i> = 14.1 Hz, 1H), 6.14 (t, <i>J</i> = 7.5 Hz, 1H), 4.25–4.10 (m, 5H), 3.91–3.86 (m, 1H), 3.80 (d, <i>J</i> = 11.4 Hz, 2H), 3.67 (d, <i>J</i> = 3.5 Hz, 1H), 3.64 (d, <i>J</i> = 3.5 Hz, 1H), 3.08 (t, <i>J</i> = 6.5 Hz, 2H), 2.78 (t, <i>J</i> = 6.5 Hz, 2H), 2.70–2.60 (m, 4H), 2.54 (d, <i>J</i> = 7.2 Hz, 2H), 2.21 (t, <i>J</i> = 7.3 Hz, 2H), 2.06 (s, 1H), 1.90–1.79 (m, 4H), 1.79–1.68 (m, 4H), 1.67–1.62 (m, 12H), 1.62–1.53 (m, 2H), 1.45–1.35 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 174.31, 172.32, 171.71, 171.12, 162.73, 154.94, 154.11, 145.28, 144.86, 144.07, 142.27, 142.10, 141.01, 140.75, 133.52, 132.69, 128.61, 128.52, 125.47, 125.06, 124.57, 122.90, 122.34, 118.01, 117.22, 111.53, 110.96, 101.87, 100.75, 96.05, 81.14, 68.45, 58.83, 50.65, 48.92, 48.60, 43.80, 43.38, 36.83, 33.51, 31.77, 27.54, 27.49, 27.42, 27.37, 26.57, 26.05, 25.79, 25.71, 24.18, 22.49, 20.47. Measured M<sup>+</sup> (C<sub>52</sub>H<sub>64</sub>F<sub>2</sub>N<sub>5</sub>O<sub>10</sub>S<sub>2</sub><sup>+</sup>) (<i>m</i>/<i>z</i>): 1020.4040. Calculated M<sup>+</sup>: 1020.4057 (1.7 ppm).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-((<i>E</i>)-2-((<i>E</i>)-2-((3-((1-((2<i>R</i>,4<i>R</i>,5<i>R</i>)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-3-oxopropyl)thio)-3-(2-((<i>E</i>)-3,3-dimethyl-1-propylindolin-2-ylidene)ethylidene)cyclohex-1-en-1-yl)vinyl)-3,3-dimethyl-1-propyl-3<i>H</i>-indol-1-ium (<b>1d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.71–8.63 (m, 2H), 8.24 (d, <i>J</i> = 7.6 Hz, 1H), 7.57 (d, <i>J</i> = 7.4 Hz, 2H), 7.47–7.37 (m, 4H), 7.31–7.20 (m, 3H), 6.39–6.25 (m, 2H), 6.14 (t, <i>J</i> = 7.5 Hz, 1H), 4.24–4.10 (m, 6H), 3.94–3.60 (m, 4H), 3.07 (t, <i>J</i> = 6.6 Hz, 2H), 2.77 (t, <i>J</i> = 6.5 Hz, 2H), 2.64 (t, <i>J</i> = 5.6 Hz, 4H), 1.89–1.60 (m, 19H), 1.00–0.92 (m, 6H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 171.91, 171.88, 171.62, 162.65, 154.83, 154.01, 144.83, 144.59, 142.27, 140.80, 132.93, 128.49, 124.78, 122.83, 122.34, 111.24, 101.24, 95.91, 81.12, 68.44, 58.78, 48.74, 44.93, 36.70, 31.63, 27.46, 27.40, 25.73, 20.36, 11.05. Measured M<sup>+</sup> (C<sub>48</sub>H<sub>58</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub>S <sup>+</sup>) (<i>m</i>/<i>z</i>): 854.4091. Calculated M<sup>+</sup>: 854.4121 (3.5 ppm).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Syntheses of <b>2a</b>,<b>b</b>,<b>d</b></h3><div class="NLM_p">Compounds <b>2a</b>,<b>b</b>,<b>d</b> were prepared in the same way as for compounds <b>1</b> described above (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Scheme S2</a>). Briefly, TBTU (3.86 g, 1.2 equiv) and compound <b>H</b> (3.49 g, 1.0 equiv) were dissolved in DMF (0.3 M) in an ice bath. 2′-Deoxycytidine (2.27 g, 10.0 mmol, 1.0 equiv) and <sup><i>i</i></sup>Pr<sub>2</sub>NEt (2.10 mL, 1.2 equiv) were then added to the reaction mixture, and the mixture was stirred at room temperature for 18 h. Product compound <b>3</b> was purified via flash chromatography (2–4% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) with 22% yield (1.20 g). Protecting group of the thiol in <b>3</b> was then removed under acidic conditions in 1:3 (v/v) TFA/CH<sub>2</sub>Cl<sub>2</sub> (0.2 M) on ice for 1 h, with Et<sub>3</sub>SiH (2.4 equiv) as scavenger. After removal of the solvents, the sample was washed with diethyl ether 5 mL × 2 to get compound <b>4</b> (quantitative).</div><div class="NLM_p last">Then equal equivalents of compound <b>4</b> and representative free heptamethine dye <b>A</b>, <b>B</b>, or <b>D</b> were dissolved in DMF (0.06 M), followed by 2.0 equiv of Et<sub>3</sub>N, and the mixture was stirred at 25 °C for 6 h. Solvent was removed in vacuum, and compound was purified via prep-HPLC and lyophilized to get <b>2a</b>, <b>2b</b>, or <b>2d</b> (30–40% yield).</div></div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 1-(5-Carboxypentyl)-2-((<i>E</i>)-2-((<i>E</i>)-3-(2-((<i>E</i>)-1-(5-carboxypentyl)-3,3-dimethylindolin-2-ylidene)ethylidene)-2-((3-((1-((2<i>R</i>,4<i>S</i>,5<i>R</i>)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-3-oxopropyl)thio)cyclohex-1-en-1-yl)vinyl)-3,3-dimethyl-3<i>H</i>-indol-1-ium (<b>2a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.67 (d, <i>J</i> = 14.0 Hz, 2H), 8.37 (d, <i>J</i> = 7.5 Hz, 1H), 7.57 (d, <i>J</i> = 7.4 Hz, 2H), 7.46–7.36 (m, 5H), 7.31–7.21 (m, 2H), 7.18 (d, <i>J</i> = 7.5 Hz, 1H), 6.29 (d, <i>J</i> = 14.2 Hz, 2H), 6.07 (t, <i>J</i> = 6.3 Hz, 1H), 4.27–4.10 (m, 5H), 3.90–3.82 (m, 1H), 3.58 (qd, <i>J</i> = 12.0, 3.8 Hz, 1H), 3.06 (t, <i>J</i> = 6.4 Hz, 2H), 2.76 (t, <i>J</i> = 6.2 Hz, 2H), 2.69–2.59 (m, 4H), 2.31–2.15 (m, 5H), 1.99–1.80 (m, 3H), 1.78–1.35 (m, 28H), 1.27–1.18 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 174.20, 171.74, 171.43, 161.93, 154.85, 154.09, 145.18, 144.62, 142.13, 140.85, 133.01, 128.51, 124.79, 122.37, 111.18, 101.23, 95.34, 87.99, 86.20, 69.92, 60.87, 48.75, 43.51, 40.89, 36.63, 33.51, 31.84, 27.42, 26.60, 25.73, 25.68, 24.15, 20.40. Measured M<sup>+</sup> (C<sub>54</sub>H<sub>68</sub>N<sub>5</sub>O<sub>9</sub>S<sup>+</sup>) (<i>m</i>/<i>z</i>): 962.4721. Calculated M<sup>+</sup>: 962.4732 (1.1 ppm).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-((<i>E</i>)-2-((<i>E</i>)-3-((<i>E</i>)-2-(3,3-Dimethyl-1-(4-sulfobutyl)indolin-2-ylidene)ethylidene)-2-(3-(1-((2<i>R</i>,4<i>S</i>,5<i>R</i>)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-ylamino)-3-oxopropylthio)cyclohex-1-enyl)vinyl)-3,3-dimethyl-1-(4-sulfobutyl)-3<i>H</i>-indolium (<b>2b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 9.73–9.54 (m, 1H), 8.89–8.67 (m, 4H), 8.23 (d, <i>J</i> = 7.9 Hz, 1H), 8.11–7.75 (m, 3H), 7.70–7.55 (m, 3H), 7.49–7.36 (m, 3H), 7.25 (t, <i>J</i> = 7.3 Hz, 2H), 6.35 (d, <i>J</i> = 14.2 Hz, 1H), 6.16 (d, <i>J</i> = 7.9 Hz, 1H), 6.10–5.98 (m, 1H), 4.29–4.13 (m, 4H), 3.85 (q, <i>J</i> = 3.4 Hz, 1H), 3.59 (dd, <i>J</i> = 9.5, 3.6 Hz, 1H), 2.99 (t, <i>J</i> = 6.8 Hz, 1H), 2.70–2.62 (m, 4H), 2.60–2.51 (m, 6H), 2.28–2.02 (m, 3H), 1.90–1.63 (m, 24H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 172.22, 171.73, 159.23, 154.82, 147.59, 146.87, 144.77, 144.41, 142.20, 140.90, 133.11, 128.51, 124.75, 122.34, 111.29, 101.39, 99.49, 93.75, 88.05, 85.82, 69.74, 60.74, 50.71, 48.74, 43.57, 40.43, 34.48, 27.43, 26.01, 25.70, 22.41. Measured M<sup>+</sup> (C<sub>50</sub>H<sub>64</sub>N<sub>5</sub>O<sub>11</sub>S<sub>3</sub><sup>+</sup>) 1006.3757 (<i>m</i>/<i>z</i>). Calculated M<sup>+</sup>: 1006.3759 (0.2 ppm).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-((<i>E</i>)-2-((<i>E</i>)-3-(2-((<i>E</i>)-3,3-Dimethyl-1-propylindolin-2-ylidene)ethylidene)-2-((3-((1-((2<i>R</i>,4<i>S</i>,5<i>R</i>)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-3-oxopropyl)thio)cyclohex-1-en-1-yl)vinyl)-3,3-dimethyl-1-propyl-3<i>H</i>-indol-1-ium (<b>2d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.98 (d, <i>J</i> = 16.3 Hz, 1H), 8.74–8.66 (m, 2H), 8.26 (d, <i>J</i> = 7.8 Hz, 1H), 7.73–7.66 (m, 1H), 7.60 (d, <i>J</i> = 7.4 Hz, 2H), 7.47–7.37 (m, 4H), 7.29–7.22 (m, 1H), 6.39–6.27 (m, 1H), 6.23 (d, <i>J</i> = 7.8 Hz, 1H), 6.07 (dd, <i>J</i> = 13.7, 6.9 Hz, 1H), 4.29–4.12 (m, 5H), 3.85 (dd, <i>J</i> = 7.1, 3.5 Hz, 1H), 3.59 (ddd, <i>J</i> = 21.8, 12.0, 3.7 Hz, 2H), 3.03–2.94 (m, 2H), 2.69–2.60 (m, 3H), 2.58–2.51 (m, 2H), 2.31–2.09 (m, 2H), 2.08 (s, 2H), 1.89–1.72 (m, 8H), 1.70–1.64 (m, 12H), 1.08–1.02 (m, 1H), 0.99–0.93 (m, 5H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 172.18, 171.99, 159.55, 154.82, 147.33, 146.69, 144.70, 142.30, 140.88, 132.94, 128.50, 124.80, 122.41, 111.28, 101.34, 93.69, 88.07, 85.82, 69.70, 60.68, 52.61, 48.80, 44.97, 34.49, 32.35, 30.63, 27.45, 25.79, 20.40, 11.09. Measured M<sup>+</sup> (C<sub>48</sub>H<sub>60</sub>N<sub>5</sub>O<sub>5</sub>S<sup>+</sup>) (<i>m</i>/<i>z</i>): 818.4293. Calculated M<sup>+</sup>: 818.4310 (2.1 ppm).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-(1-((2<i>R</i>,4<i>S</i>,5<i>R</i>)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-3-(tritylthio)propenamide (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.31 (d, <i>J</i> = 7.4 Hz, 1H), 7.40–7.28 (m, 12H), 7.28–7.21 (m, 3H), 7.15 (d, <i>J</i> = 7.5 Hz, 1H), 6.10 (t, <i>J</i> = 6.3 Hz, 1H), 5.20 (d, <i>J</i> = 15.2 Hz, 1H), 5.05–4.96 (m, 1H), 4.27–4.15 (m, 1H), 4.09–3.96 (m, 1H), 3.86 (q, <i>J</i> = 3.7 Hz, 1H), 3.66–3.50 (m, 2H), 3.28 (d, <i>J</i> = 9.5 Hz, 1H), 2.38–2.23 (m, 3H), 2.09–1.95 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 171.68, 161.89, 154.31, 145.01, 144.29, 129.01, 127.98, 126.69, 95.13, 87.79, 86.12, 69.78, 66.13, 60.79, 40.79, 35.18, 26.50.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-(1-((2<i>R</i>,4<i>S</i>,5<i>R</i>)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-3-mercaptopropanamide (<b>4</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.33 (d, <i>J</i> = 7.4 Hz, 1H), 7.84 (d, <i>J</i> = 7.0 Hz, 1H), 7.20 (d, <i>J</i> = 7.4 Hz, 1H), 7.09 (d, <i>J</i> = 7.0 Hz, 1H), 6.10 (t, <i>J</i> = 6.2 Hz, 1H), 4.31–4.15 (m, 1H), 3.86 (d, <i>J</i> = 3.5 Hz, 1H), 3.59 (qd, <i>J</i> = 11.9, 3.8 Hz, 2H), 2.86–2.62 (m, 5H), 2.38 (m, 1H), 2.34–2.22 (m, 1H), 2.08–1.90 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO) δ 172.01, 162.04, 154.30, 145.04, 95.25, 87.89, 86.15, 69.89, 60.91, 40.86, 40.35, 18.90. Measured M + H (<i>m</i>/<i>z</i>): 316.0963. Calculated M + H: 316.0962 (0.3 ppm).</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Preparation of 2-((<i>E</i>)-2-((<i>E</i>)-2-((2-Carboxyethyl)thio)-3-(2-((<i>E</i>)-1-(5-carboxypentyl)-3,3-dimethylindolin-2-ylidene)ethylidene)cyclohex-1-en-1-yl)vinyl)-1-(5-carboxypentyl)-3,3-dimethyl-3<i>H</i>-indol-1-ium (<b>5</b>)</h3><div class="NLM_p last">2.0 equiv of 3-mercaptopropionic acid and 1.0 equiv of heptamethine dye <b>A</b> were dissolved in DMF (0.1 M), followed by 3.0 equiv of Et<sub>3</sub>N, and the mixture was stirred at 25 °C for 6 h. Solvent was removed in vacuum, and compound was purified via prep-HPLC and lyophilized to get <b>5</b> (4.0 mg, 20% yield). <sup>1</sup>H NMR (500 MHz, DMSO) δ 8.71 (d, <i>J</i> = 14.1 Hz, 2H), 7.60 (d, <i>J</i> = 7.3 Hz, 2H), 7.45–7.38 (m, 4H), 7.29–7.23 (m, 2H), 6.30 (d, <i>J</i> = 14.2 Hz, 2H), 4.18 (t, <i>J</i> = 7.2 Hz, 4H), 2.99 (t, <i>J</i> = 6.9 Hz, 2H), 2.64 (t, <i>J</i> = 5.9 Hz, 4H), 2.55–2.51 (m, 2H), 2.24–2.13 (m, 4H), 1.88–1.80 (m, 2H), 1.77–1.71 (m, 4H), 1.70 (s, 12H), 1.62–1.53 (m, 5H), 1.45–1.34 (m, 4H), 1.25 (s, 2H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 174.29, 172.33, 171.86, 154.94, 144.75, 142.18, 141.58, 140.92, 135.35, 132.99, 128.55, 124.84, 122.44, 111.21, 101.29, 48.80, 43.50, 43.29, 33.52, 27.41, 26.64, 25.70, 24.18, 20.49. Measured M<sup>+</sup> (C<sub>45</sub>H<sub>57</sub>N<sub>2</sub>O<sub>6</sub>S<sup>+</sup>) (<i>m</i>/<i>z</i>): 753.3922. Calculated M<sup>+</sup>: 753.3932 (1.3 ppm).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Photophysical Properties of <b>1</b></h3><div class="NLM_p last">Compounds <b>1</b> were solubilized as DMSO stock solutions before diluting to 1 μM in PBS buffer. Absorbance and fluorescence spectra of each compound were measured at the same concentration first (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S1a</a>). The absorbance spectrum was taken with a Cary 100 Bio UV–visible spectrophotometer (absorbance region 500–900 nm, blank solvent as baseline), and the fluorescence spectrum was taken by Cary Eclipse fluorescence spectrophotometer (excited with 750 nm light and emission region of 780–900 nm, blank solvent as baseline). Extinction coefficient (ε) of compounds <b>1</b> were calculated based on Lambert–Beer’s law (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Table S1</a>). Different concentrations of each compound were then prepared with <i>A</i><sub>750</sub> lying in the range between 0.01 and 0.1 (<i>X</i> axis in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S1b</a>), and corresponding fluorescence spectrum was taken with area under curve calculated (<i>Y</i> axis in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S1b</a>). Fluorescence quantum yield (Φ, in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Table S1</a>) of each compound was then calculated based on the equation shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S1</a>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The brightness of each conjugate equals ε × Φ.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Subcellular Localization of Conjugates <b>1</b> and Dyes (<b>A</b>–<b>D</b>)</h3><div class="NLM_p">U87 cells were seeded in a 4-well imaging chamber (Lab-Tek no. 155383, ThermoFisher) as 10 000 per well and incubated at 37 °C overnight. 20 μM test compound (conjugates <b>1</b> or free dyes <b>A</b>–<b>D</b>) were prepared in FluoroBrite DMEM medium (ThermoFisher) and added to the imaging chamber after removing the original culture medium and incubated at 37 °C for 45 min. The medium was removed and cells were washed with Hank’s balanced salt solution (HBSS) buffer twice. Then cells were incubated with either LysoTracker (1:10 000 dilution, no. L5726, Invitrogen) or MitoTracker (1:15 000 dilution, no. M5714, Invitrogen) for 15 min at 37 °C before the HBSS wash. 0.5 mL of FluoroBrite DMEM medium was then added to the imaging chamber followed by 1 drop of NucBlue Live Cell Stain ReadyProbes reagent (no. R37605, Invitrogen). 5 min after incubation, the medium was removed and washed with HBSS buffer once, and fresh FluoroBrite DMEM medium was added.</div><div class="NLM_p last">All images were taken by a confocal fluorescence microscope (Olympus 1000) with 60× (water immerse, NA 1.20) objective, with excitation laser applied: 405 nm for nuclei stain, 488 nm for Lyso- or Mito-tracker, 633 nm for tested near-infrared dye or conjugate in the Microscopy and Imaging Center at Texas A&M University. Pearson’s correlation coefficient (PCC) was used to quantify colocalization of the tested fluorescent compound and stained organelle.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> PCC for the region of interest in each set of image was calculated by the Coloc 2 plug-in in Fiji software.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Solubility Determination of <b>1a</b></h3><div class="NLM_p">U87 cell lysate and tumor homogenate were prepared to check the conjugate <b>1a</b> stability. ∼2 g of U87 tumor tissue from a mouse model was cut into small pieces and incubated with 2 mL of RIPA buffer (no. 89901, Thermofisher) on ice for 15 min before being blended. The blended mixture was then centrifuged down, and the supernatant was taken out and filtered through a 0.2 μm mesh filter as the tumor homogenate. To generate U87 cell lysate, U87 cells were cultured in a 75 cm<sup>2</sup> tissue culture flask to 80% confluency. After removal of the culturing medium, cells were washed with 8 mL of cold PBS buffer twice and then incubated with 1 mL of RIPA buffer on ice for 25 min. Mixtures were scratched and transferred into a 1.5 mL Eppendorf tube and centrifuged down (12 500<i>g</i>, 4 °C, 20 min) to collect the supernatant as cell lysate. <b>1a</b> was prepared as 50 μM in U87 tumor homogenate or cell lysate and incubated at 37 °C for up to 72 h. At designed incubation time, 5 μL samples were injected to analytical C4 HPLC column (0.50 mL/min flow rate, 5% MeCN/95% water to 90% MeCN/10% water gradient with 0.1% TFA in 15 min), and traces of absorbance at 780 nm were collected (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S4</a>). Area under the curves for <b>1a</b> was normalized and plotted in GraphPad Prism 6.0 software (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_p last">Stability of <b>1a</b> in mouse serum was also tested in the same way by solubilizing <b>1a</b> in commercial mouse serum and checked traces of absorbance at 780 nm (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S5a</a>). Conjugate <b>1a</b> was metabolized generating a new compound with longer retention time. When protease and phosphatase inhibitor cocktail (no. 78440, Thermo Fisher) were premixed with serum (10% in serum), the metabolism of <b>1a</b> was inhibited; incubating <b>1a</b> in serum at low temperature also inhibited the metabolism (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S5b,c</a>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vitro Cytotoxicity</h3><div class="NLM_p">U87 cells were seeded in 96-well plates as 5000 cells/well (50 μL) and incubated in the incubator overnight. Various concentrations of gemcitabine (<b>gem</b>), its derivative <b>F</b>, conjugates <b>1a</b>–<b>d</b>, <b>2a</b>, <b>2b</b>, <b>2d</b> as well as free heptamethine dyes <b>A</b>–<b>D</b> were prepared in 50 μL of protein-free hybridoma medium (PFHM II) and added to cells to make final concentrations from 0.001 to 10 μM. All plates were incubated for 72 h, and cell viability was tested with AlamarBlue assay (Invitrogen). Briefly, in a well containing 100 μL of medium, 10 μL of AlamarBlue reagent was added, and the mixture was incubated for 2 h. Fluorescence intensity (Ex/Em 560/590 nm) was measured on a microplate reader (BioTek Synergy H4). Results are processed through GraphPad Prism 6.0 software. Cytotoxicity of dye <b>D</b> was also observed in other’s work.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p last">To further investigate the tumor targeting effect of compound <b>1a</b> in vitro, cytotoxicity tests of <b>gem</b>, <b>1a</b>, <b>2a</b>, and <b>A</b> against more glioblastoma cell lines LN18 and LN229 as well as a control cell line HEK293 were conducted. Cells were seeded on 96-well plates as 2500 cells/well (50 μL) and incubated in the incubator overnight. Various concentrations of <b>gem</b>, <b>1a</b>, <b>2a</b>, and <b>A</b> were prepared in 50 μL of protein-free hybridoma medium (PFHM II) and added to cells to make final concentrations from 0.0001 to 10 μM. All plates were incubated for 72 h, and cell viability was tested with AlamarBlue assay (Invitrogen).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vivo Tumor Model Settings</h3><div class="NLM_p">All animal experiments were performed under approved protocols in compliance with the guidelines established by the Institutional Animal Care and Use Committee (IACUC 2018-0483).</div><div class="NLM_p last">Mice were anesthetized with isoflurane and then imaged for fluorescence or luminescence on an IVIS Spectrum (in vivo imaging system; PerkinElmer). For luminescence imaging, mice were subcutaneously injected with <span class="smallcaps smallerCapital">d</span>-luciferin (15 mg/mL; PerkinElmer, no. 122796) in μL at 10× the mouse weight. During imaging mice remained anesthetized by isoflurane. Fluorescence was measured by radiant efficiency, and luminescence was measured by counts. Red fluorescence protein (RFP) from the U87 cells was captured at an excitation wavelength of 570 nm and an emission wavelength of 620 nm. The near IR dye fluorescence was captured at an excitation wavelength of 745 nm and an emission wavelength of 840 nm. Images were captured and data were analyzed using Living Image software (PerkinElmer).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> In Vivo Therapeutic Study</h3><div class="NLM_p">7-week-old Foxn1 nu females were ordered from Jackson Lab. 5 ×10<sup>5</sup> U87-RFP-LUC cells were injected subcutaneously into the right flank of the mice. Four days later (day 4) intravenous injections of the drugs and vehicle were administered through retro-orbital injections. The mice were injected again 4 days later (day 8), and the injections were subsequently administered once weekly. Compounds were administered at a concentration of 10 mg/kg for 5 weeks. Tumor growth was monitored by luminescence and fluorescence (RFP; 570–620 nm) imaging, and drug clearance/localization of <b>1a</b> was monitored by the fluorescence imaging (745–840 nm).</div><div class="NLM_p last">A cocktail vehicle (2% DMSO, 9% ethanol, 9% BSA in PBS buffer) was applied to solubilize <b>1a</b> and <b>gem</b> for retro-orbital injections. <b>1a</b> was prepared as 3 mM solution, and <b>gem</b> was prepared as 10 mM solution. The volume (<100 μL) of each compound administered was calculated based on the body weight of each mouse to deliver 10 mg/kg dose.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01147" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53373" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53373" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01147" class="ext-link">10.1021/acs.jmedchem.9b01147</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Characterization of all compounds, photophysical properties of compounds <b>1</b>, subcellular localization of compounds <b>1</b> and their parent dyes, stability test of <b>1a</b>, and more in vitro cytotoxicity and in vivo tumor model study details (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf">jm9b01147_si_001.pdf (2.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_002.csv">jm9b01147_si_002.csv (1.4 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01147" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83636" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83636" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raquel Sitcheran</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular & Cellular Medicine, Texas
A&M University Health Science Center, College Station, Texas 77843, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7003190413181502111e3004111d055e151405"><span class="__cf_email__" data-cfemail="0f7c667b6c676a7d6e614f7b6e627a216a6b7a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Burgess</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6597-1842" title="Orcid link">http://orcid.org/0000-0001-6597-1842</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#096b7c7b6e6c7a7a497d68647c276c6d7c"><span class="__cf_email__" data-cfemail="6b091e190c0e18182b1f0a061e450e0f1e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhengyang Jiang</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1725-2883" title="Orcid link">http://orcid.org/0000-0002-1725-2883</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathryn Pflug</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular & Cellular Medicine, Texas
A&M University Health Science Center, College Station, Texas 77843, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Syed Muhammad Usama</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7487-1568" title="Orcid link">http://orcid.org/0000-0002-7487-1568</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dacheng Kuai</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Yan</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United
States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>This study was conceived by K.B., Z.J., and S.M.U. Z.J. performed all the experimental work except the following: K.P. performed the in vivo studies under the direction of R.S.; S.M.U. provided the dye starting materials and assisted with the confocal imaging experiments; and D.K. and X.Y. performed the mass spectroscopic analyses to characterize the metabolite 5 (from 1a). The paper was mostly written by K.B. and Z.J.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2585-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support was provided by a DoD BCRP Breakthrough Award (Grant BC141561), CPRIT (Grant RP180875), The Robert A. Welch Foundation (Grant A-1121), The National Science Foundation (NSF, Grant CHE1608009), NIH Grant R01EY029645, and the Texas A&M University T3-Grants Program (246292-00000). NMR instrumentation at Texas A&M University was supported by a grant from the NSF (Grant DBI-9970232) and the Texas A&M University System. The use of the Microscopy and Imaging Center facility at Texas A&M University is acknowledged. The Olympus FV1000 confocal microscope acquisition was supported by the Office of the Vice President for Research at Texas A&M University.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Cy7</td><td class="NLM_def"><p class="first last">heptamethine dye</p></td></tr><tr><td class="NLM_term">NIR</td><td class="NLM_def"><p class="first last">near-infrared</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma multiforme</p></td></tr><tr><td class="NLM_term">TMZ</td><td class="NLM_def"><p class="first last">temozolomide</p></td></tr><tr><td class="NLM_term">dFdC or gem</td><td class="NLM_def"><p class="first last">gemcitabine</p></td></tr><tr><td class="NLM_term">RNR</td><td class="NLM_def"><p class="first last">ribonucleotide reductase</p></td></tr><tr><td class="NLM_term">PCC</td><td class="NLM_def"><p class="first last">Pearson’s correlation coefficient</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.-J.</span></span> <span> </span><span class="NLM_article-title">Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant with Radiation and Bevacizumab: A Population-based Study</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">44015</span>– <span class="NLM_lpage">44031</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.17054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.18632%2Foncotarget.17054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=28467795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC1crjs1Citg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=44015-44031&author=P.+Zhuauthor=X.+L.+Duauthor=G.+Luauthor=J.-J.+Zhu&title=Survival+Benefit+of+Glioblastoma+Patients+After+FDA+Approval+of+Temozolomide+Concomitant+with+Radiation+and+Bevacizumab%3A+A+Population-based+Study&doi=10.18632%2Foncotarget.17054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study</span></div><div class="casAuthors">Zhu Ping; Du Xianglin L; Zhu Ping; Lu Guangrong; Zhu Jay-Jiguang</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">44015-44031</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Few population-based analyses have investigated survival change in glioblastoma multiforme (GBM) patients treated with concomitant radiotherapy-temozolomide (RT-TMZ) and adjuvant temozolomide (TMZ) and then bevacizumab (BEV) after Food and Drug Administration (FDA) approval, respectively.  We aimed to explore the effects on survival with RT-TMZ, adjuvant TMZ and BEV in general GBM population based on the Surveillance, Epidemiology, and End Results (SEER) and Texas Cancer Registry (TCR) databases.  A total of 28933 GBM patients from SEER (N = 24578) and TCR (N = 4355) between January 2000 and December 2013 were included.  Patients were grouped into three calendar periods based on date of diagnosis: pre-RT-TMZ and pre-BEV (1/2000-2/2005, P1), post-RT-TMZ and pre-BEV (3/2005-4/2009, P2), and post-RT-TMZ and post-BEV (5/2009-12/2013, P3).  The association between calendar period of diagnosis and survival was analyzed in SEER and TCR, separately, by the Kaplan-Meier method and Cox proportional hazards model.  We found a significant increase in median overall survival (OS) across the three periods in both populations.  In multivariate models, the risk of death was significantly reduced during P2 and further decreased in P3, which remained unchanged after stratification.  Comparison and validation analysis were performed in the combined dataset, and consistent results were observed.  We conclude that the OS of GBM patients in a "real-world" setting has been steadily improved from January 2000 to December 2013, which likely resulted from the administrations of TMZ concomitant with RT and adjuvant TMZ for newly diagnosed GBM and then BEV for recurrent GBM after respective FDA approval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVn-pfX7PHl9yzdcP07UmufW6udTcc2ebeilo2Tw3kx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crjs1Citg%253D%253D&md5=ba621c089ab1493c9ca7ec776ea9e513</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.17054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.17054%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DDu%26aufirst%3DX.%2BL.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DJ.-J.%26atitle%3DSurvival%2520Benefit%2520of%2520Glioblastoma%2520Patients%2520After%2520FDA%2520Approval%2520of%2520Temozolomide%2520Concomitant%2520with%2520Radiation%2520and%2520Bevacizumab%253A%2520A%2520Population-based%2520Study%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D44015%26epage%3D44031%26doi%3D10.18632%2Foncotarget.17054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">6767</span>– <span class="NLM_lpage">6771</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1158%2F1078-0432.CCR-05-0722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=16203762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKiurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=6767-6771&author=M.+H.+Cohenauthor=J.+R.+Johnsonauthor=R.+Pazdur&title=Food+and+Drug+Administration+Drug+Approval+Summary%3A+Temozolomide+Plus+Radiation+Therapy+for+the+Treatment+of+Newly+Diagnosed+Glioblastoma+Multiforme&doi=10.1158%2F1078-0432.CCR-05-0722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme</span></div><div class="casAuthors">Cohen, Martin H.; Johnson, John R.; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">19, Pt. 1</span>),
    <span class="NLM_cas:pages">6767-6771</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">On Mar. 15, 2005, the U.S.  Food and Drug Administration approved temozolomide (Temodar capsules, Schering-Plough Research Institute) for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment.  Five hundred seventy-three glioblastoma multiforme patients were randomized to receive either temozolomide + radiotherapy (n = 287) or radiotherapy alone (n = 286).  Patients in the temozolomide + radiotherapy arm received concomitant temozolomide (75 mg/m2) once daily for the duration of radiation therapy (42-49 days).  This was followed, 4 wk later, by six cycles of temozolomide, 150 or 200 mg/m2 daily for 5 days, every 4 wk.  Patients in the control arm received radiotherapy only.  In both arms, radiotherapy was delivered as 60 Gy/30 fractions to the tumor site with a 2 to 3 cm margin.  Pneumocystis carinii pneumonia prophylaxis was required during temozolomide + radiotherapy treatment and was continued until recovery of lymphocytopenia (Common Toxicity Criteria grade <1).  At disease progression, temozolomide salvage treatment was given to 161 of 282 patients (57%) in the radiotherapy alone arm, and to 62 of 277 patients (22%) in the temozolomide + radiotherapy arm.  Patients receiving concomitant and maintenance temozolomide + radiotherapy had significantly improved overall survival.  The hazard ratio was 0.63 (95% confidence interval, 0.52-0.75; log-rank, P < 0.0001).  Median survival was 14.6 mo (temozolomide + radiotherapy) vs. 12.1 mo (radiotherapy alone).  Adverse events during temozolomide treatment included thrombocytopenia, nausea, vomiting, anorexia, constipation, alopecia, headache, fatigue, and convulsions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBMna9_OqZfbVg90H21EOLACvtfcHk0ljgoZTv33xRMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKiurzF&md5=50680b8f67e11307567287f2149d9613</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0722%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DM.%2BH.%26aulast%3DJohnson%26aufirst%3DJ.%2BR.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFood%2520and%2520Drug%2520Administration%2520Drug%2520Approval%2520Summary%253A%2520Temozolomide%2520Plus%2520Radiation%2520Therapy%2520for%2520the%2520Treatment%2520of%2520Newly%2520Diagnosed%2520Glioblastoma%2520Multiforme%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D6767%26epage%3D6771%26doi%3D10.1158%2F1078-0432.CCR-05-0722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis
Mary, E.</span></span> <span> </span><span class="NLM_article-title">Glioblastoma: Overview of Disease and Treatment</span>. <i>Clin. J. Oncol. Nurs.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">S2</span>– <span class="NLM_lpage">S8</span>, <span class="refDoi"> DOI: 10.1188/16.CJON.S1.2-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1188%2F16.CJON.S1.2-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=27668386" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=S2-S8&author=E.+Davis%0AMary&title=Glioblastoma%3A+Overview+of+Disease+and+Treatment&doi=10.1188%2F16.CJON.S1.2-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1188%2F16.CJON.S1.2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1188%252F16.CJON.S1.2-8%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%2BMary%26aufirst%3DE.%26atitle%3DGlioblastoma%253A%2520Overview%2520of%2520Disease%2520and%2520Treatment%26jtitle%3DClin.%2520J.%2520Oncol.%2520Nurs.%26date%3D2016%26volume%3D20%26spage%3DS2%26epage%3DS8%26doi%3D10.1188%2F16.CJON.S1.2-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastiancich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastiat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagarce, F.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine and Glioblastoma: Challenges and Current Perspectives</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.drudis.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=29074439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsleltL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=416-423&author=C.+Bastiancichauthor=G.+Bastiatauthor=F.+Lagarce&title=Gemcitabine+and+Glioblastoma%3A+Challenges+and+Current+Perspectives&doi=10.1016%2Fj.drudis.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine and glioblastoma: challenges and current perspectives</span></div><div class="casAuthors">Bastiancich, Chiara; Bastiat, Guillaume; Lagarce, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">416-423</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Gemcitabine is a nucleoside analog currently used for the treatment of various solid tumors as a single agent or in combination with other chemotherapeutic drugs.  Its use against highly aggressive brain tumors (glioblastoma) has been evaluated in preclin. and clin. trials leading to controversial results.  Gemcitabine can inhibit DNA chain elongation, is a potent radiosensitizer and it can enhance antitumor immune activity, but it also presents some drawbacks (e.g., short half-life, side effects, chemoresistance).  The aim of this review is to discuss the challenges related to the use of gemcitabine for glioblastoma and to report recent studies that suggest overcoming these obstacles opening new perspectives for its use in the field (e.g., gemcitabine derivs. and/or nanomedicines).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk8Zj9iUEy7LVg90H21EOLACvtfcHk0ljgoZTv33xRMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsleltL%252FP&md5=505958acba227ed03611dbd7140c513d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DBastiancich%26aufirst%3DC.%26aulast%3DBastiat%26aufirst%3DG.%26aulast%3DLagarce%26aufirst%3DF.%26atitle%3DGemcitabine%2520and%2520Glioblastoma%253A%2520Challenges%2520and%2520Current%2520Perspectives%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D416%26epage%3D423%26doi%3D10.1016%2Fj.drudis.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stupp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Bent, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taphoorn, M. J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzer, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwin, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allgeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandes, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijtenbeek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marosi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecht, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhtari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesseling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhauer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorlia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacombe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairncross, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirimanoff, R.-O.</span></span> <span> </span><span class="NLM_article-title">Effects of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study: 5-year Analysis of the EORTC-NCIC Trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(09)70025-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2FS1470-2045%2809%2970025-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=19269895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVKhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=459-466&author=R.+Stuppauthor=M.+E.+Hegiauthor=W.+P.+Masonauthor=M.+J.+van+den+Bentauthor=M.+J.+B.+Taphoornauthor=R.+C.+Janzerauthor=S.+K.+Ludwinauthor=A.+Allgeierauthor=B.+Fisherauthor=K.+Belangerauthor=P.+Hauauthor=A.+A.+Brandesauthor=J.+Gijtenbeekauthor=C.+Marosiauthor=C.+J.+Vechtauthor=K.+Mokhtariauthor=P.+Wesselingauthor=S.+Villaauthor=E.+Eisenhauerauthor=T.+Gorliaauthor=M.+Wellerauthor=D.+Lacombeauthor=J.+G.+Cairncrossauthor=R.-O.+Mirimanoff&title=Effects+of+Radiotherapy+with+Concomitant+and+Adjuvant+Temozolomide+versus+Radiotherapy+Alone+on+Survival+in+Glioblastoma+in+a+Randomised+Phase+III+Study%3A+5-year+Analysis+of+the+EORTC-NCIC+Trial&doi=10.1016%2FS1470-2045%2809%2970025-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial</span></div><div class="casAuthors">Stupp, Roger; Hegi, Monika E.; Mason, Warren P.; van den Bent, Martin J.; Taphoorn, Martin J. B.; Janzer, Robert C.; Ludwin, Samuel K.; Allgeier, Anouk; Fisher, Barbara; Belanger, Karl; Hau, Peter; Brandes, Alba A.; Gijtenbeek, Johanna; Marosi, Christine; Vecht, Charles J.; Mokhtari, Karima; Wesseling, Pieter; Villa, Salvador; Eisenhauer, Elizabeth; Gorlia, Thierry; Weller, Michael; Lacombe, Denis; Cairncross, J. Gregory; Mirimanoff, Rene-Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In 2004, a randomized phase III trial by the European Organization for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clin. Trials Group (NCIC) reported improved median and 2-yr survival for patients with glioblastoma treated with concomitant and adjuvant temozolomide and radiotherapy.  We report the final results with a median follow-up of more than 5 years.  Adult patients with newly diagnosed glioblastoma were randomly assigned to receive either std. radiotherapy or identical radiotherapy with concomitant temozolomide followed by up to six cycles of adjuvant temozolomide.  The methylation status of the methyl-guanine Me transferase gene, MGMT, was detd. retrospectively from the tumor tissue of 206 patients.  The primary endpoint was overall survival.  Analyses were by intention to treat.  This trial is registered with, no.  Between Aug 17, 2000, and March 22, 2002, 573 patients were assigned to treatment. 278 (97%) of 286 patients in the radiotherapy alone group and 254 (89%) of 287 in the combined-treatment group died during 5 years of follow-up.  Overall survival was 27.2% (95% CI 22.2-32.5) at 2 years, 16.0% (12.0-20.6) at 3 years, 12.1% (8.5-16.4) at 4 years, and 9.8% (6.4-14.0) at 5 years with temozolomide, vs. 10.9% (7.6-14.8), 4.4% (2.4-7.2), 3.0% (1.4-5.7), and 1.9% (0.6-4.4) with radiotherapy alone (hazard ratio 0.6, 95% CI 0.5-0.7; p<0.0001).  A benefit of combined therapy was recorded in all clin. prognostic subgroups, including patients aged 60-70 years.  Methylation of the MGMT promoter was the strongest predictor for outcome and benefit from temozolomide chemotherapy.  Benefits of adjuvant temozolomide with radiotherapy lasted throughout 5 years of follow-up.  A few patients in favorable prognostic categories survive longer than 5 years.  MGMT methylation status identifies patients most likely to benefit from the addn. of temozolomide.  Funding: EORTC, NCIC, Nelia and Amadeo Barletta Foundation, Schering-Plough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodXEfj7tq5LLVg90H21EOLACvtfcHk0liV92V3S9sSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVKhs74%253D&md5=5cc84038ab5ca34ce0f18049c053483b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2809%2970025-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252809%252970025-7%26sid%3Dliteratum%253Aachs%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DMason%26aufirst%3DW.%2BP.%26aulast%3Dvan%2Bden%2BBent%26aufirst%3DM.%2BJ.%26aulast%3DTaphoorn%26aufirst%3DM.%2BJ.%2BB.%26aulast%3DJanzer%26aufirst%3DR.%2BC.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DAllgeier%26aufirst%3DA.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DBelanger%26aufirst%3DK.%26aulast%3DHau%26aufirst%3DP.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DGijtenbeek%26aufirst%3DJ.%26aulast%3DMarosi%26aufirst%3DC.%26aulast%3DVecht%26aufirst%3DC.%2BJ.%26aulast%3DMokhtari%26aufirst%3DK.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DS.%26aulast%3DEisenhauer%26aufirst%3DE.%26aulast%3DGorlia%26aufirst%3DT.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DLacombe%26aufirst%3DD.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DMirimanoff%26aufirst%3DR.-O.%26atitle%3DEffects%2520of%2520Radiotherapy%2520with%2520Concomitant%2520and%2520Adjuvant%2520Temozolomide%2520versus%2520Radiotherapy%2520Alone%2520on%2520Survival%2520in%2520Glioblastoma%2520in%2520a%2520Randomised%2520Phase%2520III%2520Study%253A%25205-year%2520Analysis%2520of%2520the%2520EORTC-NCIC%2520Trial%26jtitle%3DLancet%2520Oncol.%26date%3D2009%26volume%3D10%26spage%3D459%26epage%3D466%26doi%3D10.1016%2FS1470-2045%2809%2970025-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moysan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastiat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, J.-P.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1021/mp300370t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300370t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGjsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=430-444&author=E.+Moysanauthor=G.+Bastiatauthor=J.-P.+Benoit&title=Gemcitabine+versus+Modified+Gemcitabine%3A+A+Review+of+Several+Promising+Chemical+Modifications&doi=10.1021%2Fmp300370t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications</span></div><div class="casAuthors">Moysan, Elodie; Bastiat, Guillaume; Benoit, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-444</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Gemcitabine, an anticancer agent which acts against a wide range of solid tumors, is known to be rapidly deaminated in blood to the inactive metabolite 2',2'-difluorodeoxyuridine and to be rapidly excreted by the urine.  Moreover, many cancers develop resistance against this drug, such as loss of transporters and kinases responsible for the first phosphorylation step.  To increase its therapeutic levels, gemcitabine is administered at high doses (1000 mg/m2) causing side effects (neutropenia, nausea, and so forth).  To improve its metabolic stability and cytotoxic activity and to limit the phenomena of resistance many alternatives have emerged, such as the synthesis of prodrugs.  Modifying an anticancer agent is not new; paclitaxel or ara-C has been subjected to such changes.  This review summarizes the various chem. modifications that can be found in the 4-(N)- and 5'-positions of gemcitabine.  They can provide (i) a protection against deamination, (ii) a better storage and (iii) a prolonged release in the cell, (iv) a possible use in the case of deoxycytidine kinase deficiency, and (v) transporter deficiency.  These new gemcitabine-based sysems have the potential to improve the clin. outcome of a chemotherapy strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp72pKu9l1uzbVg90H21EOLACvtfcHk0liV92V3S9sSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGjsbbJ&md5=1c7be7b7a6aa90cb1df2a420358ec77e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fmp300370t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300370t%26sid%3Dliteratum%253Aachs%26aulast%3DMoysan%26aufirst%3DE.%26aulast%3DBastiat%26aufirst%3DG.%26aulast%3DBenoit%26aufirst%3DJ.-P.%26atitle%3DGemcitabine%2520versus%2520Modified%2520Gemcitabine%253A%2520A%2520Review%2520of%2520Several%2520Promising%2520Chemical%2520Modifications%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D430%26epage%3D444%26doi%3D10.1021%2Fmp300370t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plunkett, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunewald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine: Metabolism, Mechanisms of Action, and Self-potentiation</span>. <i>Semin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=7481842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADyaK2MXpsFGntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1995&pages=3-10&author=W.+Plunkettauthor=P.+Huangauthor=Y.-Z.+Xuauthor=V.+Heinemannauthor=R.+Grunewaldauthor=V.+Gandhi&title=Gemcitabine%3A+Metabolism%2C+Mechanisms+of+Action%2C+and+Self-potentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine: metabolism, mechanisms of action, and self-potentiation</span></div><div class="casAuthors">Plunkett, William; Huang, Peng; Xu, Yi-Zheng; Heinemann, Volker; Grunewald, Ralf; Gandhi, Varsha</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4, Suppl. 11</span>),
    <span class="NLM_cas:pages">3-10</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">Saunders</span>)
        </div><div class="casAbstract">A review, with 26 refs., discussing the metabolic and mechanistic aspects of gemcitabine.  The unique actions that gemcitabine metabolites exert on cellular regulatory processes serve to enhance the drug's overall inhibitory activities on cell growth.  This interaction is termed "self-potentiation" and is evidenced in very few other anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUB562hnsSFbVg90H21EOLACvtfcHk0lh_nwxOLimCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsFGntbY%253D&md5=fd6b0da38663e5ed22c15599afc5b2d1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlunkett%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DY.-Z.%26aulast%3DHeinemann%26aufirst%3DV.%26aulast%3DGrunewald%26aufirst%3DR.%26aulast%3DGandhi%26aufirst%3DV.%26atitle%3DGemcitabine%253A%2520Metabolism%252C%2520Mechanisms%2520of%2520Action%252C%2520and%2520Self-potentiation%26jtitle%3DSemin.%2520Oncol.%26date%3D1995%26volume%3D22%26spage%3D3%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pulido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobczak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wnuk, S. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Cytostatic Evaluation of 4-N-Alkanoyl and 4-N-Alkyl Gemcitabine Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1021/jm401586a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401586a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=191-203&author=J.+Pulidoauthor=A.+J.+Sobczakauthor=J.+Balzariniauthor=S.+F.+Wnuk&title=Synthesis+and+Cytostatic+Evaluation+of+4-N-Alkanoyl+and+4-N-Alkyl+Gemcitabine+Analogs&doi=10.1021%2Fjm401586a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Cytostatic Evaluation of 4-N-Alkanoyl and 4-N-Alkyl Gemcitabine Analogs</span></div><div class="casAuthors">Pulido, Jesse; Sobczak, Adam J.; Balzarini, Jan; Wnuk, Stanislaw F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The coupling of gemcitabine with functionalized carboxylic acids (C9-C13) or reactions of 4-N-tosylgemcitabine with the corresponding alkyl amines afforded 4-N-alkanoyl and 4-N-alkyl gemcitabine derivs., e.g. I.  The analogs with a terminal hydroxyl group on the alkyl chain were efficiently fluorinated under conditions that are compatible with protocols for 18F labeling.  The 4-N-alkanoylgemcitabines showed potent cytostatic activities in the low nano-molar range against a panel of tumor cell lines, whereas cytotoxicity of the 4-N-alkylgemcitabines were in the low micro-molar range.  The cytotoxicity for the 4-N-alkanoylgemcitabine analogs was reduced approx. by 2 orders of magnitude in the 2'-deoxycytidine kinase (dCK)-deficient CEM/dCK- cell line, whereas cytotoxicity of the 4-N-alkylgemcitabines was only 2-5 times lower.  None of the compds. acted as efficient substrates for cytosolic dCK; therefore, the 4-N-alkanoyl analogs need to be converted first to gemcitabine to display a significant cytostatic potential, whereas 4-N-alkyl derivs. attain modest activity without measurable conversion to gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFGYp7BEu1r7Vg90H21EOLACvtfcHk0lh_nwxOLimCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsbrJ&md5=5236bc0faafb691009c5c443170e5267</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm401586a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401586a%26sid%3Dliteratum%253Aachs%26aulast%3DPulido%26aufirst%3DJ.%26aulast%3DSobczak%26aufirst%3DA.%2BJ.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DWnuk%26aufirst%3DS.%2BF.%26atitle%3DSynthesis%2520and%2520Cytostatic%2520Evaluation%2520of%25204-N-Alkanoyl%2520and%25204-N-Alkyl%2520Gemcitabine%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D191%26epage%3D203%26doi%3D10.1021%2Fjm401586a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichgans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine Cytotoxicity of Human Malignant Glioma Cells: Modulation by Antioxidants, BCL-2 and Dexamethasone</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(98)00883-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2FS0014-2999%2898%2900883-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=9988115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADyaK1MXksFCntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1999&pages=301-308&author=J.+Riegerauthor=S.+Durkaauthor=J.+Strefferauthor=J.+Dichgansauthor=M.+Weller&title=Gemcitabine+Cytotoxicity+of+Human+Malignant+Glioma+Cells%3A+Modulation+by+Antioxidants%2C+BCL-2+and+Dexamethasone&doi=10.1016%2FS0014-2999%2898%2900883-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone</span></div><div class="casAuthors">Rieger, Johannes; Durka, Silke; Streffer, Johannes; Dichgans, Johannes; Weller, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">301-308</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Gemcitabine is a novel antimetabolite drug that acts by multiple mechanisms, including inhibition of ribonucleoside diphosphate reductase, of dCMP deaminase and of dCTP incorporation into DNA and RNA.  Here, the authors report that gemcitabine induces cytotoxic and clonogenic death of 12 human malignant glioma cell lines at clin. relevant concns. around 1 μM.  Gemcitabine is thus approx. 100-fold more active than the congener drug, cytarabine.  Gemcitabine cytotoxicity of glioma cells does not require wild-type p53 activity: (i) there was no difference in the susceptibility to gemcitabine between cell lines with wild-type p53 and cell lines with mutant or deleted p53; (ii) ectopic expression of a temp.-sensitive p53 protein either at wild-type (32.5°) or at mutant (38.5°) conformation had no significant influence on gemcitabine-induced cell death.  Gemcitabine cytotoxicity was unaffected by the antioxidants, N-acetylcysteine and phenyl-N-tert-butyl-α-phenylnitrone.  There was no correlation between the susceptibility to gemcitabine and the endogenous expression of the B cell lymphoma-2 (BCL-2)-family proteins BCL-2, BCL-XL, myeloid cell leukemia-1 (MCL-1), BCL-2-assocd. X protein (BAX), BCL-2 homologous antagonist/killer (BAK) and BCL-XS.  Ectopic expression of BCL-2 moderately attenuated gemcitabine-induced cell death.  Similarly, preexposure to the synthetic steroid, dexamethasone, which is commonly used to control cerebral edema in brain tumor patients, reduced gemcitabine cytotoxicity.  The authors conclude that the clin. evaluation of gemcitabine for the adjuvant chemotherapy of malignant glioma is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-I2dQQRuoY7Vg90H21EOLACvtfcHk0lh_nwxOLimCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksFCntQ%253D%253D&md5=9eac54c5a6bc6a57b817c983e81fe7ea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2898%2900883-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252898%252900883-8%26sid%3Dliteratum%253Aachs%26aulast%3DRieger%26aufirst%3DJ.%26aulast%3DDurka%26aufirst%3DS.%26aulast%3DStreffer%26aufirst%3DJ.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DM.%26atitle%3DGemcitabine%2520Cytotoxicity%2520of%2520Human%2520Malignant%2520Glioma%2520Cells%253A%2520Modulation%2520by%2520Antioxidants%252C%2520BCL-2%2520and%2520Dexamethasone%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D365%26spage%3D301%26epage%3D308%26doi%3D10.1016%2FS0014-2999%2898%2900883-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuchtern, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egorin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuffey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleksic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, S.</span></span> <span> </span><span class="NLM_article-title">Plasma and Cerebrospinal Fluid Pharmacokinetics of Gemcitabine After Intravenous Administration in Nonhuman Primates</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1007/s002800000253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1007%2Fs002800000253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=11391856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVKqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2001&pages=411-414&author=J.+Z.+Kerrauthor=S.+L.+Bergauthor=R.+Dauserauthor=J.+Nuchternauthor=M.+J.+Egorinauthor=L.+McGuffeyauthor=A.+Aleksicauthor=S.+Blaney&title=Plasma+and+Cerebrospinal+Fluid+Pharmacokinetics+of+Gemcitabine+After+Intravenous+Administration+in+Nonhuman+Primates&doi=10.1007%2Fs002800000253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates</span></div><div class="casAuthors">Kerr, Jody Z.; Berg, Stacey L.; Dauser, Robert; Nuchtern, Jed; Egorin, Merrill J.; McGuffey, Leticia; Aleksic, Alexander; Blaney, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-414</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">This study was performed in rhesus monkeys to det. the plasma and cerebrospinal fluid (CSF) pharmacokinetics of gemcitabine and its inactive metabolite, difluorodeoxyuridine (dFdU) following i.v. administration.  Gemcitabine, 200 mg/kg, was administered i.v. over 45 min.  Serial plasma and CSF samples were obtained prior to, during, and after completion of the infusion for detn. of gemcitabine and dFdU concns.  Gemcitabine and dFdU were measured by HPLC and modeled with model-dependent and model-independent methods.  Plasma elimination was rapid, with a mean half life of 8 min for gemcitabine and 83 min for dFdU.  Gemcitabine total-body clearance was 177 mL/min/kg and the steady-state vol. of distribution was 5.5 L/kg.  The max. concns. and areas under the time-concn. curves for gemcitabine in plasma were 194 μM and 63.8 μM·h, resp., and for dFdU were 783 μM and 1725 μM·h, resp.  The peak CSF concns. of gemcitabine and dFdU were 2.5 μM and 32 μM, resp.  The mean CSF:plasma ratio was 6.7% for gemcitabine and 23.8% for dFdU.  There is only modest penetration of gemcitabine into the CSF after i.v. administration.  The relatively low CSF exposure to gemcitabine after i.v. administration suggests that systemic administration of this agent is not optimal for the treatment of overt leptomeningeal disease.  However, the clin. spectrum of antitumor activity and lack of neurotoxicity after systemic administration of gemcitabine make this agent an excellent candidate for further studies to assess the safety and feasibility of intrathecal administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBJ3tqovl_i7Vg90H21EOLACvtfcHk0ljM8LDlvnFD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVKqtrc%253D&md5=f0f0dbddf510f6bee4e5a9ce326ffbfc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs002800000253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800000253%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BZ.%26aulast%3DBerg%26aufirst%3DS.%2BL.%26aulast%3DDauser%26aufirst%3DR.%26aulast%3DNuchtern%26aufirst%3DJ.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DMcGuffey%26aufirst%3DL.%26aulast%3DAleksic%26aufirst%3DA.%26aulast%3DBlaney%26aufirst%3DS.%26atitle%3DPlasma%2520and%2520Cerebrospinal%2520Fluid%2520Pharmacokinetics%2520of%2520Gemcitabine%2520After%2520Intravenous%2520Administration%2520in%2520Nonhuman%2520Primates%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2001%26volume%3D47%26spage%3D411%26epage%3D414%26doi%3D10.1007%2Fs002800000253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Apparaju, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudelsky, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, P. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of Gemcitabine in Tumor and Non-tumor Extracellular Fluid of Brain: an In Vivo Assessment in Rats Employing Intracerebral Microdialysis</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1007/s00280-007-0464-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1007%2Fs00280-007-0464-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=17443325" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=223-229&author=S.+K.+Apparajuauthor=G.+A.+Gudelskyauthor=P.+B.+Desai&title=Pharmacokinetics+of+Gemcitabine+in+Tumor+and+Non-tumor+Extracellular+Fluid+of+Brain%3A+an+In+Vivo+Assessment+in+Rats+Employing+Intracerebral+Microdialysis&doi=10.1007%2Fs00280-007-0464-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00280-007-0464-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-007-0464-1%26sid%3Dliteratum%253Aachs%26aulast%3DApparaju%26aufirst%3DS.%2BK.%26aulast%3DGudelsky%26aufirst%3DG.%2BA.%26aulast%3DDesai%26aufirst%3DP.%2BB.%26atitle%3DPharmacokinetics%2520of%2520Gemcitabine%2520in%2520Tumor%2520and%2520Non-tumor%2520Extracellular%2520Fluid%2520of%2520Brain%253A%2520an%2520In%2520Vivo%2520Assessment%2520in%2520Rats%2520Employing%2520Intracerebral%2520Microdialysis%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2007%26volume%3D61%26spage%3D223%26epage%3D229%26doi%3D10.1007%2Fs00280-007-0464-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farokhzad, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margalit, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, R.</span></span> <span> </span><span class="NLM_article-title">Nanocarriers as an Emerging Platform for Cancer Therapy</span>. <i>Nat. Nanotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1038/nnano.2007.387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1038%2Fnnano.2007.387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=18654426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlyktL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=751-760&author=D.+Peerauthor=J.+M.+Karpauthor=S.+Hongauthor=O.+C.+Farokhzadauthor=R.+Margalitauthor=R.+Langer&title=Nanocarriers+as+an+Emerging+Platform+for+Cancer+Therapy&doi=10.1038%2Fnnano.2007.387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nanocarriers as an emerging platform for cancer therapy</span></div><div class="casAuthors">Peer, Dan; Karp, Jeffrey M.; Hong, Seungpyo; Farokhzad, Omid C.; Margalit, Rimona; Langer, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Nanotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">751-760</span>CODEN:
                <span class="NLM_cas:coden">NNAABX</span>;
        ISSN:<span class="NLM_cas:issn">1748-3387</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nanotechnol. has the potential to revolutionize cancer diagnosis and therapy.  Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients.  Several therapeutic nanocarriers were approved for clin. use.  However, to date, there are only a few clin. approved nanocarriers that incorporate mols. to selectively bind and target cancer cells.  This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic.  The authors detail the arsenal of nanocarriers and mols. available for selective tumor targeting, and emphasize the challenges in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSaHhszNVn2LVg90H21EOLACvtfcHk0ljM8LDlvnFD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlyktL%252FI&md5=5f24033175e23e13d59e4a5b38753cad</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnnano.2007.387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnnano.2007.387%26sid%3Dliteratum%253Aachs%26aulast%3DPeer%26aufirst%3DD.%26aulast%3DKarp%26aufirst%3DJ.%2BM.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DFarokhzad%26aufirst%3DO.%2BC.%26aulast%3DMargalit%26aufirst%3DR.%26aulast%3DLanger%26aufirst%3DR.%26atitle%3DNanocarriers%2520as%2520an%2520Emerging%2520Platform%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Nanotechnol.%26date%3D2007%26volume%3D2%26spage%3D751%26epage%3D760%26doi%3D10.1038%2Fnnano.2007.387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhau, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henary, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strekowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, L. W. K.</span></span> <span> </span><span class="NLM_article-title">Near IR Heptamethine Cyanine Dye-Mediated Cancer Imaging</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2833</span>– <span class="NLM_lpage">2844</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1158%2F1078-0432.CCR-10-0059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=20410058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvF2hsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2833-2844&author=X.+Yangauthor=C.+Shiauthor=R.+Tongauthor=W.+Qianauthor=H.+E.+Zhauauthor=R.+Wangauthor=G.+Zhuauthor=J.+Chengauthor=V.+W.+Yangauthor=T.+Chengauthor=M.+Henaryauthor=L.+Strekowskiauthor=L.+W.+K.+Chung&title=Near+IR+Heptamethine+Cyanine+Dye-Mediated+Cancer+Imaging&doi=10.1158%2F1078-0432.CCR-10-0059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Near IR Heptamethine Cyanine Dye-Mediated Cancer Imaging</span></div><div class="casAuthors">Yang, Xiaojian; Shi, Chunmeng; Tong, Rong; Qian, Weiping; Zhau, Haiyen E.; Wang, Ruoxiang; Zhu, Guodong; Cheng, Jianjun; Yang, Vincent W.; Cheng, Tianmin; Henary, Maged; Strekowski, Lucjan; Chung, Leland W. K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2833-2844</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Near-IR fluorescence imaging has great potential for noninvasive in vivo imaging of tumors.  In this study, we show the preferential uptake and retention of two heptamethine cyanine dyes, IR-783 and MHI-148, in tumor cells and tissues.  IR-783 and MHI-148 were investigated for their ability to accumulate in human cancer cells, tumor xenografts, and spontaneous mouse tumors in transgenic animals.  Time- and concn.-dependent dye uptake and retention in normal and cancer cells and tissues were compared, and subcellular localization of the dyes and mechanisms of the dye uptake and retention in tumor cells were evaluated using organelle-specific tracking dyes and bromosulfophthalein, a competitive inhibitor of org. anion transporting peptides.  These dyes were used to detect human cancer metastases in a mouse model and differentiate cancer cells from normal cells in blood.  These near-IR heptamethine cyanine dyes were retained in cancer cells but not normal cells, in tumor xenografts, and in spontaneous tumors in transgenic mice.  They can be used to detect cancer metastasis and cancer cells in blood with a high degree of sensitivity.  The dyes were found to conc. in the mitochondria and lysosomes of cancer cells, probably through org. anion transporting peptides, because the dye uptake and retention in cancer cells can be blocked completely by bromosulfophthalein.  These dyes, when injected to mice, did not cause systemic toxicity.  These two heptamethine cyanine dyes are promising imaging agents for human cancers and can be further exploited to improve cancer detection, prognosis, and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGPPPJLJuOuLVg90H21EOLACvtfcHk0li_6Smm4qRxoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvF2hsrs%253D&md5=97002a4174f0188ab69a5bdb77755e60</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-0059%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DR.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DZhau%26aufirst%3DH.%2BE.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DV.%2BW.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DHenary%26aufirst%3DM.%26aulast%3DStrekowski%26aufirst%3DL.%26aulast%3DChung%26aufirst%3DL.%2BW.%2BK.%26atitle%3DNear%2520IR%2520Heptamethine%2520Cyanine%2520Dye-Mediated%2520Cancer%2520Imaging%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D2833%26epage%3D2844%26doi%3D10.1158%2F1078-0432.CCR-10-0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">A Near-infrared Fluorescent Heptamethine Indocyanine Dye with Preferential Tumor Accumulation for In Vivo Imaging</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">6612</span>– <span class="NLM_lpage">6617</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2010.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.biomaterials.2010.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=20542559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFKisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=6612-6617&author=C.+Zhangauthor=T.+Liuauthor=Y.+Suauthor=S.+Luoauthor=Y.+Zhuauthor=X.+Tanauthor=S.+Fanauthor=L.+Zhangauthor=Y.+Zhouauthor=T.+Chengauthor=C.+Shi&title=A+Near-infrared+Fluorescent+Heptamethine+Indocyanine+Dye+with+Preferential+Tumor+Accumulation+for+In+Vivo+Imaging&doi=10.1016%2Fj.biomaterials.2010.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging</span></div><div class="casAuthors">Zhang, Chao; Liu, Tao; Su, Yongping; Luo, Shenglin; Zhu, Ying; Tan, Xu; Fan, Song; Zhang, Lilong; Zhou, Yue; Cheng, Tianmin; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6612-6617</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Near-IR (NIR) fluorescence imaging holds great promise for tumor imaging due to low tissue autofluorescence and deep tissue penetration.  However, most tumor-targeting fluorescent probes require combination of targeting agents and fluorescent reporters.  In this study, we described a NIR heptamethine cyanine dye, IR-780 iodide, with preferential accumulation in multiple tumor cells without the necessity of chem. conjugation.  The IR-780 iodide was found to retain in tumors but not normal cells in multiple tumor xenografts in nude mice and chem.-induced lung tumors in C57BL/6 mice.  The fluorescent signal of tumors could persist at least 20 days with a significant signal-to-background ratio.  As a lipophilic cation, a predominant accumulation of IR-780 iodide was shown in the mitochondria of tumor cells owing to the high magnitude of mitochondrial membrane potential in tumor cells than normal cells.  We further showed that the transportation of IR-780 iodide into tumor cells was mediated by the org. anion transporter peptides (OATPs) because the dye accumulation was significantly inhibited by sulfobromophthalein (BSP), a competitive inhibitor of OATPs.  Our study shows that IR-780 iodide that preferentially accumulates in tumor cells and is natively NIR fluorescent would be useful in tumor detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvGjElacAyfbVg90H21EOLACvtfcHk0li_6Smm4qRxoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFKisrc%253D&md5=7cd88e4a01c8be0aec0d4c4356475142</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2010.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2010.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DA%2520Near-infrared%2520Fluorescent%2520Heptamethine%2520Indocyanine%2520Dye%2520with%2520Preferential%2520Tumor%2520Accumulation%2520for%2520In%2520Vivo%2520Imaging%26jtitle%3DBiomaterials%26date%3D2010%26volume%3D31%26spage%3D6612%26epage%3D6617%26doi%3D10.1016%2Fj.biomaterials.2010.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G. C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhau, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, L. W. K.</span></span> <span> </span><span class="NLM_article-title">Near-Infrared Fluorescence Heptamethine Carbocyanine Dyes Mediate Imaging and Targeted Drug Delivery for Human Brain Tumor</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2015.07.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.biomaterials.2015.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=26197410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyhtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=1-10&author=J.+B.+Wuauthor=C.+Shiauthor=G.+C.-Y.+Chuauthor=Q.+Xuauthor=Y.+Zhangauthor=Q.+Liauthor=J.+S.+Yuauthor=H.+E.+Zhauauthor=L.+W.+K.+Chung&title=Near-Infrared+Fluorescence+Heptamethine+Carbocyanine+Dyes+Mediate+Imaging+and+Targeted+Drug+Delivery+for+Human+Brain+Tumor&doi=10.1016%2Fj.biomaterials.2015.07.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor</span></div><div class="casAuthors">Wu, Jason Boyang; Shi, Changhong; Chu, Gina Chia-Yi; Xu, Qijin; Zhang, Yi; Li, Qinlong; Yu, John S.; Zhau, Haiyen E.; Chung, Leland W. K.</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Brain tumors and brain metastases are among the deadliest malignancies of all human cancers, largely due to the cellular blood-brain and blood-tumor barriers that limit the delivery of imaging and therapeutic agents from the systemic circulation to tumors.  Thus, improved strategies for brain tumor visualization and targeted treatment are critically needed.  Here we identified and synthesized a group of near-IR fluorescence (NIRF) heptamethine carbocyanine dyes and deriv. NIRF dye-drug conjugates for effective imaging and therapeutic targeting of brain tumors of either primary or metastatic origin in mice, which is mechanistically mediated by tumor hypoxia and org. anion-transporting polypeptide genes.  We also demonstrate that these dyes, when conjugated to chemotherapeutic agents such as gemcitabine, significantly restricted the growth of both intracranial glioma xenografts and prostate tumor brain metastases and prolonged survival in mice.  These results show promise in the application of NIRF dyes as novel theranostic agents for the detection and treatment of brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgeQV_yKtpHbVg90H21EOLACvtfcHk0li_6Smm4qRxoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyhtLfN&md5=a7e2cf51bdd6544767842b3b0ce6f947</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2015.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2015.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BB.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DChu%26aufirst%3DG.%2BC.-Y.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DJ.%2BS.%26aulast%3DZhau%26aufirst%3DH.%2BE.%26aulast%3DChung%26aufirst%3DL.%2BW.%2BK.%26atitle%3DNear-Infrared%2520Fluorescence%2520Heptamethine%2520Carbocyanine%2520Dyes%2520Mediate%2520Imaging%2520and%2520Targeted%2520Drug%2520Delivery%2520for%2520Human%2520Brain%2520Tumor%26jtitle%3DBiomaterials%26date%3D2015%26volume%3D67%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.biomaterials.2015.07.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, D.</span></span> <span> </span><span class="NLM_article-title">Review on Near-infrared Heptamethine Cyanine Dyes as Theranostic Agents for Tumor Imaging, Targeting, and Photodynamic Therapy</span>. <i>J. Biomed. Opt.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">050901</span>, <span class="refDoi"> DOI: 10.1117/1.JBO.21.5.050901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1117%2F1.JBO.21.5.050901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=27165449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC28bosVGkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=050901&author=C.+Shiauthor=J.+B.+Wuauthor=D.+Pan&title=Review+on+Near-infrared+Heptamethine+Cyanine+Dyes+as+Theranostic+Agents+for+Tumor+Imaging%2C+Targeting%2C+and+Photodynamic+Therapy&doi=10.1117%2F1.JBO.21.5.050901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy</span></div><div class="casAuthors">Shi Changhong; Wu Jason Boyang; Pan Dongfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedical optics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">50901</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A class of near-infrared fluorescence (NIRF) heptamethine cyanine dyes that are taken up and accumulated specifically in cancer cells without chemical conjugation have recently emerged as promising tools for tumor imaging and targeting.  In addition to their fluorescence and nuclear imaging-based tumor-imaging properties, these dyes can be developed as drug carriers to safely deliver chemotherapy drugs to tumors.  They can also be used as effective agents for photodynamic therapy with remarkable tumoricidal activity via photodependent cytotoxic activity.  The preferential uptake of dyes into cancer but not normal cells is co-operatively mediated by the prevailing activation of a group of organic anion-transporting polypeptides on cancer cell membranes, as well as tumor hypoxia and increased mitochondrial membrane potential in cancer cells.  Such mechanistic explorations have greatly advanced the current application and future development of NIRF dyes and their derivatives as anticancer theranostic agents.  This review summarizes current knowledge and emerging advances in NIRF dyes, including molecular characterization, photophysical properties, multimodal development and uptake mechanisms, and their growing potential for preclinical and clinical use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTJ1MFAJUM5vx2phytoz6_fW6udTcc2eYmjJjqQTPq_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bosVGkuw%253D%253D&md5=ea99cf33ad3dfd2406a87ee7728c2def</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1117%2F1.JBO.21.5.050901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1117%252F1.JBO.21.5.050901%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%2BB.%26aulast%3DPan%26aufirst%3DD.%26atitle%3DReview%2520on%2520Near-infrared%2520Heptamethine%2520Cyanine%2520Dyes%2520as%2520Theranostic%2520Agents%2520for%2520Tumor%2520Imaging%252C%2520Targeting%252C%2520and%2520Photodynamic%2520Therapy%26jtitle%3DJ.%2520Biomed.%2520Opt.%26date%3D2016%26volume%3D21%26spage%3D050901%26doi%3D10.1117%2F1.JBO.21.5.050901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">Mechanistic Study of IR-780 Dye as a Potential Tumor Targeting and Drug Delivery Agent</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">778</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2013.10.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.biomaterials.2013.10.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=24148240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yitb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=771-778&author=E.+Zhangauthor=S.+Luoauthor=X.+Tanauthor=C.+Shi&title=Mechanistic+Study+of+IR-780+Dye+as+a+Potential+Tumor+Targeting+and+Drug+Delivery+Agent&doi=10.1016%2Fj.biomaterials.2013.10.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent</span></div><div class="casAuthors">Zhang, Erlong; Luo, Shenglin; Tan, Xu; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">771-778</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">IR-780 iodide, a near-IR fluorescent heptamethine dye, has been recently characterized to exhibit preferential accumulation property in the mitochondria of tumor cells.  In this study, we investigated the possible mechanisms for its tumor selective activity and its potential as a drug delivery carrier.  Results showed that the energy-dependent uptake of IR-780 iodide into the mitochondria of tumor cells was affected by glycolysis and plasma membrane potential.  Moreover, OATP1B3 subtype of org. anion transporter peptides (OATPs) may play a dominant role in the transportation of IR-780 iodide into tumor cells, while cellular endocytosis, mitochondrial membrane potential and the ATP-binding cassette transporters did not show significant influence to its accumulation.  We further evaluated the potential of IR-780 iodide as a drug delivery carrier by covalent conjugation of IR-780 with nitrogen mustard (IR-780NM).  In vivo imaging showed that IR-780NM remained the tumor targeting property, indicating that IR-780 iodide could be potentially applied as a drug delivery agent for cancer targeted imaging and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog7OizKmeZ5bVg90H21EOLACvtfcHk0liavJemLtkK0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yitb7O&md5=f53ae1e7857dd901bc1da574806c61e1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2013.10.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2013.10.033%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DMechanistic%2520Study%2520of%2520IR-780%2520Dye%2520as%2520a%2520Potential%2520Tumor%2520Targeting%2520and%2520Drug%2520Delivery%2520Agent%26jtitle%3DBiomaterials%26date%3D2014%26volume%3D35%26spage%3D771%26epage%3D778%26doi%3D10.1016%2Fj.biomaterials.2013.10.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaikari, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kota, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhaveri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groshen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofman, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, J. C.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase A (MAO A) Inhibitors Decrease Glioma Progression</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13842</span>– <span class="NLM_lpage">13853</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.18632%2Foncotarget.7283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=26871599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC28npvF2qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13842-13853&author=S.+Kushalauthor=W.+Wangauthor=V.+P.+Vaikariauthor=R.+Kotaauthor=K.+Chenauthor=T.-S.+Yehauthor=N.+Jhaveriauthor=S.+L.+Groshenauthor=B.+Z.+Olenyukauthor=T.+C.+Chenauthor=F.+M.+Hofmanauthor=J.+C.+Shih&title=Monoamine+Oxidase+A+%28MAO+A%29+Inhibitors+Decrease+Glioma+Progression&doi=10.18632%2Foncotarget.7283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase A (MAO A) inhibitors decrease glioma progression</span></div><div class="casAuthors">Kushal Swati; Vaikari Vijaya Pooja; Kota Rajesh; Chen Kevin; Yeh Tzu-Shao; Olenyuk Bogdan Z; Shih Jean C; Kushal Swati; Wang Weijun; Vaikari Vijaya Pooja; Kota Rajesh; Chen Kevin; Yeh Tzu-Shao; Chen Thomas C; Hofman Florence M; Shih Jean C; Wang Weijun; Chen Thomas C; Hofman Florence M; Yeh Tzu-Shao; Shih Jean C; Jhaveri Niyati; Hofman Florence M; Groshen Susan L; Shih Jean C</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">13842-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma (GBM) is an aggressive brain tumor which is currently treated with temozolomide (TMZ).  Tumors usually become resistant to TMZ and recur; no effective therapy is then available.  Monoamine Oxidase A (MAO A) oxidizes monoamine neurotransmitters resulting in reactive oxygen species which cause cancer.  This study shows that MAO A expression is increased in human glioma tissues and cell lines.  MAO A inhibitors, clorgyline or the near-infrared-dye MHI-148 conjugated to clorgyline (NMI), were cytotoxic for glioma and decreased invasion in vitro.  Using the intracranial TMZ-resistant glioma model, clorgyline or NMI alone or in combination with low-dose TMZ reduced tumor growth and increased animal survival.  NMI was localized specifically to the tumor.  Immunocytochemistry studies showed that the MAO A inhibitor reduced proliferation, microvessel density and invasion, and increased macrophage infiltration.  In conclusion, we have identified MAO A inhibitors as potential novel stand-alone drugs or as combination therapy with low dose TMZ for drug-resistant gliomas.  NMI can also be used as a non-invasive imaging tool.  Thus has a dual function for both therapy and diagnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrf8QTiCasNgwxfk_AGB-EfW6udTcc2eYmjJjqQTPq_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28npvF2qsA%253D%253D&md5=cc8c65fe768793756d82a91e8377b812</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7283%26sid%3Dliteratum%253Aachs%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DVaikari%26aufirst%3DV.%2BP.%26aulast%3DKota%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DYeh%26aufirst%3DT.-S.%26aulast%3DJhaveri%26aufirst%3DN.%26aulast%3DGroshen%26aufirst%3DS.%2BL.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DChen%26aufirst%3DT.%2BC.%26aulast%3DHofman%26aufirst%3DF.%2BM.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DMonoamine%2520Oxidase%2520A%2520%2528MAO%2520A%2529%2520Inhibitors%2520Decrease%2520Glioma%2520Progression%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D13842%26epage%3D13853%26doi%3D10.18632%2Foncotarget.7283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dasari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinaro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, N.</span></span> <span> </span><span class="NLM_article-title">H-Gemcitabine: A New Gemcitabine Prodrug for Treating Cancer</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/bc300095m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc300095m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaqu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=4-8&author=M.+Dasariauthor=A.+P.+Acharyaauthor=D.+Kimauthor=S.+Leeauthor=S.+Leeauthor=J.+Rheaauthor=R.+Molinaroauthor=N.+Murthy&title=H-Gemcitabine%3A+A+New+Gemcitabine+Prodrug+for+Treating+Cancer&doi=10.1021%2Fbc300095m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">H-Gemcitabine: A New Gemcitabine Prodrug for Treating Cancer</span></div><div class="casAuthors">Dasari, Madhuri; Acharya, Abhinav P.; Kim, Dongin; Lee, Seungjun; Lee, Sungmun; Rhea, Jeanne; Molinaro, Ross; Murthy, Niren</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-8</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this report, we present a new strategy for targeting chemotherapeutics to tumors, based on targeting extracellular DNA.  A gemcitabine prodrug (I) was synthesized, termed H-gemcitabine, which is composed of Hoechst conjugated to gemcitabine.  H-gemcitabine has low toxicity because it is membrane-impermeable; however, it still has high tumor efficacy because of its ability to target gemcitabine to E-DNA in tumors.  We demonstrate here that H-gemcitabine has a wider therapeutic window than free gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaarjwWWYWq7Vg90H21EOLACvtfcHk0lholq_GbfIhdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaqu77N&md5=326311706a2a58c2ef17af1e340e481f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbc300095m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc300095m%26sid%3Dliteratum%253Aachs%26aulast%3DDasari%26aufirst%3DM.%26aulast%3DAcharya%26aufirst%3DA.%2BP.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DRhea%26aufirst%3DJ.%26aulast%3DMolinaro%26aufirst%3DR.%26aulast%3DMurthy%26aufirst%3DN.%26atitle%3DH-Gemcitabine%253A%2520A%2520New%2520Gemcitabine%2520Prodrug%2520for%2520Treating%2520Cancer%26jtitle%3DBioconjugate%2520Chem.%26date%3D2013%26volume%3D24%26spage%3D4%26epage%3D8%26doi%3D10.1021%2Fbc300095m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee Jae, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">11657</span>– <span class="NLM_lpage">11662</span>, <span class="refDoi"> DOI: 10.1021/ja405372k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405372k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=11657-11662&author=Z.+Yangauthor=H.+Lee+Jaeauthor=H.+M.+Jeonauthor=J.+H.+Hanauthor=N.+Parkauthor=Y.+Heauthor=H.+Leeauthor=K.+S.+Hongauthor=C.+Kangauthor=J.+S.+Kim&title=Folate-Based+Near-Infrared+Fluorescent+Theranostic+Gemcitabine+Delivery&doi=10.1021%2Fja405372k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery</span></div><div class="casAuthors">Yang, Zhigang; Lee, Jae Hong; Jeon, Hyun Mi; Han, Ji Hye; Park, Nayoung; He, Yanxia; Lee, Hyunseung; Hong, Kwan Soo; Kang, Chulhun; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11657-11662</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of heptamethine cyanine derivs. bearing a carbamate Et disulfide group and gemcitabine, an anticancer drug, have been newly synthesized.  Their disulfide bonds are readily cleaved by various thiols including glutathione, to result in a subsequent decompn. of the carbamate into amine followed by release of the active gemcitabine, which can be monitored by the fluorescence changes.  In the biol. expt., prodrug (I) is preferentially up-taken by folate-pos. KB cells over folate-neg. A549 cells via receptor-mediated endocytosis to release gemcitabine causing cell death and to emit fluorescence in endoplasmic reticulum.  Moreover, it is selectively accumulated in the KB cells which were treated to mice by dorsal s.c. injection.  This drug delivery system is a new theranostic agent, wherein both therapeutic effect and drug uptake can be easily monitored at the subcellular level, by in vivo and in vitro fluorescence imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGxwlND_CfJbVg90H21EOLACvtfcHk0lholq_GbfIhdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsrbP&md5=04a9f30059882d60566b5f0aa108afcb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja405372k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405372k%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLee%2BJae%26aufirst%3DH.%26aulast%3DJeon%26aufirst%3DH.%2BM.%26aulast%3DHan%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DK.%2BS.%26aulast%3DKang%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DFolate-Based%2520Near-Infrared%2520Fluorescent%2520Theranostic%2520Gemcitabine%2520Delivery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D11657%26epage%3D11662%26doi%3D10.1021%2Fja405372k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barile, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emdad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morvaridi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandol, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Therapy of Pancreatic Cancer via an EphA2 Receptor-Targeted Delivery of Gemcitabine</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">17103</span>– <span class="NLM_lpage">17110</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.18632%2Foncotarget.7931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=26959746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC28jotlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=17103-17110&author=B.+A.+Quinnauthor=S.+Wangauthor=E.+Barileauthor=S.+K.+Dasauthor=L.+Emdadauthor=D.+Sarkarauthor=S.+K.+Deauthor=S.+K.+Morvaridiauthor=J.+L.+Stebbinsauthor=S.+J.+Pandolauthor=P.+B.+Fisherauthor=M.+Pellecchia&title=Therapy+of+Pancreatic+Cancer+via+an+EphA2+Receptor-Targeted+Delivery+of+Gemcitabine&doi=10.18632%2Foncotarget.7931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine</span></div><div class="casAuthors">Quinn Bridget A; Das Swadesh K; Emdad Luni; Sarkar Devanand; Fisher Paul B; Wang Si; Barile Elisa; De Surya K; Stebbins John L; Fisher Paul B; Pellecchia Maurizio; Barile Elisa; De Surya K; Pellecchia Maurizio; Morvaridi Susan Kharagh; Pandol Stephen J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">17103-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">First line treatment for pancreatic cancer consists of surgical resection, if possible, and a subsequent course of chemotherapy using the nucleoside analogue gemcitabine.  In some patients, an active transport mechanism allows gemcitabine to enter efficiently into the tumor cells, resulting in a significant clinical benefit.  However, in most patients, low expression of gemcitabine transporters limits the efficacy of the drug to marginal levels, and patients need frequent administration of the drug at high doses, significantly increasing systemic drug toxicity.  In this article we focus on a novel targeted delivery approach for gemcitabine consisting of conjugating the drug with an EphA2 targeting agent.  We show that the EphA2 receptor is highly expressed in pancreatic cancers, and accordingly, the drug-conjugate is more effective than gemcitabine alone in targeting pancreatic tumors.  Our preliminary observations suggest that this approach may provide a general benefit to pancreatic cancer patients and offers a comprehensive strategy for enhancing delivery of diverse therapeutic agents to a wide range of cancers overexpressing EphA2, thereby potentially reducing toxicity while enhancing therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkle74R4yp-ekdrW1FkXG-fW6udTcc2eY8XciUHaKmBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jotlGitA%253D%253D&md5=0b5e311729fc3517d90882844ab3d3f2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7931%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DB.%2BA.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBarile%26aufirst%3DE.%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DEmdad%26aufirst%3DL.%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DDe%26aufirst%3DS.%2BK.%26aulast%3DMorvaridi%26aufirst%3DS.%2BK.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DPandol%26aufirst%3DS.%2BJ.%26aulast%3DFisher%26aufirst%3DP.%2BB.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DTherapy%2520of%2520Pancreatic%2520Cancer%2520via%2520an%2520EphA2%2520Receptor-Targeted%2520Delivery%2520of%2520Gemcitabine%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D17103%26epage%3D17110%26doi%3D10.18632%2Foncotarget.7931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span> <span> </span><span class="NLM_article-title">Structure-inherent Near-infrared Fluorescent Probe Mediates Apoptosis Imaging and Targeted Drug Delivery In Vivo</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2016.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.dyepig.2016.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFymu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=204-212&author=X.+Zhangauthor=N.+Zhaoauthor=B.+Wangauthor=Z.+Tianauthor=Y.+Daiauthor=P.+Ningauthor=D.+Chen&title=Structure-inherent+Near-infrared+Fluorescent+Probe+Mediates+Apoptosis+Imaging+and+Targeted+Drug+Delivery+In+Vivo&doi=10.1016%2Fj.dyepig.2016.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-inherent near-infrared fluorescent probe mediates apoptosis imaging and targeted drug delivery in vivo</span></div><div class="casAuthors">Zhang, Xianghan; Zhao, Na; Wang, Bo; Tian, Zuhong; Dai, Yunpeng; Ning, Pengbo; Chen, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204-212</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Imaging of tumor apoptosis can provide invaluable information in regards to drug treatment effectiveness, drug development and tumor therapeutic response.  Thus, the development of apoptotic specific and sensitive targeted fluorescence probes is critically needed.  In this work, we developed a novel and simple one-step synthetic method for producing monocarboxylate near-IR cyanine dyes.  The hydrophobic cationic dyes possess advantageous optical properties and good membrane permeability.  One hydrophilic zwitterionic probe is able to both increase specificity and image apoptotic cells owing to its inherent chem. structure.  Furthermore, we conjugated the probe with the antitumor drug gemcitabine for effective apoptosis imaging and therapeutic targeting of gastric tumors in vitro and in vivo.  The novel dye-drug conjugate imaged apoptosis successfully in vitro and in vivo and restricted the growth of SGC7901 s.c. xenograft models.  This strategy may offer the advantages of NIR apoptosis imaging probes for non-invasive tumor imaging and should provide the application for targeted drug delivery and the evaluation of therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtYrK2IzDbcLVg90H21EOLACvtfcHk0liyd4-dbWk82w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFymu7bK&md5=b8b1c560c1bdaf35c980f7e323d459bb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2016.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2016.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DNing%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DD.%26atitle%3DStructure-inherent%2520Near-infrared%2520Fluorescent%2520Probe%2520Mediates%2520Apoptosis%2520Imaging%2520and%2520Targeted%2520Drug%2520Delivery%2520In%2520Vivo%26jtitle%3DDyes%2520Pigm.%26date%3D2017%26volume%3D138%26spage%3D204%26epage%3D212%26doi%3D10.1016%2Fj.dyepig.2016.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usama, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span> <span> </span><span class="NLM_article-title">Site-specific Labeling of Proteins with Near-IR Dyes</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2900</span>, <span class="refDoi"> DOI: 10.3390/molecules23112900</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.3390%2Fmolecules23112900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVWgsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=2900&author=C.-M.+Linauthor=S.+M.+Usamaauthor=K.+Burgess&title=Site-specific+Labeling+of+Proteins+with+Near-IR+Dyes&doi=10.3390%2Fmolecules23112900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific labeling of proteins with near-IR heptamethine cyanine dyes</span></div><div class="casAuthors">Lin, Chen-Ming; Usama, Syed Muhammad; Burgess, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2900/1-2900/11</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Convenient labeling of proteins is important for observing its function under physiol. conditions.  In tissues particularly, heptamethine cyanine dyes (Cy-7) are valuable because they absorb in the near-IR (NIR) region (750-900 nm) where light penetration is maximal.  In this work, we found Cy-7 dyes with a meso-C1 functionality covalently binding to proteins with free Cys residues under physiol. conditions (aq. environments, at near neutral pH, and 37 °C).  It transpired that the meso-Cl of the dye was displaced by free thiols in protein, while nucleophilic side-chains from amino acids like Tyr, Lys, and Ser did not react.  This finding shows a new possibility for convenient and selective labeling of proteins with NIR fluorescent probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph0WcsC-7-zrVg90H21EOLACvtfcHk0liyd4-dbWk82w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVWgsrvF&md5=65d3742978c72536efd068c5e7a48d47</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23112900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23112900%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.-M.%26aulast%3DUsama%26aufirst%3DS.%2BM.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DSite-specific%2520Labeling%2520of%2520Proteins%2520with%2520Near-IR%2520Dyes%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D2900%26doi%3D10.3390%2Fmolecules23112900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usama, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span> <span> </span><span class="NLM_article-title">On the Mechanisms of Update of Tumor-seeking Cyanine Dyes</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">3886</span>– <span class="NLM_lpage">3895</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOnu7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=3886-3895&author=S.+M.+Usamaauthor=C.-M.+Linauthor=K.+Burgess&title=On+the+Mechanisms+of+Update+of+Tumor-seeking+Cyanine+Dyes&doi=10.1021%2Facs.bioconjchem.8b00708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">On the Mechanisms of Uptake of Tumor-Seeking Cyanine Dyes</span></div><div class="casAuthors">Usama, Syed Muhammad; Lin, Chen-Ming; Burgess, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3886-3895</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. entities that localize in tumor tissue are clin. important for targeted delivery of diagnostic, imaging, and therapeutic reagents.  Often these targeting entities are designed for specific receptors (eg EGFR or integrin receptors).  However, there is a subset of cyanine-7 dyes that apparently localize in every type of solid tumor tissue (at least, no exceptions have been reported so far), and they persist there for several days.  Consequently, these dyes can be used for near-IR optical imaging of tumors in animal studies, they can be conjugated with cytotoxic species to give exptl. theranostics, and there is potential for expanding their use into the development of clin. useful derivs.  Data presented in the literature and in this work indicate the half-live of these compds. in serum at 37 °C is of the order of minutes to a few hours, so what accounts for the persistent fluorescence of these dyes in tumor tissue over periods of several days.  Literature, solely based on tissue culture expts. featuring a particular receptor blocker, indicates that uptake of these dyes is mediated by the org. anion transporter proteins (OATPs).  Data presented in this paper agrees with that conclusion for short-term uptake, but significantly expands understanding of the likely reasons for long-term uptake and persistent tumor localization in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoexlK2uA0etLVg90H21EOLACvtfcHk0liyd4-dbWk82w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOnu7bJ&md5=895fbe8c2e3ff50985d09874881ebb11</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00708%26sid%3Dliteratum%253Aachs%26aulast%3DUsama%26aufirst%3DS.%2BM.%26aulast%3DLin%26aufirst%3DC.-M.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DOn%2520the%2520Mechanisms%2520of%2520Update%2520of%2520Tumor-seeking%2520Cyanine%2520Dyes%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D3886%26epage%3D3895%26doi%3D10.1021%2Facs.bioconjchem.8b00708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levitt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitt, M. D.</span></span> <span> </span><span class="NLM_article-title">Human Serum Albumin Homeostasis: a New Look at the Roles of Synthesis, Catabolism, Renal and Gastrointestinal Excretion, and the Clinical Value of Serum Albumin Measurements</span>. <i>Int. J. Gen. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.2147/IJGM.S102819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.2147%2FIJGM.S102819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=27486341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1OrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=229-255&author=D.+G.+Levittauthor=M.+D.+Levitt&title=Human+Serum+Albumin+Homeostasis%3A+a+New+Look+at+the+Roles+of+Synthesis%2C+Catabolism%2C+Renal+and+Gastrointestinal+Excretion%2C+and+the+Clinical+Value+of+Serum+Albumin+Measurements&doi=10.2147%2FIJGM.S102819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements</span></div><div class="casAuthors">Levitt, David G.; Levitt, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of General Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">229-255</span>CODEN:
                <span class="NLM_cas:coden">IJGMBG</span>;
        ISSN:<span class="NLM_cas:issn">1178-7074</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Serum albumin concn. (CP) is a remarkably strong prognostic indicator of morbidity and mortality in both sick and seemingly healthy subjects.  Surprisingly, the specifics of the pathophysiol. underlying the relationship between CP and ill-health are poorly understood.  This review provides a summary that is not previously available in the literature, concerning how synthesis, catabolism, and renal and gastrointestinal clearance of albumin interact to bring about albumin homeostasis, with a focus on the clin. factors that influence this homeostasis.  In normal humans, the albumin turnover time of about 25 days reflects a liver albumin synthesis rate of about 10.5 g/day balanced by renal (≈6%), gastrointestinal (≈10%), and catabolic (≈84%) clearances.  The acute development of hypoalbuminemia with sepsis or trauma results from increased albumin capillary permeability leading to redistribution of albumin from the vascular to interstitial space.  The best understood mechanism of chronic hypoalbuminemia is the decreased albumin synthesis obsd. in liver disease.  Decreased albumin prodn. also accounts for hypoalbuminemia obsd. with a low-protein and normal caloric diet.  However, a calorie- and protein-deficient diet does not reduce albumin synthesis and is not assocd. with hypoalbuminemia, and CP is not a useful marker of malnutrition.  In most disease states other than liver disease, albumin synthesis is normal or increased, and hypoalbuminemia reflects an enhanced rate of albumin turnover resulting either from an increased rate of catabolism (a poorly understood phenomenon) or enhanced loss of albumin into the urine (nephrosis) or intestine (protein-losing enteropathy).  The latter may occur with subtle intestinal pathol. and hence may be more prevalent than commonly appreciated.  Clin., reduced CP appears to be a result rather than a cause of ill-health, and therapy designed to increase CP has limited benefit.  The ubiquitous occurrence of hypoalbuminemia in disease states limits the diagnostic utility of the CP measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKR3oLyDIoObVg90H21EOLACvtfcHk0lhvSpK5kBo21g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1OrsL0%253D&md5=d089ab0a8d8b1e6ab698f5f69e84b7d9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2147%2FIJGM.S102819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJGM.S102819%26sid%3Dliteratum%253Aachs%26aulast%3DLevitt%26aufirst%3DD.%2BG.%26aulast%3DLevitt%26aufirst%3DM.%2BD.%26atitle%3DHuman%2520Serum%2520Albumin%2520Homeostasis%253A%2520a%2520New%2520Look%2520at%2520the%2520Roles%2520of%2520Synthesis%252C%2520Catabolism%252C%2520Renal%2520and%2520Gastrointestinal%2520Excretion%252C%2520and%2520the%2520Clinical%2520Value%2520of%2520Serum%2520Albumin%2520Measurements%26jtitle%3DInt.%2520J.%2520Gen.%2520Med.%26date%3D2016%26volume%3D9%26spage%3D229%26epage%3D255%26doi%3D10.2147%2FIJGM.S102819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Simple Bioconjugate Chemistry Serves Great Clinical Advances: Albumin as a Versatile Platform for Diagnosis and Precision Therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1039/C5CS00158G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1039%2FC5CS00158G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=26771036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=1432-1456&author=Z.+Liuauthor=X.+Chen&title=Simple+Bioconjugate+Chemistry+Serves+Great+Clinical+Advances%3A+Albumin+as+a+Versatile+Platform+for+Diagnosis+and+Precision+Therapy&doi=10.1039%2FC5CS00158G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy</span></div><div class="casAuthors">Liu, Zhibo; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1432-1456</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Albumin is the most abundant circulating protein in plasma and has recently emerged as a versatile protein carrier for drug targeting and for improving the pharmacokinetic profile of peptide or protein based drugs.  Three drug delivery technologies related to albumin have been developed, which include the coupling of low-mol. wt. drugs to exogenous or endogenous albumin, conjugating bioactive proteins by albumin fusion technol. (AFT), and encapsulation of drugs into albumin nanoparticles.  This review article starts with a brief introduction of human serum albumin (HSA), and then summarizes the mainstream chem. strategies of developing HSA binding mols. for coupling with drug mols.  Moreover, we also concisely condense the recent progress of the most important clin. applications of HSA-binding platforms, and specify the current challenges that need to be met for a bright future of HSA-binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX_KUb4v-V6LVg90H21EOLACvtfcHk0lhvSpK5kBo21g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVKkug%253D%253D&md5=6cbd8231b0f3dcdd776d464a835d535e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC5CS00158G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00158G%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DSimple%2520Bioconjugate%2520Chemistry%2520Serves%2520Great%2520Clinical%2520Advances%253A%2520Albumin%2520as%2520a%2520Versatile%2520Platform%2520for%2520Diagnosis%2520and%2520Precision%2520Therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D1432%26epage%3D1456%26doi%3D10.1039%2FC5CS00158G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frei, E.</span></span> <span> </span><span class="NLM_article-title">Albumin Binding Ligands and Albumin Conjugate Uptake by Cancer Cells</span>. <i>Diabetol. Metab. Syndr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi"> DOI: 10.1186/1758-5996-3-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1186%2F1758-5996-3-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=21676260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Gmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=11&author=E.+Frei&title=Albumin+Binding+Ligands+and+Albumin+Conjugate+Uptake+by+Cancer+Cells&doi=10.1186%2F1758-5996-3-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin binding ligands and albumin conjugate uptake by cancer cells</span></div><div class="casAuthors">Frei, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Diabetology & Metabolic Syndrome</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11</span>CODEN:
                <span class="NLM_cas:coden">DMSIBU</span>;
        ISSN:<span class="NLM_cas:issn">1758-5996</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The scope of this short review is to summarise the knowledge gleaned from the fate of drugs transported by albumin upon contact with the target cancer cell or cells in inflamed tissues.  The authors expertise covers covalently bound drugs and their cellular uptake and release from albumin.  This review therefore aims to deduce what will happen to drugs such as insulin detemir which is considered to bind non-covalently to albumin and may have a fate similar to fatty acids transported by albumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEAGqCuOopDLVg90H21EOLACvtfcHk0lhvSpK5kBo21g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Gmt7s%253D&md5=95b808fa029e5a56eded077308199f7f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2F1758-5996-3-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-5996-3-11%26sid%3Dliteratum%253Aachs%26aulast%3DFrei%26aufirst%3DE.%26atitle%3DAlbumin%2520Binding%2520Ligands%2520and%2520Albumin%2520Conjugate%2520Uptake%2520by%2520Cancer%2520Cells%26jtitle%3DDiabetol.%2520Metab.%2520Syndr.%26date%3D2011%26volume%3D3%26spage%3D11%26doi%3D10.1186%2F1758-5996-3-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stehle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrenk, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier-Borst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heene, D. L.</span></span> <span> </span><span class="NLM_article-title">The Loading Rate Determines Tumor Targeting Properties of Methotrexate-albumin Conjugates in Rats</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1097/00001813-199708000-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1097%2F00001813-199708000-00006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=667-685&author=G.+Stehleauthor=H.+Sinnauthor=A.+Wunderauthor=H.+H.+Schrenkauthor=S.+Schuttauthor=W.+Maier-Borstauthor=D.+L.+Heene&title=The+Loading+Rate+Determines+Tumor+Targeting+Properties+of+Methotrexate-albumin+Conjugates+in+Rats&doi=10.1097%2F00001813-199708000-00006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1097%2F00001813-199708000-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-199708000-00006%26sid%3Dliteratum%253Aachs%26aulast%3DStehle%26aufirst%3DG.%26aulast%3DSinn%26aufirst%3DH.%26aulast%3DWunder%26aufirst%3DA.%26aulast%3DSchrenk%26aufirst%3DH.%2BH.%26aulast%3DSchutt%26aufirst%3DS.%26aulast%3DMaier-Borst%26aufirst%3DW.%26aulast%3DHeene%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Loading%2520Rate%2520Determines%2520Tumor%2520Targeting%2520Properties%2520of%2520Methotrexate-albumin%2520Conjugates%2520in%2520Rats%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D1997%26volume%3D8%26spage%3D667%26epage%3D685%26doi%3D10.1097%2F00001813-199708000-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canovas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellaye, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romieu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, V.</span></span> <span> </span><span class="NLM_article-title">Site-specific Near-infrared Fluorescent Labelling of Proteins on Cysteine Residues with Meso-chloro-substituted Heptamethine Cyanine Dyes</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">8831</span>– <span class="NLM_lpage">8836</span>, <span class="refDoi"> DOI: 10.1039/C8OB02646G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1039%2FC8OB02646G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=30411777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyhsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=8831-8836&author=C.+Canovasauthor=P.-S.+Bellayeauthor=M.+Moreauauthor=A.+Romieuauthor=F.+Denatauthor=V.+Goncalves&title=Site-specific+Near-infrared+Fluorescent+Labelling+of+Proteins+on+Cysteine+Residues+with+Meso-chloro-substituted+Heptamethine+Cyanine+Dyes&doi=10.1039%2FC8OB02646G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific near-infrared fluorescent labelling of proteins on cysteine residues with meso-chloro-substituted heptamethine cyanine dyes</span></div><div class="casAuthors">Canovas, Coline; Bellaye, Pierre-Simon; Moreau, Mathieu; Romieu, Anthony; Denat, Franck; Goncalves, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8831-8836</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Near-IR (NIR) fluorescence imaging is a promising new medical imaging modality.  Assocd. with a targeting mol., NIR fluorophores can accumulate selectively in tissues of interest and become valuable tools for the diagnosis and therapy of various pathologies.  To facilitate the design of targeted NIR imaging agents, it is important to identify simple and affordable fluorescent probes, allowing rapid labeling of biovectors such as proteins, ideally in a site-specific manner.  Here, we demonstrate that heptamethine cyanine based fluorophores, such as IR-783, that contain a chloro-cyclohexyl moiety within their polymethine chain can react selectively, at neutral pH, with cysteine residues in proteins to give stable, site-specifically labeled conjugates, that emit in the NIR spectral window.  This reaction is exemplified with the labeling of peptides and two protein models: albumin and a Fab' antibody fragment.  The resulting fluorescent proteins are stable and suitable for in vivo NIR imaging applications, as shown on a mice model.  This straightforward one-step procedure, that does not require the prior derivatisation of the fluorophore with a bioconjugatable handle, should facilitate the prodn. and use of near-IR labeled proteins in life sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXzYUbIi6th7Vg90H21EOLACvtfcHk0lhtOb6gLDCu8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyhsbrI&md5=cfbda9533268404a37f3d678f52eac07</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC8OB02646G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8OB02646G%26sid%3Dliteratum%253Aachs%26aulast%3DCanovas%26aufirst%3DC.%26aulast%3DBellaye%26aufirst%3DP.-S.%26aulast%3DMoreau%26aufirst%3DM.%26aulast%3DRomieu%26aufirst%3DA.%26aulast%3DDenat%26aufirst%3DF.%26aulast%3DGoncalves%26aufirst%3DV.%26atitle%3DSite-specific%2520Near-infrared%2520Fluorescent%2520Labelling%2520of%2520Proteins%2520on%2520Cysteine%2520Residues%2520with%2520Meso-chloro-substituted%2520Heptamethine%2520Cyanine%2520Dyes%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2018%26volume%3D16%26spage%3D8831%26epage%3D8836%26doi%3D10.1039%2FC8OB02646G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koolen, S. L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witteveen, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langenberg, M. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronemeijer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ribas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhadji, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slapak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voest, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H. M.</span></span> <span> </span><span class="NLM_article-title">Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6071</span>– <span class="NLM_lpage">6082</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-0353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1158%2F1078-0432.CCR-11-0353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=21753156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOitb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6071-6082&author=S.+L.+W.+Koolenauthor=P.+O.+Witteveenauthor=R.+S.+Jansenauthor=M.+H.+G.+Langenbergauthor=R.+H.+Kronemeijerauthor=A.+Nolauthor=I.+Garcia-Ribasauthor=S.+Calliesauthor=K.+A.+Benhadjiauthor=C.+A.+Slapakauthor=J.+H.+Beijnenauthor=E.+E.+Voestauthor=J.+H.+M.+Schellens&title=Phase+I+Study+of+Oral+Gemcitabine+Prodrug+%28LY2334737%29+Alone+and+in+Combination+with+Erlotinib+in+Patients+with+Advanced+Solid+Tumors&doi=10.1158%2F1078-0432.CCR-11-0353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Koolen, Stijn L. W.; Witteveen, Petronella O.; Jansen, Robert S.; Langenberg, Marlies H. G.; Kronemeijer, Roelien H.; Nol, Annemarie; Garcia-Ribas, Ignacio; Callies, Sophie; Benhadji, Karim A.; Slapak, Christopher A.; Beijnen, Jos H.; Voest, Emile E.; Schellens, Jan H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6071-6082</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: LY2334737 is an orally available prodrug of gemcitabine.  The objective of this study was to det. the max. tolerated dose (MTD) and dose limiting toxicities (DLT) of daily administration of LY2334737 with or without erlotinib.  Exptl. Design: Patients with advanced or metastatic cancer were treated with escalating doses of LY2334737 monotherapy or in combination with continuous daily administration of 100 mg erlotinib.  LY2334737 was given once daily for 14 days of a 21-day cycle.  The study was extended with a bioequivalence trial to investigate a novel LY2334737 drug formulation.  RESULTS: A total of 65 patients were treated in this study.  The MTD was 40 mg LY2334737.  Fatigue was the most frequent DLT for LY2334737 monotherapy (4 patients) followed by elevated transaminase levels (2 patients), both obsd. at the 40- to 50-mg dose levels.  Among the 10 patients in the combination arm, 2 had DLTs at the 40-mg dose level.  These were fatigue and elevated liver enzyme levels.  The most common adverse events were fatigue (n = 38), nausea (n = 27), vomiting (n = 24), diarrhea (n = 23), anorexia (n = 20), pyrexia (n = 18), and elevated transaminase levels (n = 14).  The pharmacokinetics showed dose proportional increase in LY2334737 and gemcitabine exposure.  The metabolite 2',2'-difluorodeoxyuridine accumulated with an accumulation index of 4.3 (coeff. of variation: 20%).  In one patient, complete response in prostate-specific antigen was obsd. for 4 cycles, and stable disease was achieved in 22 patients overall.  Pharmacokinetic anal. showed that the 2 investigated LY2334737 drug formulations were bioequivalent.  CONCLUSIONS: LY2334737 displays linear pharmacokinetics and the MTD is 40 mg with or without daily administration of 100 mg erlotinib.  Signs of antitumor activity warrant further development.  Clin Cancer Res; 17(18); 6071-82.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34fxoY2J29LVg90H21EOLACvtfcHk0lhtOb6gLDCu8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOitb3P&md5=0bd39336d09f2e9c0bc4505b3e63332e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0353%26sid%3Dliteratum%253Aachs%26aulast%3DKoolen%26aufirst%3DS.%2BL.%2BW.%26aulast%3DWitteveen%26aufirst%3DP.%2BO.%26aulast%3DJansen%26aufirst%3DR.%2BS.%26aulast%3DLangenberg%26aufirst%3DM.%2BH.%2BG.%26aulast%3DKronemeijer%26aufirst%3DR.%2BH.%26aulast%3DNol%26aufirst%3DA.%26aulast%3DGarcia-Ribas%26aufirst%3DI.%26aulast%3DCallies%26aufirst%3DS.%26aulast%3DBenhadji%26aufirst%3DK.%2BA.%26aulast%3DSlapak%26aufirst%3DC.%2BA.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DVoest%26aufirst%3DE.%2BE.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DPhase%2520I%2520Study%2520of%2520Oral%2520Gemcitabine%2520Prodrug%2520%2528LY2334737%2529%2520Alone%2520and%2520in%2520Combination%2520with%2520Erlotinib%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D6071%26epage%3D6082%26doi%3D10.1158%2F1078-0432.CCR-11-0353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, G.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-S.</span></span> <span> </span><span class="NLM_article-title">CD133 Antibody-conjugated Immunoliposomes Encapsulating Gemcitabine for Targeting Glioblastoma Stem Cells</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3771</span>– <span class="NLM_lpage">3781</span>, <span class="refDoi"> DOI: 10.1039/c4tb00185k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1039%2Fc4tb00185k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVanur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=3771-3781&author=D.+H.+Shinauthor=S.+Xuanauthor=W.-Y.+Kimauthor=G.-U.+Baeauthor=J.-S.+Kim&title=CD133+Antibody-conjugated+Immunoliposomes+Encapsulating+Gemcitabine+for+Targeting+Glioblastoma+Stem+Cells&doi=10.1039%2Fc4tb00185k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">CD133 antibody-conjugated immunoliposomes encapsulating gemcitabine for targeting glioblastoma stem cells</span></div><div class="casAuthors">Shin, Dae Hwan; Xuan, Shuhua; Kim, Woo-Young; Bae, Gyu-Un; Kim, Jin-Seok</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3771-3781</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">CD133+ cells in glioblastoma multiforme (GBM) display glioma stem cell (GSC) properties and have been considered to be the culprit in tumor recurrence, justifying the exploration of potential therapeutic modalities targeting CD133+ cells.  Such strategies require a drug-delivery vehicle, and increasingly, the unique properties of PEGylated liposomes are being exploited for this purpose.  More advanced liposomal delivery studies have suggested conjugation of CD133 antibodies as a suitable method for targeting GSCs.  For targeting studies, GSCs sepd. from U87 GBM cells using a magnetic bead sepn. method were challenged with liposomes encapsulating gemcitabine (GEM) conjugated with a CD133 monoclonal antibody (PEG-lipo-CD133-GEM).  An in vitro study showed that conjugation of CD133 antibody significantly enhanced the cytotoxicity of GEM through endocytosis of CD133 surface markers overexpressed on GSCs.  The anti-tumor effect of PEG-lipo-CD133-GEM was 15 times higher than that of free GEM, presumably reflecting the specific targeting of the CD133 surface marker by PEG-lipo-CD133-GEM and the enhanced stability and cytotoxicity through the PEGylated liposome formulation in xenograft models.  Moreover, monitoring of body wt. changes showed that the use of PEGylated liposomes significantly reduced the toxicity of GEM.  Taken together, our studies demonstrate that PEG-lipo-CD133-GEM shows promise for the treatment of gliomas in vitro and in xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplRF9kSzO7ybVg90H21EOLACvtfcHk0ljJrE7e257w1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVanur0%253D&md5=34ba65ddddad0b9c9d16510094a586f9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fc4tb00185k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4tb00185k%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DXuan%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DW.-Y.%26aulast%3DBae%26aufirst%3DG.-U.%26aulast%3DKim%26aufirst%3DJ.-S.%26atitle%3DCD133%2520Antibody-conjugated%2520Immunoliposomes%2520Encapsulating%2520Gemcitabine%2520for%2520Targeting%2520Glioblastoma%2520Stem%2520Cells%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2014%26volume%3D2%26spage%3D3771%26epage%3D3781%26doi%3D10.1039%2Fc4tb00185k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-Targeted Small-Molecule Fluorophores for Dual Modal Cancer Phototherapy</span>. <i>Adv. Funct. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2826</span>– <span class="NLM_lpage">2835</span>, <span class="refDoi"> DOI: 10.1002/adfm.201600159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1002%2Fadfm.201600159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1Cjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2826-2835&author=S.+Luoauthor=X.+Tanauthor=S.+Fangauthor=Y.+Wangauthor=T.+Liuauthor=X.+Wangauthor=Y.+Yuanauthor=H.+Sunauthor=Q.+Qiauthor=C.+Shi&title=Mitochondria-Targeted+Small-Molecule+Fluorophores+for+Dual+Modal+Cancer+Phototherapy&doi=10.1002%2Fadfm.201600159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Small-Molecule Fluorophores for Dual Modal Cancer Phototherapy</span></div><div class="casAuthors">Luo, Shenglin; Tan, Xu; Fang, Shengtao; Wang, Yu; Liu, Tao; Wang, Xin; Yuan, Yi; Sun, Huiqin; Qi, Qingrong; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Functional Materials</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2826-2835</span>CODEN:
                <span class="NLM_cas:coden">AFMDC6</span>;
        ISSN:<span class="NLM_cas:issn">1616-301X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Mitochondria are recognized as the ideal target for cancer treatment because they play a central role in oxidative metab. and apoptosis.  In this work, a mitochondria-targeted near-IR (NIR) photosensitizer (PS) for synchronous cancer photodynamic therapy (PDT) and photothermal therapy (PTT) is synthesized.  This multifunctional small-mol. PS is developed from a variety of synthesized heptamethine cyanine dyes, which are modified with various N-alkyl side chains on the lipophilic cationic heptamethine core.  It is demonstrated to preferentially accumulate in cancer cells by org.-anion transporting polypeptide mediated active transport and retain in mitochondria by its lipophilic cationic property.  As mitochondria are susceptible to hyperthermia and excessive reactive oxygen species, this new PS integrating PTT and PDT treatment exhibits highly efficient phototherapy in multiple cancer cells and animal xenograft models.  Furthermore, this targeted PS with NIR imaging property also enables tumors and their margins clearly visualized, providing the potential for precisely imaging-guided phototherapy and treatment monitoring.  This is the first report that a small-mol. PS integrates both cancer PTT and PDT treatment by targeting mitochondria, significantly increasing the photosensitization.  This work may also present a practicable strategy to develop small-mol.-based cancer theranostic agents for simultaneous cancer targeting, imaging, and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzLHBN3w1PKrVg90H21EOLACvtfcHk0ljJrE7e257w1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1Cjuro%253D&md5=e883af613349362d09d55b07e56c14dd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fadfm.201600159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadfm.201600159%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DQi%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DMitochondria-Targeted%2520Small-Molecule%2520Fluorophores%2520for%2520Dual%2520Modal%2520Cancer%2520Phototherapy%26jtitle%3DAdv.%2520Funct.%2520Mater.%26date%3D2016%26volume%3D26%26spage%3D2826%26epage%3D2835%26doi%3D10.1002%2Fadfm.201600159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Repurposing Antitubercular Agent Isoniazid for Treatment of Prostate Cancer</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1039/C8BM01189C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1039%2FC8BM01189C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFGnsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&pages=296-306&author=Q.+Lvauthor=D.+Wangauthor=Z.+Yangauthor=J.+Yangauthor=R.+Zhangauthor=X.+Yangauthor=M.+Wangauthor=Y.+Wang&title=Repurposing+Antitubercular+Agent+Isoniazid+for+Treatment+of+Prostate+Cancer&doi=10.1039%2FC8BM01189C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing antitubercular agent isoniazid for treatment of prostate cancer</span></div><div class="casAuthors">Lv, Qingzhi; Wang, Dun; Yang, Zimeng; Yang, Jincheng; Zhang, Ruoshi; Yang, Xiaoguang; Wang, Menglin; Wang, Yongjun</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">296-306</span>CODEN:
                <span class="NLM_cas:coden">BSICCH</span>;
        ISSN:<span class="NLM_cas:issn">2047-4849</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of versatile antitumor agents with tumor-imaging, targeting and therapeutic activity is promising for clin. cancer therapy.  Prostate cancer is still the one of the leading threats to males.  Current therapies have restricted clin. efficiency for patients with advanced and metastatic prostate cancer.  Recent studies demonstrate that monoamine oxidase A (MAOA) levels elevate with prostate cancer aggression and metastasis.  In addn., MAOA inhibitor therapies have been reported as an effective means to reduce the metastasis of prostate cancer and extend mouse survival.  Thus, these findings provide evidence that MAOA is promising for the treatment of metastatic and advanced prostate cancer.  Herein, three isoniazid (INH)-dye conjugates were synthesized by conjugating MAOA inhibitor INH with mitochondria-targeting NIRF heptamethine dyes to improve the therapeutic efficacy of prostate cancer.  These INH-dye conjugates could accumulate in PC-3 cellular mitochondria via org. anion transport peptide (OATP), increase ROS generation, and induce cancer cells apoptosis.  In prostate cancer bearing xenografts, INH-dye conjugates showed significantly improved tumor-homing characteristics, resulting in potent antitumor activity via a redn. in MAOA activity.  These results suggest that INH-dye conjugates have great potential to be used as versatile antitumor agents with prostate cancer targeting, NIR imaging, and potent antitumor efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosA8SyqAULZrVg90H21EOLACvtfcHk0lji2ECbOTyHog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFGnsrjJ&md5=1ebce8e355c89cf562f6434ef2c4958e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2FC8BM01189C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8BM01189C%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DRepurposing%2520Antitubercular%2520Agent%2520Isoniazid%2520for%2520Treatment%2520of%2520Prostate%2520Cancer%26jtitle%3DBiomater.%2520Sci.%26date%3D2019%26volume%3D7%26spage%3D296%26epage%3D306%26doi%3D10.1039%2FC8BM01189C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usama, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thavornpradit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span> <span> </span><span class="NLM_article-title">Optimized Heptamethine Cyanines for Photodynamic Therapy</span>. <i>ACS Appl. Bio Mater.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1021/acsabm.8b00414</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsabm.8b00414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWitLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&pages=1195-1205&author=S.+M.+Usamaauthor=S.+Thavornpraditauthor=K.+Burgess&title=Optimized+Heptamethine+Cyanines+for+Photodynamic+Therapy&doi=10.1021%2Facsabm.8b00414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Optimized Heptamethine Cyanines for Photodynamic Therapy</span></div><div class="casAuthors">Usama, Syed Muhammad; Thavornpradit, Sopida; Burgess, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Bio Materials</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1195-1205</span>CODEN:
                <span class="NLM_cas:coden">AABMCB</span>;
        ISSN:<span class="NLM_cas:issn">2576-6422</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over 10 near-IR fluorescent sensitizers were prepd. to explore their properties relevant to potential applications in photodynamic therapy (PDT).  Key properties of these compds. are that they can be excited around 800 nm, (i) are hydrophilic, (ii) generate singlet oxygen with acceptable quantum yields, and (iii) are imported into cancer cells via the org. anion transporter proteins (OATPs). (This is crucial to tumor localization.) The N-substituents of these cyanines were varied to adjust their charges and polarities and to accommodate conjugation to other entities (e.g., biomols. or fragments to expand their theranostic modalities).  Thus, it was possible to optimize their photocytotoxicities without compromising their other desirable characteristics for PDT.  Overall, sensitizers like this have superior characteristics relative to clin. approved sensitizers for PDT insofar as they can be excited at greater depths in tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiqLfjWjCtErVg90H21EOLACvtfcHk0lji2ECbOTyHog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWitLbI&md5=b7e9bd55fee266adb65276e7665edc32</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsabm.8b00414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsabm.8b00414%26sid%3Dliteratum%253Aachs%26aulast%3DUsama%26aufirst%3DS.%2BM.%26aulast%3DThavornpradit%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DOptimized%2520Heptamethine%2520Cyanines%2520for%2520Photodynamic%2520Therapy%26jtitle%3DACS%2520Appl.%2520Bio%2520Mater.%26date%3D2018%26volume%3D1%26spage%3D1195%26epage%3D1205%26doi%3D10.1021%2Facsabm.8b00414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mottram, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddox, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaufils, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, B. R.</span></span> <span> </span><span class="NLM_article-title">A Concise Synthesis of the Pennsylvania Green Fluorophore and Labeling of Intracellular Targets with O6-Benzylguanine Derivatives</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3741</span>– <span class="NLM_lpage">3744</span>, <span class="refDoi"> DOI: 10.1021/ol7015093</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol7015093" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFSmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3741-3744&author=L.+F.+Mottramauthor=E.+Maddoxauthor=M.+Schwabauthor=F.+Beaufilsauthor=B.+R.+Peterson&title=A+Concise+Synthesis+of+the+Pennsylvania+Green+Fluorophore+and+Labeling+of+Intracellular+Targets+with+O6-Benzylguanine+Derivatives&doi=10.1021%2Fol7015093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Concise Synthesis of the Pennsylvania Green Fluorophore and Labeling of Intracellular Targets with O6-Benzylguanine Derivatives</span></div><div class="casAuthors">Mottram, Laurie F.; Maddox, Ewa; Schwab, Markus; Beaufils, Florent; Peterson, Blake R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3741-3744</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report improved syntheses of the Pennsylvania Green and 4-carboxy-Pennsylvania Green fluorophores; the latter compd. was prepd. from Me 4-iodo-3-methylbenzoate in a three-pot process (32% overall yield).  Chinese hamster ovary cells expressing O6-alkylguanine-DNA alkyltransferase fusion proteins were treated with Pennsylvania Green and Oregon Green linked to O6-benzylguanine (SNAP-Tag substrates).  Anal. of living cells by confocal microscopy revealed that Pennsylvania Green derivs. exhibit substantially higher cell permeability than analogous Oregon Green-derived mol. probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeObWc6EsrNLVg90H21EOLACvtfcHk0lji2ECbOTyHog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFSmtr0%253D&md5=98c70a3647a53727943264c87eb12458</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol7015093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol7015093%26sid%3Dliteratum%253Aachs%26aulast%3DMottram%26aufirst%3DL.%2BF.%26aulast%3DMaddox%26aufirst%3DE.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DBeaufils%26aufirst%3DF.%26aulast%3DPeterson%26aufirst%3DB.%2BR.%26atitle%3DA%2520Concise%2520Synthesis%2520of%2520the%2520Pennsylvania%2520Green%2520Fluorophore%2520and%2520Labeling%2520of%2520Intracellular%2520Targets%2520with%2520O6-Benzylguanine%2520Derivatives%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D3741%26epage%3D3744%26doi%3D10.1021%2Fol7015093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmryd, I.</span></span> <span> </span><span class="NLM_article-title">Quantifying Colocalization by Correlation: The Pearson Correlation Coefficient Is Superior to the Mander’s Overlap Coefficient</span>. <i>Cytometry, Part A</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1002/cyto.a.20896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1002%2Fcyto.a.20896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=20653013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC3cnpsV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=733-742&author=J.+Adlerauthor=I.+Parmryd&title=Quantifying+Colocalization+by+Correlation%3A+The+Pearson+Correlation+Coefficient+Is+Superior+to+the+Mander%E2%80%99s+Overlap+Coefficient&doi=10.1002%2Fcyto.a.20896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient</span></div><div class="casAuthors">Adler Jeremy; Parmryd Ingela</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry. Part A : the journal of the International Society for Analytical Cytology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">733-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Pearson correlation coefficient (PCC) and the Mander's overlap coefficient (MOC) are used to quantify the degree of colocalization between fluorophores.  The MOC was introduced to overcome perceived problems with the PCC.  The two coefficients are mathematically similar, differing in the use of either the absolute intensities (MOC) or of the deviation from the mean (PCC).  A range of correlated datasets, which extend to the limits of the PCC, only evoked a limited response from the MOC.  The PCC is unaffected by changes to the offset while the MOC increases when the offset is positive.  Both coefficients are independent of gain.  The MOC is a confusing hybrid measurement, that combines correlation with a heavily weighted form of co-occurrence, favors high intensity combinations, downplays combinations in which either or both intensities are low and ignores blank pixels.  The PCC only measures correlation.  A surprising finding was that the addition of a second uncorrelated population can substantially increase the measured correlation, demonstrating the importance of excluding background pixels.  Overall, since the MOC is unresponsive to substantial changes in the data and is hard to interpret, it is neither an alternative to nor a useful substitute for the PCC.  The MOC is not suitable for making measurements of colocalization either by correlation or co-occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEIj-50ALgMgpJitSxOdIlfW6udTcc2eY9Mi1LAOeN5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnpsV2luw%253D%253D&md5=4ad5fdfa78023b9110ed68bf9f230a38</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcyto.a.20896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcyto.a.20896%26sid%3Dliteratum%253Aachs%26aulast%3DAdler%26aufirst%3DJ.%26aulast%3DParmryd%26aufirst%3DI.%26atitle%3DQuantifying%2520Colocalization%2520by%2520Correlation%253A%2520The%2520Pearson%2520Correlation%2520Coefficient%2520Is%2520Superior%2520to%2520the%2520Mander%25E2%2580%2599s%2520Overlap%2520Coefficient%26jtitle%3DCytometry%252C%2520Part%2520A%26date%3D2010%26volume%3D77%26spage%3D733%26epage%3D742%26doi%3D10.1002%2Fcyto.a.20896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamocka, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J. H.</span></span> <span> </span><span class="NLM_article-title">A Practical Guide to Evaluating Colocalization in Biological Microscopy</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">C723</span>– <span class="NLM_lpage">C742</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.00462.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1152%2Fajpcell.00462.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=21209361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Orsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2011&pages=C723-C742&author=K.+W.+Dunnauthor=M.+M.+Kamockaauthor=J.+H.+McDonald&title=A+Practical+Guide+to+Evaluating+Colocalization+in+Biological+Microscopy&doi=10.1152%2Fajpcell.00462.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A practical guide to evaluating colocalization in biological microscopy</span></div><div class="casAuthors">Dunn, Kenneth W.; Kamocka, Malgorzata M.; McDonald, John H.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">4, Pt.1</span>),
    <span class="NLM_cas:pages">C723-C742</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Fluorescence microscopy is one of the most powerful tools for elucidating the cellular functions of proteins and other mols.  In many cases, the function of a mol. can be inferred from its assocn. with specific intracellular compartments or mol. complexes, which is typically detd. by comparing the distribution of a fluorescently labeled version of the mol. with that of a second, complementarily labeled probe.  Although arguably the most common application of fluorescence microscopy in biomedical research, studies evaluating the "colocalization" of two probes are seldom quantified, despite a diversity of image anal. tools that have been specifically developed for that purpose.  Here we provide a guide to analyzing colocalization in cell biol. studies, emphasizing practical application of quant. tools that are now widely available in com. and free image anal. software.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW4EjMG9jdebVg90H21EOLACvtfcHk0lhD_mlC60sfKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Orsrs%253D&md5=1b6a515733532b20e82a6a8d21cc1448</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00462.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00462.2010%26sid%3Dliteratum%253Aachs%26aulast%3DDunn%26aufirst%3DK.%2BW.%26aulast%3DKamocka%26aufirst%3DM.%2BM.%26aulast%3DMcDonald%26aufirst%3DJ.%2BH.%26atitle%3DA%2520Practical%2520Guide%2520to%2520Evaluating%2520Colocalization%2520in%2520Biological%2520Microscopy%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2011%26volume%3D300%26spage%3DC723%26epage%3DC742%26doi%3D10.1152%2Fajpcell.00462.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">Preferential Accumulation of the Near Iinfrared Heptamethine Dye IR-780 in the Mitochondria of Drug-resistant Lung Cancer Cells</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">4116</span>– <span class="NLM_lpage">4124</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2014.01.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.biomaterials.2014.01.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=24529902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=4116-4124&author=Y.+Wangauthor=T.+Liuauthor=E.+Zhangauthor=S.+Luoauthor=X.+Tanauthor=C.+Shi&title=Preferential+Accumulation+of+the+Near+Iinfrared+Heptamethine+Dye+IR-780+in+the+Mitochondria+of+Drug-resistant+Lung+Cancer+Cells&doi=10.1016%2Fj.biomaterials.2014.01.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells</span></div><div class="casAuthors">Wang, Yang; Liu, Tao; Zhang, Erlong; Luo, Shenglin; Tan, Xu; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4116-4124</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Personalized oncol. significantly relies on the development of theranostic agents to integrate cancer therapeutics and diagnostics.  Current strategy for development of such multifunctional agents requires multistep chem. conjugation with cancer specific ligands, contrast agents and therapeutic drugs.  In this study, we reported a near IR (NIR) heptamethine indocyanine dye, IR-780, which selectively accumulated in the mitochondria of drug-resistant human lung cancer cells (A549/DR) and significantly inhibited cell growth, self-renewal and migration without the need of any chem. conjugation.  IR-780 was also able to induce A549/DR cell apoptosis by disrupting the mitochondrial function.  Furthermore, IR-780 dye exhibited remarkable tumoricidal activity and inhibited tumor recurrence in mouse syngeneic Lewis lung carcinoma xenograft model.  With the unique properties of targeting, near IR imaging and inhibitive effect to the drug-resistant cancer cells both in vitro and in vivo, IR-780 may represent a potential theranostic agent for tumor recurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBxTST4XZ3g7Vg90H21EOLACvtfcHk0lhD_mlC60sfKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlSnsrw%253D&md5=93e2ae9019ad4a5ee66328f634141b3e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2014.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2014.01.061%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DPreferential%2520Accumulation%2520of%2520the%2520Near%2520Iinfrared%2520Heptamethine%2520Dye%2520IR-780%2520in%2520the%2520Mitochondria%2520of%2520Drug-resistant%2520Lung%2520Cancer%2520Cells%26jtitle%3DBiomaterials%26date%3D2014%26volume%3D35%26spage%3D4116%26epage%3D4124%26doi%3D10.1016%2Fj.biomaterials.2014.01.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Syed Muhammad Usama, <span class="NLM_string-name hlFld-ContribAuthor">Kevin Burgess</span>. </span><span class="cited-content_cbyCitation_article-title">Hows and Whys of Tumor-Seeking Dyes. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (9)
                                     , 2121-2131. <a href="https://doi.org/10.1021/acs.accounts.0c00733" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00733%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DHows%252Band%252BWhys%252Bof%252BTumor-Seeking%252BDyes%26aulast%3DUsama%26aufirst%3DSyed%2BMuhammad%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05112020%26date%3D20042021%26volume%3D54%26issue%3D9%26spage%3D2121%26epage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Cooper</span>, <span class="hlFld-ContribAuthor ">Peter J.  Choi</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Jiney  Jose</span>, <span class="hlFld-ContribAuthor ">Mike  Dragunow</span>, <span class="hlFld-ContribAuthor ">Thomas I.-H.  Park</span>. </span><span class="cited-content_cbyCitation_article-title">The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.654921" title="DOI URL">https://doi.org/10.3389/fonc.2021.654921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.654921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.654921%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DThe%252BUse%252Bof%252BHeptamethine%252BCyanine%252BDyes%252Bas%252BDrug-Conjugate%252BSystems%252Bin%252Bthe%252BTreatment%252Bof%252BPrimary%252Band%252BMetastatic%252BBrain%252BTumors%26aulast%3DCooper%26aufirst%3DElizabeth%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Lange</span>, <span class="hlFld-ContribAuthor ">Wojciech  Szlasa</span>, <span class="hlFld-ContribAuthor ">Jolanta  Saczko</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Chwiłkowska</span>. </span><span class="cited-content_cbyCitation_article-title">Potential of Cyanine Derived Dyes in Photodynamic Therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (6)
                                     , 818. <a href="https://doi.org/10.3390/pharmaceutics13060818" title="DOI URL">https://doi.org/10.3390/pharmaceutics13060818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13060818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13060818%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DPotential%252Bof%252BCyanine%252BDerived%252BDyes%252Bin%252BPhotodynamic%252BTherapy%26aulast%3DLange%26aufirst%3DNatalia%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D6%26spage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinzeyu  Yi</span>, <span class="hlFld-ContribAuthor ">Zhi  Cao</span>, <span class="hlFld-ContribAuthor ">Ying  Yuan</span>, <span class="hlFld-ContribAuthor ">Wen  Li</span>, <span class="hlFld-ContribAuthor ">Xinyue  Cui</span>, <span class="hlFld-ContribAuthor ">Zilin  Chen</span>, <span class="hlFld-ContribAuthor ">Xiang  Hu</span>, <span class="hlFld-ContribAuthor ">Aixi  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of a novel mitochondria-targeted osteosarcoma theranostic agent based on a PIM1 kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Controlled Release</span><span> <strong>2021,</strong> <em>332 </em>, 434-447. <a href="https://doi.org/10.1016/j.jconrel.2021.02.028" title="DOI URL">https://doi.org/10.1016/j.jconrel.2021.02.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jconrel.2021.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jconrel.2021.02.028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Controlled%2520Release%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Ba%252Bnovel%252Bmitochondria-targeted%252Bosteosarcoma%252Btheranostic%252Bagent%252Bbased%252Bon%252Ba%252BPIM1%252Bkinase%252Binhibitor%26aulast%3DYi%26aufirst%3DXinzeyu%26date%3D2021%26volume%3D332%26spage%3D434%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher B.  Rodell</span>, <span class="hlFld-ContribAuthor ">Paige  Baldwin</span>, <span class="hlFld-ContribAuthor ">Bianca  Fernandez</span>, <span class="hlFld-ContribAuthor ">Ralph  Weissleder</span>, <span class="hlFld-ContribAuthor ">Srinivas  Sridhar</span>, <span class="hlFld-ContribAuthor ">John Matthew  Dubach</span>. </span><span class="cited-content_cbyCitation_article-title">Quantification of Cellular Drug Biodistribution Addresses Challenges in Evaluating In Vitro and In Vivo Encapsulated Drug Delivery. </span><span class="cited-content_cbyCitation_journal-name">Advanced Therapeutics</span><span> <strong>2021,</strong> <em>4 </em>
                                    (3)
                                     , 2000125. <a href="https://doi.org/10.1002/adtp.202000125" title="DOI URL">https://doi.org/10.1002/adtp.202000125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adtp.202000125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadtp.202000125%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Therapeutics%26atitle%3DQuantification%252Bof%252BCellular%252BDrug%252BBiodistribution%252BAddresses%252BChallenges%252Bin%252BEvaluating%252BIn%252BVitro%252Band%252BIn%252BVivo%252BEncapsulated%252BDrug%252BDelivery%26aulast%3DRodell%26aufirst%3DChristopher%2BB.%26date%3D2021%26date%3D2020%26volume%3D4%26issue%3D3%26spage%3D2000125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Yiming  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiuli  Yue</span>, <span class="hlFld-ContribAuthor ">Zhifei  Dai</span>. </span><span class="cited-content_cbyCitation_article-title">Cyanine conjugates in cancer theranostics. </span><span class="cited-content_cbyCitation_journal-name">Bioactive Materials</span><span> <strong>2021,</strong> <em>6 </em>
                                    (3)
                                     , 794-809. <a href="https://doi.org/10.1016/j.bioactmat.2020.09.009" title="DOI URL">https://doi.org/10.1016/j.bioactmat.2020.09.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioactmat.2020.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioactmat.2020.09.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioactive%2520Materials%26atitle%3DCyanine%252Bconjugates%252Bin%252Bcancer%252Btheranostics%26aulast%3DLi%26aufirst%3DYang%26date%3D2021%26volume%3D6%26issue%3D3%26spage%3D794%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongmei  Liu</span>, <span class="hlFld-ContribAuthor ">Wenguang  Zhang</span>, <span class="hlFld-ContribAuthor ">Xinju  Liu</span>, <span class="hlFld-ContribAuthor ">Rongliang  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
              in vitro
              and
              in vivo
              antitumor efficacy toward the treatment of nasopharyngeal cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Drug Delivery</span><span> <strong>2021,</strong> <em>28 </em>
                                    (1)
                                     , 776-786. <a href="https://doi.org/10.1080/10717544.2021.1902022" title="DOI URL">https://doi.org/10.1080/10717544.2021.1902022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10717544.2021.1902022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10717544.2021.1902022%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Delivery%26atitle%3DPrecise%252Bengineering%252Bof%252Bhybrid%252Bmolecules-loaded%252Bmacromolecular%252Bnanoparticles%252Bshows%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bantitumor%252Befficacy%252Btoward%252Bthe%252Btreatment%252Bof%252Bnasopharyngeal%252Bcancer%252Bcells%26aulast%3DLiu%26aufirst%3DDongmei%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D1%26spage%3D776%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed Muhammad  Usama</span>, <span class="hlFld-ContribAuthor ">Bosheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Kevin  Burgess</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent kinase inhibitors as probes in cancer. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>36 </em><a href="https://doi.org/10.1039/D1CS00017A" title="DOI URL">https://doi.org/10.1039/D1CS00017A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1CS00017A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1CS00017A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DFluorescent%252Bkinase%252Binhibitors%252Bas%252Bprobes%252Bin%252Bcancer%26aulast%3DUsama%26aufirst%3DSyed%2BMuhammad%26date%3D2021%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ralph  Hübner</span>, <span class="hlFld-ContribAuthor ">Xia  Cheng</span>, <span class="hlFld-ContribAuthor ">Björn  Wängler</span>, <span class="hlFld-ContribAuthor ">Carmen  Wängler</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Hybrid Molecules for the Visualization of Cancer: PESIN‐Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR‐Positive Malignant Tissue**. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (69)
                                     , 16349-16356. <a href="https://doi.org/10.1002/chem.202002386" title="DOI URL">https://doi.org/10.1002/chem.202002386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202002386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202002386%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DFunctional%252BHybrid%252BMolecules%252Bfor%252Bthe%252BVisualization%252Bof%252BCancer%25253A%252BPESIN%2525E2%252580%252590Homodimers%252BCombined%252Bwith%252BMultimodal%252BMolecular%252BImaging%252BProbes%252Bfor%252BPositron%252BEmission%252BTomography%252Band%252BOptical%252BImaging%25253A%252BSuited%252Bfor%252BTracking%252Bof%252BGRPR%2525E2%252580%252590Positive%252BMalignant%252BTissue%252A%252A%26aulast%3DH%25C3%25BCbner%26aufirst%3DRalph%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D69%26spage%3D16349%26epage%3D16356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoguang  Yang</span>, <span class="hlFld-ContribAuthor ">Zhuang  Hou</span>, <span class="hlFld-ContribAuthor ">Dun  Wang</span>, <span class="hlFld-ContribAuthor ">Yanhua  Mou</span>, <span class="hlFld-ContribAuthor ">Chun  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (23)
                                     , 127557. <a href="https://doi.org/10.1016/j.bmcl.2020.127557" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127557%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bheptamethine%252Bcyanine%252Bdye-erlotinib%252Bconjugates%252Bas%252Bantitumor%252Bagents%26aulast%3DYang%26aufirst%3DXiaoguang%26date%3D2020%26volume%3D30%26issue%3D23%26spage%3D127557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Xiao</span>, <span class="hlFld-ContribAuthor ">Yuewen  Gao</span>, <span class="hlFld-ContribAuthor ">Fajuan  Li</span>, <span class="hlFld-ContribAuthor ">Zhihe  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients. </span><span class="cited-content_cbyCitation_journal-name">Drug Delivery</span><span> <strong>2020,</strong> <em>27 </em>
                                    (1)
                                     , 1491-1500. <a href="https://doi.org/10.1080/10717544.2020.1822460" title="DOI URL">https://doi.org/10.1080/10717544.2020.1822460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10717544.2020.1822460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10717544.2020.1822460%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Delivery%26atitle%3DCombinational%252Bdual%252Bdrug%252Bdelivery%252Bsystem%252Bto%252Benhance%252Bthe%252Bcare%252Band%252Btreatment%252Bof%252Bgastric%252Bcancer%252Bpatients%26aulast%3DXiao%26aufirst%3DYing%26date%3D2020%26date%3D2020%26volume%3D27%26issue%3D1%26spage%3D1491%26epage%3D1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Guan</span>, <span class="hlFld-ContribAuthor ">Yi  Zhang</span>, <span class="hlFld-ContribAuthor ">Juan  Zou</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Mahendra D.  Chordia</span>, <span class="hlFld-ContribAuthor ">Wei  Yue</span>, <span class="hlFld-ContribAuthor ">Jin-Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Dong-Feng  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Genistein-IR783 Conjugate: Cancer Cell Targeted Delivery in MCF-7 for Superior Anti-Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (22)
                                     , 4120. <a href="https://doi.org/10.3390/molecules24224120" title="DOI URL">https://doi.org/10.3390/molecules24224120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24224120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24224120%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BGenistein-IR783%252BConjugate%25253A%252BCancer%252BCell%252BTargeted%252BDelivery%252Bin%252BMCF-7%252Bfor%252BSuperior%252BAnti-Cancer%252BTherapy%26aulast%3DGuan%26aufirst%3DYang%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D22%26spage%3D4120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0009.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Background structures and compounds featured in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Conjugates <b>1a</b>–<b>d</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Conjugate stability of <b>1a</b> in physiological conditions. Tumor tissue or cultured U87 cells were homogenized with RIPA buffer on ice before centrifuging to collect supernatant. Conjugates were incubated at 50 μM at 37 °C for up to 72 h. The % compound remaining was calculated based on area under curve from the analytical HPLC trace through a C4 column (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf" class="ext-link">Figure S4</a>). (a) Conjugate stability of <b>1a</b> in U87 tumor homogenate and U87 cell lysate. (b) In serum in vitro at 37 °C, conjugate <b>1a</b> was metabolized to a new compound in ∼3 h. (c) The half-life of <b>1a</b> in mouse serum at 37 °C was determined to be ∼1 h. Compound <b>5</b> was identified as <b>1a</b> metabolite by mass spectrometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conjugate <b>1a</b> uptake and subcellular localization in U87 cells at 37 °C. Pearson’s correlation coefficient (PCC) for colocalization between red (<b>1a</b>) and green (organelle stain) fluorescence was 0.74 with mitochondria and 0.62 with lysosomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cytotoxicity of conjugates <b>1</b>, their cytidine analogs <b>2</b>, and their parent dyes. (a) Compounds <b>2d</b> and <b>D</b> were shown to be significantly toxic below 10 μM (IC<sub>50</sub>: <b>2d</b>, 3.4 ± 0.4; <b>D</b>, 7.1 ± 1.7 μM). Conversely, in the sets <b>1a</b>, <b>2a</b>, and <b>A</b>, and <b>1b</b>, <b>2b</b>, and <b>B</b>, gemcitabine and compounds <b>1</b> are significantly more cytotoxic than the controls <b>2</b> and the free dyes (parts b and c, respectively). IC<sub>50</sub> values are the following: <b>gem</b>, 8.2 ± 1.7; <b>1a</b>, 20.9 ± 5.0; <b>1b</b>, 20.7 ± 3.2 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Therapeutic effect of <b>1a</b>. (a) Luminescence images of mice harboring U87-RFP-Luc subcutaneuous tumors and treated with indicated compounds were acquired with an IVIS Spectrum in vivo imaging system (PerkinElmer) at 2 and 5 weeks after drug administration. (b) Mean tumor size (cm<sup>2</sup>) with SEM over a 5-week period after drug administration (<i>n</i> = 3). Two-way ANOVA with Bonferroni posttest shows statistically significant differences between <b>1a</b> or <b>gem</b> compared with vehicle control group at 4 weeks (**<i>p</i> < 0.01) and 5 weeks (***<i>p</i> < 0.001). (c) Mean tumor luminescence (photons per second, p/s) with SEM over a week period (<i>n</i> = 3). Two-way ANOVA with Bonferroni posttest shows statistically significant differences between <b>1a</b> or <b>gem</b> and the vehicle group at 5 weeks (<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Localization/clearance of <b>1a</b> in vivo. (a) Mice were injected with 10 mg/kg <b>1a</b> with an uninjected control (last mouse in each view). Images were taken at 0.5, 1, 2, 24, 48, and 144 h after intravenous injection, and their fluorescence intensities are normalized to be on the same scale. (b) Images at 10× lower scale show persistence of fluorescence in <b>1a</b>-treated mice, indicating residual drug localization over extended periods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/medium/jm9b01147_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Localization of <b>1a</b> post-mortem via fluorescence imaging on tissues: (a) dissected 2 h after intravenous injection of <b>1a</b>; (b) removed from <b>1a</b>-, <b>gem</b>-, and vehicle-injected mice 2 d after intravenous injection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01147/20191018/images/large/jm9b01147_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01147&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80258" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80258" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.-J.</span></span> <span> </span><span class="NLM_article-title">Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant with Radiation and Bevacizumab: A Population-based Study</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">44015</span>– <span class="NLM_lpage">44031</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.17054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.18632%2Foncotarget.17054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=28467795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC1crjs1Citg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=44015-44031&author=P.+Zhuauthor=X.+L.+Duauthor=G.+Luauthor=J.-J.+Zhu&title=Survival+Benefit+of+Glioblastoma+Patients+After+FDA+Approval+of+Temozolomide+Concomitant+with+Radiation+and+Bevacizumab%3A+A+Population-based+Study&doi=10.18632%2Foncotarget.17054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study</span></div><div class="casAuthors">Zhu Ping; Du Xianglin L; Zhu Ping; Lu Guangrong; Zhu Jay-Jiguang</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">44015-44031</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Few population-based analyses have investigated survival change in glioblastoma multiforme (GBM) patients treated with concomitant radiotherapy-temozolomide (RT-TMZ) and adjuvant temozolomide (TMZ) and then bevacizumab (BEV) after Food and Drug Administration (FDA) approval, respectively.  We aimed to explore the effects on survival with RT-TMZ, adjuvant TMZ and BEV in general GBM population based on the Surveillance, Epidemiology, and End Results (SEER) and Texas Cancer Registry (TCR) databases.  A total of 28933 GBM patients from SEER (N = 24578) and TCR (N = 4355) between January 2000 and December 2013 were included.  Patients were grouped into three calendar periods based on date of diagnosis: pre-RT-TMZ and pre-BEV (1/2000-2/2005, P1), post-RT-TMZ and pre-BEV (3/2005-4/2009, P2), and post-RT-TMZ and post-BEV (5/2009-12/2013, P3).  The association between calendar period of diagnosis and survival was analyzed in SEER and TCR, separately, by the Kaplan-Meier method and Cox proportional hazards model.  We found a significant increase in median overall survival (OS) across the three periods in both populations.  In multivariate models, the risk of death was significantly reduced during P2 and further decreased in P3, which remained unchanged after stratification.  Comparison and validation analysis were performed in the combined dataset, and consistent results were observed.  We conclude that the OS of GBM patients in a "real-world" setting has been steadily improved from January 2000 to December 2013, which likely resulted from the administrations of TMZ concomitant with RT and adjuvant TMZ for newly diagnosed GBM and then BEV for recurrent GBM after respective FDA approval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVn-pfX7PHl9yzdcP07UmufW6udTcc2eYGVgO4ucO4g7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crjs1Citg%253D%253D&md5=ba621c089ab1493c9ca7ec776ea9e513</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.17054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.17054%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DDu%26aufirst%3DX.%2BL.%26aulast%3DLu%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DJ.-J.%26atitle%3DSurvival%2520Benefit%2520of%2520Glioblastoma%2520Patients%2520After%2520FDA%2520Approval%2520of%2520Temozolomide%2520Concomitant%2520with%2520Radiation%2520and%2520Bevacizumab%253A%2520A%2520Population-based%2520Study%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D44015%26epage%3D44031%26doi%3D10.18632%2Foncotarget.17054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">6767</span>– <span class="NLM_lpage">6771</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1158%2F1078-0432.CCR-05-0722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=16203762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKiurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=6767-6771&author=M.+H.+Cohenauthor=J.+R.+Johnsonauthor=R.+Pazdur&title=Food+and+Drug+Administration+Drug+Approval+Summary%3A+Temozolomide+Plus+Radiation+Therapy+for+the+Treatment+of+Newly+Diagnosed+Glioblastoma+Multiforme&doi=10.1158%2F1078-0432.CCR-05-0722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme</span></div><div class="casAuthors">Cohen, Martin H.; Johnson, John R.; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">19, Pt. 1</span>),
    <span class="NLM_cas:pages">6767-6771</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">On Mar. 15, 2005, the U.S.  Food and Drug Administration approved temozolomide (Temodar capsules, Schering-Plough Research Institute) for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment.  Five hundred seventy-three glioblastoma multiforme patients were randomized to receive either temozolomide + radiotherapy (n = 287) or radiotherapy alone (n = 286).  Patients in the temozolomide + radiotherapy arm received concomitant temozolomide (75 mg/m2) once daily for the duration of radiation therapy (42-49 days).  This was followed, 4 wk later, by six cycles of temozolomide, 150 or 200 mg/m2 daily for 5 days, every 4 wk.  Patients in the control arm received radiotherapy only.  In both arms, radiotherapy was delivered as 60 Gy/30 fractions to the tumor site with a 2 to 3 cm margin.  Pneumocystis carinii pneumonia prophylaxis was required during temozolomide + radiotherapy treatment and was continued until recovery of lymphocytopenia (Common Toxicity Criteria grade <1).  At disease progression, temozolomide salvage treatment was given to 161 of 282 patients (57%) in the radiotherapy alone arm, and to 62 of 277 patients (22%) in the temozolomide + radiotherapy arm.  Patients receiving concomitant and maintenance temozolomide + radiotherapy had significantly improved overall survival.  The hazard ratio was 0.63 (95% confidence interval, 0.52-0.75; log-rank, P < 0.0001).  Median survival was 14.6 mo (temozolomide + radiotherapy) vs. 12.1 mo (radiotherapy alone).  Adverse events during temozolomide treatment included thrombocytopenia, nausea, vomiting, anorexia, constipation, alopecia, headache, fatigue, and convulsions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBMna9_OqZfbVg90H21EOLACvtfcHk0lh8nJd2M2Akbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKiurzF&md5=50680b8f67e11307567287f2149d9613</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0722%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DM.%2BH.%26aulast%3DJohnson%26aufirst%3DJ.%2BR.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFood%2520and%2520Drug%2520Administration%2520Drug%2520Approval%2520Summary%253A%2520Temozolomide%2520Plus%2520Radiation%2520Therapy%2520for%2520the%2520Treatment%2520of%2520Newly%2520Diagnosed%2520Glioblastoma%2520Multiforme%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D6767%26epage%3D6771%26doi%3D10.1158%2F1078-0432.CCR-05-0722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis
Mary, E.</span></span> <span> </span><span class="NLM_article-title">Glioblastoma: Overview of Disease and Treatment</span>. <i>Clin. J. Oncol. Nurs.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">S2</span>– <span class="NLM_lpage">S8</span>, <span class="refDoi"> DOI: 10.1188/16.CJON.S1.2-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1188%2F16.CJON.S1.2-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=27668386" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=S2-S8&author=E.+Davis%0AMary&title=Glioblastoma%3A+Overview+of+Disease+and+Treatment&doi=10.1188%2F16.CJON.S1.2-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1188%2F16.CJON.S1.2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1188%252F16.CJON.S1.2-8%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%2BMary%26aufirst%3DE.%26atitle%3DGlioblastoma%253A%2520Overview%2520of%2520Disease%2520and%2520Treatment%26jtitle%3DClin.%2520J.%2520Oncol.%2520Nurs.%26date%3D2016%26volume%3D20%26spage%3DS2%26epage%3DS8%26doi%3D10.1188%2F16.CJON.S1.2-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bastiancich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastiat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagarce, F.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine and Glioblastoma: Challenges and Current Perspectives</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.drudis.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=29074439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsleltL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=416-423&author=C.+Bastiancichauthor=G.+Bastiatauthor=F.+Lagarce&title=Gemcitabine+and+Glioblastoma%3A+Challenges+and+Current+Perspectives&doi=10.1016%2Fj.drudis.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine and glioblastoma: challenges and current perspectives</span></div><div class="casAuthors">Bastiancich, Chiara; Bastiat, Guillaume; Lagarce, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">416-423</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Gemcitabine is a nucleoside analog currently used for the treatment of various solid tumors as a single agent or in combination with other chemotherapeutic drugs.  Its use against highly aggressive brain tumors (glioblastoma) has been evaluated in preclin. and clin. trials leading to controversial results.  Gemcitabine can inhibit DNA chain elongation, is a potent radiosensitizer and it can enhance antitumor immune activity, but it also presents some drawbacks (e.g., short half-life, side effects, chemoresistance).  The aim of this review is to discuss the challenges related to the use of gemcitabine for glioblastoma and to report recent studies that suggest overcoming these obstacles opening new perspectives for its use in the field (e.g., gemcitabine derivs. and/or nanomedicines).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk8Zj9iUEy7LVg90H21EOLACvtfcHk0li25-8mVMJkUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsleltL%252FP&md5=505958acba227ed03611dbd7140c513d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DBastiancich%26aufirst%3DC.%26aulast%3DBastiat%26aufirst%3DG.%26aulast%3DLagarce%26aufirst%3DF.%26atitle%3DGemcitabine%2520and%2520Glioblastoma%253A%2520Challenges%2520and%2520Current%2520Perspectives%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D416%26epage%3D423%26doi%3D10.1016%2Fj.drudis.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stupp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegi, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Bent, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taphoorn, M. J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzer, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwin, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allgeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandes, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijtenbeek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marosi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecht, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokhtari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesseling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhauer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorlia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacombe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cairncross, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirimanoff, R.-O.</span></span> <span> </span><span class="NLM_article-title">Effects of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study: 5-year Analysis of the EORTC-NCIC Trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(09)70025-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2FS1470-2045%2809%2970025-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=19269895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVKhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=459-466&author=R.+Stuppauthor=M.+E.+Hegiauthor=W.+P.+Masonauthor=M.+J.+van+den+Bentauthor=M.+J.+B.+Taphoornauthor=R.+C.+Janzerauthor=S.+K.+Ludwinauthor=A.+Allgeierauthor=B.+Fisherauthor=K.+Belangerauthor=P.+Hauauthor=A.+A.+Brandesauthor=J.+Gijtenbeekauthor=C.+Marosiauthor=C.+J.+Vechtauthor=K.+Mokhtariauthor=P.+Wesselingauthor=S.+Villaauthor=E.+Eisenhauerauthor=T.+Gorliaauthor=M.+Wellerauthor=D.+Lacombeauthor=J.+G.+Cairncrossauthor=R.-O.+Mirimanoff&title=Effects+of+Radiotherapy+with+Concomitant+and+Adjuvant+Temozolomide+versus+Radiotherapy+Alone+on+Survival+in+Glioblastoma+in+a+Randomised+Phase+III+Study%3A+5-year+Analysis+of+the+EORTC-NCIC+Trial&doi=10.1016%2FS1470-2045%2809%2970025-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial</span></div><div class="casAuthors">Stupp, Roger; Hegi, Monika E.; Mason, Warren P.; van den Bent, Martin J.; Taphoorn, Martin J. B.; Janzer, Robert C.; Ludwin, Samuel K.; Allgeier, Anouk; Fisher, Barbara; Belanger, Karl; Hau, Peter; Brandes, Alba A.; Gijtenbeek, Johanna; Marosi, Christine; Vecht, Charles J.; Mokhtari, Karima; Wesseling, Pieter; Villa, Salvador; Eisenhauer, Elizabeth; Gorlia, Thierry; Weller, Michael; Lacombe, Denis; Cairncross, J. Gregory; Mirimanoff, Rene-Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In 2004, a randomized phase III trial by the European Organization for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clin. Trials Group (NCIC) reported improved median and 2-yr survival for patients with glioblastoma treated with concomitant and adjuvant temozolomide and radiotherapy.  We report the final results with a median follow-up of more than 5 years.  Adult patients with newly diagnosed glioblastoma were randomly assigned to receive either std. radiotherapy or identical radiotherapy with concomitant temozolomide followed by up to six cycles of adjuvant temozolomide.  The methylation status of the methyl-guanine Me transferase gene, MGMT, was detd. retrospectively from the tumor tissue of 206 patients.  The primary endpoint was overall survival.  Analyses were by intention to treat.  This trial is registered with, no.  Between Aug 17, 2000, and March 22, 2002, 573 patients were assigned to treatment. 278 (97%) of 286 patients in the radiotherapy alone group and 254 (89%) of 287 in the combined-treatment group died during 5 years of follow-up.  Overall survival was 27.2% (95% CI 22.2-32.5) at 2 years, 16.0% (12.0-20.6) at 3 years, 12.1% (8.5-16.4) at 4 years, and 9.8% (6.4-14.0) at 5 years with temozolomide, vs. 10.9% (7.6-14.8), 4.4% (2.4-7.2), 3.0% (1.4-5.7), and 1.9% (0.6-4.4) with radiotherapy alone (hazard ratio 0.6, 95% CI 0.5-0.7; p<0.0001).  A benefit of combined therapy was recorded in all clin. prognostic subgroups, including patients aged 60-70 years.  Methylation of the MGMT promoter was the strongest predictor for outcome and benefit from temozolomide chemotherapy.  Benefits of adjuvant temozolomide with radiotherapy lasted throughout 5 years of follow-up.  A few patients in favorable prognostic categories survive longer than 5 years.  MGMT methylation status identifies patients most likely to benefit from the addn. of temozolomide.  Funding: EORTC, NCIC, Nelia and Amadeo Barletta Foundation, Schering-Plough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodXEfj7tq5LLVg90H21EOLACvtfcHk0li25-8mVMJkUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVKhs74%253D&md5=5cc84038ab5ca34ce0f18049c053483b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2809%2970025-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252809%252970025-7%26sid%3Dliteratum%253Aachs%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DMason%26aufirst%3DW.%2BP.%26aulast%3Dvan%2Bden%2BBent%26aufirst%3DM.%2BJ.%26aulast%3DTaphoorn%26aufirst%3DM.%2BJ.%2BB.%26aulast%3DJanzer%26aufirst%3DR.%2BC.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DAllgeier%26aufirst%3DA.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DBelanger%26aufirst%3DK.%26aulast%3DHau%26aufirst%3DP.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DGijtenbeek%26aufirst%3DJ.%26aulast%3DMarosi%26aufirst%3DC.%26aulast%3DVecht%26aufirst%3DC.%2BJ.%26aulast%3DMokhtari%26aufirst%3DK.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DS.%26aulast%3DEisenhauer%26aufirst%3DE.%26aulast%3DGorlia%26aufirst%3DT.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DLacombe%26aufirst%3DD.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DMirimanoff%26aufirst%3DR.-O.%26atitle%3DEffects%2520of%2520Radiotherapy%2520with%2520Concomitant%2520and%2520Adjuvant%2520Temozolomide%2520versus%2520Radiotherapy%2520Alone%2520on%2520Survival%2520in%2520Glioblastoma%2520in%2520a%2520Randomised%2520Phase%2520III%2520Study%253A%25205-year%2520Analysis%2520of%2520the%2520EORTC-NCIC%2520Trial%26jtitle%3DLancet%2520Oncol.%26date%3D2009%26volume%3D10%26spage%3D459%26epage%3D466%26doi%3D10.1016%2FS1470-2045%2809%2970025-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moysan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastiat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, J.-P.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">430</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1021/mp300370t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300370t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGjsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=430-444&author=E.+Moysanauthor=G.+Bastiatauthor=J.-P.+Benoit&title=Gemcitabine+versus+Modified+Gemcitabine%3A+A+Review+of+Several+Promising+Chemical+Modifications&doi=10.1021%2Fmp300370t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications</span></div><div class="casAuthors">Moysan, Elodie; Bastiat, Guillaume; Benoit, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-444</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Gemcitabine, an anticancer agent which acts against a wide range of solid tumors, is known to be rapidly deaminated in blood to the inactive metabolite 2',2'-difluorodeoxyuridine and to be rapidly excreted by the urine.  Moreover, many cancers develop resistance against this drug, such as loss of transporters and kinases responsible for the first phosphorylation step.  To increase its therapeutic levels, gemcitabine is administered at high doses (1000 mg/m2) causing side effects (neutropenia, nausea, and so forth).  To improve its metabolic stability and cytotoxic activity and to limit the phenomena of resistance many alternatives have emerged, such as the synthesis of prodrugs.  Modifying an anticancer agent is not new; paclitaxel or ara-C has been subjected to such changes.  This review summarizes the various chem. modifications that can be found in the 4-(N)- and 5'-positions of gemcitabine.  They can provide (i) a protection against deamination, (ii) a better storage and (iii) a prolonged release in the cell, (iv) a possible use in the case of deoxycytidine kinase deficiency, and (v) transporter deficiency.  These new gemcitabine-based sysems have the potential to improve the clin. outcome of a chemotherapy strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp72pKu9l1uzbVg90H21EOLACvtfcHk0lhq3nQE9uzwGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGjsbbJ&md5=1c7be7b7a6aa90cb1df2a420358ec77e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fmp300370t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300370t%26sid%3Dliteratum%253Aachs%26aulast%3DMoysan%26aufirst%3DE.%26aulast%3DBastiat%26aufirst%3DG.%26aulast%3DBenoit%26aufirst%3DJ.-P.%26atitle%3DGemcitabine%2520versus%2520Modified%2520Gemcitabine%253A%2520A%2520Review%2520of%2520Several%2520Promising%2520Chemical%2520Modifications%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D430%26epage%3D444%26doi%3D10.1021%2Fmp300370t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plunkett, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunewald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, V.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine: Metabolism, Mechanisms of Action, and Self-potentiation</span>. <i>Semin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=7481842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADyaK2MXpsFGntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1995&pages=3-10&author=W.+Plunkettauthor=P.+Huangauthor=Y.-Z.+Xuauthor=V.+Heinemannauthor=R.+Grunewaldauthor=V.+Gandhi&title=Gemcitabine%3A+Metabolism%2C+Mechanisms+of+Action%2C+and+Self-potentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine: metabolism, mechanisms of action, and self-potentiation</span></div><div class="casAuthors">Plunkett, William; Huang, Peng; Xu, Yi-Zheng; Heinemann, Volker; Grunewald, Ralf; Gandhi, Varsha</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4, Suppl. 11</span>),
    <span class="NLM_cas:pages">3-10</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">Saunders</span>)
        </div><div class="casAbstract">A review, with 26 refs., discussing the metabolic and mechanistic aspects of gemcitabine.  The unique actions that gemcitabine metabolites exert on cellular regulatory processes serve to enhance the drug's overall inhibitory activities on cell growth.  This interaction is termed "self-potentiation" and is evidenced in very few other anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUB562hnsSFbVg90H21EOLACvtfcHk0lhq3nQE9uzwGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsFGntbY%253D&md5=fd6b0da38663e5ed22c15599afc5b2d1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlunkett%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DY.-Z.%26aulast%3DHeinemann%26aufirst%3DV.%26aulast%3DGrunewald%26aufirst%3DR.%26aulast%3DGandhi%26aufirst%3DV.%26atitle%3DGemcitabine%253A%2520Metabolism%252C%2520Mechanisms%2520of%2520Action%252C%2520and%2520Self-potentiation%26jtitle%3DSemin.%2520Oncol.%26date%3D1995%26volume%3D22%26spage%3D3%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pulido, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobczak, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wnuk, S. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Cytostatic Evaluation of 4-N-Alkanoyl and 4-N-Alkyl Gemcitabine Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1021/jm401586a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401586a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=191-203&author=J.+Pulidoauthor=A.+J.+Sobczakauthor=J.+Balzariniauthor=S.+F.+Wnuk&title=Synthesis+and+Cytostatic+Evaluation+of+4-N-Alkanoyl+and+4-N-Alkyl+Gemcitabine+Analogs&doi=10.1021%2Fjm401586a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Cytostatic Evaluation of 4-N-Alkanoyl and 4-N-Alkyl Gemcitabine Analogs</span></div><div class="casAuthors">Pulido, Jesse; Sobczak, Adam J.; Balzarini, Jan; Wnuk, Stanislaw F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-203</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The coupling of gemcitabine with functionalized carboxylic acids (C9-C13) or reactions of 4-N-tosylgemcitabine with the corresponding alkyl amines afforded 4-N-alkanoyl and 4-N-alkyl gemcitabine derivs., e.g. I.  The analogs with a terminal hydroxyl group on the alkyl chain were efficiently fluorinated under conditions that are compatible with protocols for 18F labeling.  The 4-N-alkanoylgemcitabines showed potent cytostatic activities in the low nano-molar range against a panel of tumor cell lines, whereas cytotoxicity of the 4-N-alkylgemcitabines were in the low micro-molar range.  The cytotoxicity for the 4-N-alkanoylgemcitabine analogs was reduced approx. by 2 orders of magnitude in the 2'-deoxycytidine kinase (dCK)-deficient CEM/dCK- cell line, whereas cytotoxicity of the 4-N-alkylgemcitabines was only 2-5 times lower.  None of the compds. acted as efficient substrates for cytosolic dCK; therefore, the 4-N-alkanoyl analogs need to be converted first to gemcitabine to display a significant cytostatic potential, whereas 4-N-alkyl derivs. attain modest activity without measurable conversion to gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFGYp7BEu1r7Vg90H21EOLACvtfcHk0lhY-9t9wFr6ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsbrJ&md5=5236bc0faafb691009c5c443170e5267</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm401586a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401586a%26sid%3Dliteratum%253Aachs%26aulast%3DPulido%26aufirst%3DJ.%26aulast%3DSobczak%26aufirst%3DA.%2BJ.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DWnuk%26aufirst%3DS.%2BF.%26atitle%3DSynthesis%2520and%2520Cytostatic%2520Evaluation%2520of%25204-N-Alkanoyl%2520and%25204-N-Alkyl%2520Gemcitabine%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D191%26epage%3D203%26doi%3D10.1021%2Fjm401586a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rieger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichgans, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span> <span> </span><span class="NLM_article-title">Gemcitabine Cytotoxicity of Human Malignant Glioma Cells: Modulation by Antioxidants, BCL-2 and Dexamethasone</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(98)00883-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2FS0014-2999%2898%2900883-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=9988115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADyaK1MXksFCntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1999&pages=301-308&author=J.+Riegerauthor=S.+Durkaauthor=J.+Strefferauthor=J.+Dichgansauthor=M.+Weller&title=Gemcitabine+Cytotoxicity+of+Human+Malignant+Glioma+Cells%3A+Modulation+by+Antioxidants%2C+BCL-2+and+Dexamethasone&doi=10.1016%2FS0014-2999%2898%2900883-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone</span></div><div class="casAuthors">Rieger, Johannes; Durka, Silke; Streffer, Johannes; Dichgans, Johannes; Weller, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">301-308</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Gemcitabine is a novel antimetabolite drug that acts by multiple mechanisms, including inhibition of ribonucleoside diphosphate reductase, of dCMP deaminase and of dCTP incorporation into DNA and RNA.  Here, the authors report that gemcitabine induces cytotoxic and clonogenic death of 12 human malignant glioma cell lines at clin. relevant concns. around 1 μM.  Gemcitabine is thus approx. 100-fold more active than the congener drug, cytarabine.  Gemcitabine cytotoxicity of glioma cells does not require wild-type p53 activity: (i) there was no difference in the susceptibility to gemcitabine between cell lines with wild-type p53 and cell lines with mutant or deleted p53; (ii) ectopic expression of a temp.-sensitive p53 protein either at wild-type (32.5°) or at mutant (38.5°) conformation had no significant influence on gemcitabine-induced cell death.  Gemcitabine cytotoxicity was unaffected by the antioxidants, N-acetylcysteine and phenyl-N-tert-butyl-α-phenylnitrone.  There was no correlation between the susceptibility to gemcitabine and the endogenous expression of the B cell lymphoma-2 (BCL-2)-family proteins BCL-2, BCL-XL, myeloid cell leukemia-1 (MCL-1), BCL-2-assocd. X protein (BAX), BCL-2 homologous antagonist/killer (BAK) and BCL-XS.  Ectopic expression of BCL-2 moderately attenuated gemcitabine-induced cell death.  Similarly, preexposure to the synthetic steroid, dexamethasone, which is commonly used to control cerebral edema in brain tumor patients, reduced gemcitabine cytotoxicity.  The authors conclude that the clin. evaluation of gemcitabine for the adjuvant chemotherapy of malignant glioma is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-I2dQQRuoY7Vg90H21EOLACvtfcHk0lhY-9t9wFr6ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksFCntQ%253D%253D&md5=9eac54c5a6bc6a57b817c983e81fe7ea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2898%2900883-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252898%252900883-8%26sid%3Dliteratum%253Aachs%26aulast%3DRieger%26aufirst%3DJ.%26aulast%3DDurka%26aufirst%3DS.%26aulast%3DStreffer%26aufirst%3DJ.%26aulast%3DDichgans%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DM.%26atitle%3DGemcitabine%2520Cytotoxicity%2520of%2520Human%2520Malignant%2520Glioma%2520Cells%253A%2520Modulation%2520by%2520Antioxidants%252C%2520BCL-2%2520and%2520Dexamethasone%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D365%26spage%3D301%26epage%3D308%26doi%3D10.1016%2FS0014-2999%2898%2900883-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuchtern, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egorin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuffey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleksic, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, S.</span></span> <span> </span><span class="NLM_article-title">Plasma and Cerebrospinal Fluid Pharmacokinetics of Gemcitabine After Intravenous Administration in Nonhuman Primates</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1007/s002800000253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1007%2Fs002800000253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=11391856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVKqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2001&pages=411-414&author=J.+Z.+Kerrauthor=S.+L.+Bergauthor=R.+Dauserauthor=J.+Nuchternauthor=M.+J.+Egorinauthor=L.+McGuffeyauthor=A.+Aleksicauthor=S.+Blaney&title=Plasma+and+Cerebrospinal+Fluid+Pharmacokinetics+of+Gemcitabine+After+Intravenous+Administration+in+Nonhuman+Primates&doi=10.1007%2Fs002800000253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates</span></div><div class="casAuthors">Kerr, Jody Z.; Berg, Stacey L.; Dauser, Robert; Nuchtern, Jed; Egorin, Merrill J.; McGuffey, Leticia; Aleksic, Alexander; Blaney, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-414</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">This study was performed in rhesus monkeys to det. the plasma and cerebrospinal fluid (CSF) pharmacokinetics of gemcitabine and its inactive metabolite, difluorodeoxyuridine (dFdU) following i.v. administration.  Gemcitabine, 200 mg/kg, was administered i.v. over 45 min.  Serial plasma and CSF samples were obtained prior to, during, and after completion of the infusion for detn. of gemcitabine and dFdU concns.  Gemcitabine and dFdU were measured by HPLC and modeled with model-dependent and model-independent methods.  Plasma elimination was rapid, with a mean half life of 8 min for gemcitabine and 83 min for dFdU.  Gemcitabine total-body clearance was 177 mL/min/kg and the steady-state vol. of distribution was 5.5 L/kg.  The max. concns. and areas under the time-concn. curves for gemcitabine in plasma were 194 μM and 63.8 μM·h, resp., and for dFdU were 783 μM and 1725 μM·h, resp.  The peak CSF concns. of gemcitabine and dFdU were 2.5 μM and 32 μM, resp.  The mean CSF:plasma ratio was 6.7% for gemcitabine and 23.8% for dFdU.  There is only modest penetration of gemcitabine into the CSF after i.v. administration.  The relatively low CSF exposure to gemcitabine after i.v. administration suggests that systemic administration of this agent is not optimal for the treatment of overt leptomeningeal disease.  However, the clin. spectrum of antitumor activity and lack of neurotoxicity after systemic administration of gemcitabine make this agent an excellent candidate for further studies to assess the safety and feasibility of intrathecal administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBJ3tqovl_i7Vg90H21EOLACvtfcHk0lhY-9t9wFr6ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVKqtrc%253D&md5=f0f0dbddf510f6bee4e5a9ce326ffbfc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs002800000253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002800000253%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BZ.%26aulast%3DBerg%26aufirst%3DS.%2BL.%26aulast%3DDauser%26aufirst%3DR.%26aulast%3DNuchtern%26aufirst%3DJ.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DMcGuffey%26aufirst%3DL.%26aulast%3DAleksic%26aufirst%3DA.%26aulast%3DBlaney%26aufirst%3DS.%26atitle%3DPlasma%2520and%2520Cerebrospinal%2520Fluid%2520Pharmacokinetics%2520of%2520Gemcitabine%2520After%2520Intravenous%2520Administration%2520in%2520Nonhuman%2520Primates%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2001%26volume%3D47%26spage%3D411%26epage%3D414%26doi%3D10.1007%2Fs002800000253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Apparaju, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudelsky, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, P. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics of Gemcitabine in Tumor and Non-tumor Extracellular Fluid of Brain: an In Vivo Assessment in Rats Employing Intracerebral Microdialysis</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1007/s00280-007-0464-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1007%2Fs00280-007-0464-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=17443325" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=223-229&author=S.+K.+Apparajuauthor=G.+A.+Gudelskyauthor=P.+B.+Desai&title=Pharmacokinetics+of+Gemcitabine+in+Tumor+and+Non-tumor+Extracellular+Fluid+of+Brain%3A+an+In+Vivo+Assessment+in+Rats+Employing+Intracerebral+Microdialysis&doi=10.1007%2Fs00280-007-0464-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00280-007-0464-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-007-0464-1%26sid%3Dliteratum%253Aachs%26aulast%3DApparaju%26aufirst%3DS.%2BK.%26aulast%3DGudelsky%26aufirst%3DG.%2BA.%26aulast%3DDesai%26aufirst%3DP.%2BB.%26atitle%3DPharmacokinetics%2520of%2520Gemcitabine%2520in%2520Tumor%2520and%2520Non-tumor%2520Extracellular%2520Fluid%2520of%2520Brain%253A%2520an%2520In%2520Vivo%2520Assessment%2520in%2520Rats%2520Employing%2520Intracerebral%2520Microdialysis%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2007%26volume%3D61%26spage%3D223%26epage%3D229%26doi%3D10.1007%2Fs00280-007-0464-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farokhzad, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margalit, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, R.</span></span> <span> </span><span class="NLM_article-title">Nanocarriers as an Emerging Platform for Cancer Therapy</span>. <i>Nat. Nanotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">760</span>, <span class="refDoi"> DOI: 10.1038/nnano.2007.387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1038%2Fnnano.2007.387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=18654426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlyktL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=751-760&author=D.+Peerauthor=J.+M.+Karpauthor=S.+Hongauthor=O.+C.+Farokhzadauthor=R.+Margalitauthor=R.+Langer&title=Nanocarriers+as+an+Emerging+Platform+for+Cancer+Therapy&doi=10.1038%2Fnnano.2007.387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nanocarriers as an emerging platform for cancer therapy</span></div><div class="casAuthors">Peer, Dan; Karp, Jeffrey M.; Hong, Seungpyo; Farokhzad, Omid C.; Margalit, Rimona; Langer, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Nanotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">751-760</span>CODEN:
                <span class="NLM_cas:coden">NNAABX</span>;
        ISSN:<span class="NLM_cas:issn">1748-3387</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nanotechnol. has the potential to revolutionize cancer diagnosis and therapy.  Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients.  Several therapeutic nanocarriers were approved for clin. use.  However, to date, there are only a few clin. approved nanocarriers that incorporate mols. to selectively bind and target cancer cells.  This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic.  The authors detail the arsenal of nanocarriers and mols. available for selective tumor targeting, and emphasize the challenges in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSaHhszNVn2LVg90H21EOLACvtfcHk0lhV3tve_KeNSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlyktL%252FI&md5=5f24033175e23e13d59e4a5b38753cad</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnnano.2007.387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnnano.2007.387%26sid%3Dliteratum%253Aachs%26aulast%3DPeer%26aufirst%3DD.%26aulast%3DKarp%26aufirst%3DJ.%2BM.%26aulast%3DHong%26aufirst%3DS.%26aulast%3DFarokhzad%26aufirst%3DO.%2BC.%26aulast%3DMargalit%26aufirst%3DR.%26aulast%3DLanger%26aufirst%3DR.%26atitle%3DNanocarriers%2520as%2520an%2520Emerging%2520Platform%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Nanotechnol.%26date%3D2007%26volume%3D2%26spage%3D751%26epage%3D760%26doi%3D10.1038%2Fnnano.2007.387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhau, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henary, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strekowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, L. W. K.</span></span> <span> </span><span class="NLM_article-title">Near IR Heptamethine Cyanine Dye-Mediated Cancer Imaging</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2833</span>– <span class="NLM_lpage">2844</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1158%2F1078-0432.CCR-10-0059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=20410058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvF2hsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2833-2844&author=X.+Yangauthor=C.+Shiauthor=R.+Tongauthor=W.+Qianauthor=H.+E.+Zhauauthor=R.+Wangauthor=G.+Zhuauthor=J.+Chengauthor=V.+W.+Yangauthor=T.+Chengauthor=M.+Henaryauthor=L.+Strekowskiauthor=L.+W.+K.+Chung&title=Near+IR+Heptamethine+Cyanine+Dye-Mediated+Cancer+Imaging&doi=10.1158%2F1078-0432.CCR-10-0059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Near IR Heptamethine Cyanine Dye-Mediated Cancer Imaging</span></div><div class="casAuthors">Yang, Xiaojian; Shi, Chunmeng; Tong, Rong; Qian, Weiping; Zhau, Haiyen E.; Wang, Ruoxiang; Zhu, Guodong; Cheng, Jianjun; Yang, Vincent W.; Cheng, Tianmin; Henary, Maged; Strekowski, Lucjan; Chung, Leland W. K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2833-2844</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Near-IR fluorescence imaging has great potential for noninvasive in vivo imaging of tumors.  In this study, we show the preferential uptake and retention of two heptamethine cyanine dyes, IR-783 and MHI-148, in tumor cells and tissues.  IR-783 and MHI-148 were investigated for their ability to accumulate in human cancer cells, tumor xenografts, and spontaneous mouse tumors in transgenic animals.  Time- and concn.-dependent dye uptake and retention in normal and cancer cells and tissues were compared, and subcellular localization of the dyes and mechanisms of the dye uptake and retention in tumor cells were evaluated using organelle-specific tracking dyes and bromosulfophthalein, a competitive inhibitor of org. anion transporting peptides.  These dyes were used to detect human cancer metastases in a mouse model and differentiate cancer cells from normal cells in blood.  These near-IR heptamethine cyanine dyes were retained in cancer cells but not normal cells, in tumor xenografts, and in spontaneous tumors in transgenic mice.  They can be used to detect cancer metastasis and cancer cells in blood with a high degree of sensitivity.  The dyes were found to conc. in the mitochondria and lysosomes of cancer cells, probably through org. anion transporting peptides, because the dye uptake and retention in cancer cells can be blocked completely by bromosulfophthalein.  These dyes, when injected to mice, did not cause systemic toxicity.  These two heptamethine cyanine dyes are promising imaging agents for human cancers and can be further exploited to improve cancer detection, prognosis, and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGPPPJLJuOuLVg90H21EOLACvtfcHk0lgMjFlkfn27Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvF2hsrs%253D&md5=97002a4174f0188ab69a5bdb77755e60</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-0059%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DR.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DZhau%26aufirst%3DH.%2BE.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DV.%2BW.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DHenary%26aufirst%3DM.%26aulast%3DStrekowski%26aufirst%3DL.%26aulast%3DChung%26aufirst%3DL.%2BW.%2BK.%26atitle%3DNear%2520IR%2520Heptamethine%2520Cyanine%2520Dye-Mediated%2520Cancer%2520Imaging%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D2833%26epage%3D2844%26doi%3D10.1158%2F1078-0432.CCR-10-0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">A Near-infrared Fluorescent Heptamethine Indocyanine Dye with Preferential Tumor Accumulation for In Vivo Imaging</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">6612</span>– <span class="NLM_lpage">6617</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2010.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.biomaterials.2010.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=20542559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFKisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=6612-6617&author=C.+Zhangauthor=T.+Liuauthor=Y.+Suauthor=S.+Luoauthor=Y.+Zhuauthor=X.+Tanauthor=S.+Fanauthor=L.+Zhangauthor=Y.+Zhouauthor=T.+Chengauthor=C.+Shi&title=A+Near-infrared+Fluorescent+Heptamethine+Indocyanine+Dye+with+Preferential+Tumor+Accumulation+for+In+Vivo+Imaging&doi=10.1016%2Fj.biomaterials.2010.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging</span></div><div class="casAuthors">Zhang, Chao; Liu, Tao; Su, Yongping; Luo, Shenglin; Zhu, Ying; Tan, Xu; Fan, Song; Zhang, Lilong; Zhou, Yue; Cheng, Tianmin; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6612-6617</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Near-IR (NIR) fluorescence imaging holds great promise for tumor imaging due to low tissue autofluorescence and deep tissue penetration.  However, most tumor-targeting fluorescent probes require combination of targeting agents and fluorescent reporters.  In this study, we described a NIR heptamethine cyanine dye, IR-780 iodide, with preferential accumulation in multiple tumor cells without the necessity of chem. conjugation.  The IR-780 iodide was found to retain in tumors but not normal cells in multiple tumor xenografts in nude mice and chem.-induced lung tumors in C57BL/6 mice.  The fluorescent signal of tumors could persist at least 20 days with a significant signal-to-background ratio.  As a lipophilic cation, a predominant accumulation of IR-780 iodide was shown in the mitochondria of tumor cells owing to the high magnitude of mitochondrial membrane potential in tumor cells than normal cells.  We further showed that the transportation of IR-780 iodide into tumor cells was mediated by the org. anion transporter peptides (OATPs) because the dye accumulation was significantly inhibited by sulfobromophthalein (BSP), a competitive inhibitor of OATPs.  Our study shows that IR-780 iodide that preferentially accumulates in tumor cells and is natively NIR fluorescent would be useful in tumor detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvGjElacAyfbVg90H21EOLACvtfcHk0lgMjFlkfn27Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFKisrc%253D&md5=7cd88e4a01c8be0aec0d4c4356475142</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2010.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2010.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DA%2520Near-infrared%2520Fluorescent%2520Heptamethine%2520Indocyanine%2520Dye%2520with%2520Preferential%2520Tumor%2520Accumulation%2520for%2520In%2520Vivo%2520Imaging%26jtitle%3DBiomaterials%26date%3D2010%26volume%3D31%26spage%3D6612%26epage%3D6617%26doi%3D10.1016%2Fj.biomaterials.2010.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, G. C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhau, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, L. W. K.</span></span> <span> </span><span class="NLM_article-title">Near-Infrared Fluorescence Heptamethine Carbocyanine Dyes Mediate Imaging and Targeted Drug Delivery for Human Brain Tumor</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2015.07.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.biomaterials.2015.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=26197410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyhtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=1-10&author=J.+B.+Wuauthor=C.+Shiauthor=G.+C.-Y.+Chuauthor=Q.+Xuauthor=Y.+Zhangauthor=Q.+Liauthor=J.+S.+Yuauthor=H.+E.+Zhauauthor=L.+W.+K.+Chung&title=Near-Infrared+Fluorescence+Heptamethine+Carbocyanine+Dyes+Mediate+Imaging+and+Targeted+Drug+Delivery+for+Human+Brain+Tumor&doi=10.1016%2Fj.biomaterials.2015.07.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor</span></div><div class="casAuthors">Wu, Jason Boyang; Shi, Changhong; Chu, Gina Chia-Yi; Xu, Qijin; Zhang, Yi; Li, Qinlong; Yu, John S.; Zhau, Haiyen E.; Chung, Leland W. K.</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Brain tumors and brain metastases are among the deadliest malignancies of all human cancers, largely due to the cellular blood-brain and blood-tumor barriers that limit the delivery of imaging and therapeutic agents from the systemic circulation to tumors.  Thus, improved strategies for brain tumor visualization and targeted treatment are critically needed.  Here we identified and synthesized a group of near-IR fluorescence (NIRF) heptamethine carbocyanine dyes and deriv. NIRF dye-drug conjugates for effective imaging and therapeutic targeting of brain tumors of either primary or metastatic origin in mice, which is mechanistically mediated by tumor hypoxia and org. anion-transporting polypeptide genes.  We also demonstrate that these dyes, when conjugated to chemotherapeutic agents such as gemcitabine, significantly restricted the growth of both intracranial glioma xenografts and prostate tumor brain metastases and prolonged survival in mice.  These results show promise in the application of NIRF dyes as novel theranostic agents for the detection and treatment of brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgeQV_yKtpHbVg90H21EOLACvtfcHk0ljYoaQvBJydYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyhtLfN&md5=a7e2cf51bdd6544767842b3b0ce6f947</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2015.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2015.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BB.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DChu%26aufirst%3DG.%2BC.-Y.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DJ.%2BS.%26aulast%3DZhau%26aufirst%3DH.%2BE.%26aulast%3DChung%26aufirst%3DL.%2BW.%2BK.%26atitle%3DNear-Infrared%2520Fluorescence%2520Heptamethine%2520Carbocyanine%2520Dyes%2520Mediate%2520Imaging%2520and%2520Targeted%2520Drug%2520Delivery%2520for%2520Human%2520Brain%2520Tumor%26jtitle%3DBiomaterials%26date%3D2015%26volume%3D67%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.biomaterials.2015.07.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, D.</span></span> <span> </span><span class="NLM_article-title">Review on Near-infrared Heptamethine Cyanine Dyes as Theranostic Agents for Tumor Imaging, Targeting, and Photodynamic Therapy</span>. <i>J. Biomed. Opt.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">050901</span>, <span class="refDoi"> DOI: 10.1117/1.JBO.21.5.050901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1117%2F1.JBO.21.5.050901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=27165449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC28bosVGkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=050901&author=C.+Shiauthor=J.+B.+Wuauthor=D.+Pan&title=Review+on+Near-infrared+Heptamethine+Cyanine+Dyes+as+Theranostic+Agents+for+Tumor+Imaging%2C+Targeting%2C+and+Photodynamic+Therapy&doi=10.1117%2F1.JBO.21.5.050901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy</span></div><div class="casAuthors">Shi Changhong; Wu Jason Boyang; Pan Dongfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedical optics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">50901</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A class of near-infrared fluorescence (NIRF) heptamethine cyanine dyes that are taken up and accumulated specifically in cancer cells without chemical conjugation have recently emerged as promising tools for tumor imaging and targeting.  In addition to their fluorescence and nuclear imaging-based tumor-imaging properties, these dyes can be developed as drug carriers to safely deliver chemotherapy drugs to tumors.  They can also be used as effective agents for photodynamic therapy with remarkable tumoricidal activity via photodependent cytotoxic activity.  The preferential uptake of dyes into cancer but not normal cells is co-operatively mediated by the prevailing activation of a group of organic anion-transporting polypeptides on cancer cell membranes, as well as tumor hypoxia and increased mitochondrial membrane potential in cancer cells.  Such mechanistic explorations have greatly advanced the current application and future development of NIRF dyes and their derivatives as anticancer theranostic agents.  This review summarizes current knowledge and emerging advances in NIRF dyes, including molecular characterization, photophysical properties, multimodal development and uptake mechanisms, and their growing potential for preclinical and clinical use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTJ1MFAJUM5vx2phytoz6_fW6udTcc2ea__eBUktTaTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bosVGkuw%253D%253D&md5=ea99cf33ad3dfd2406a87ee7728c2def</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1117%2F1.JBO.21.5.050901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1117%252F1.JBO.21.5.050901%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%2BB.%26aulast%3DPan%26aufirst%3DD.%26atitle%3DReview%2520on%2520Near-infrared%2520Heptamethine%2520Cyanine%2520Dyes%2520as%2520Theranostic%2520Agents%2520for%2520Tumor%2520Imaging%252C%2520Targeting%252C%2520and%2520Photodynamic%2520Therapy%26jtitle%3DJ.%2520Biomed.%2520Opt.%26date%3D2016%26volume%3D21%26spage%3D050901%26doi%3D10.1117%2F1.JBO.21.5.050901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">Mechanistic Study of IR-780 Dye as a Potential Tumor Targeting and Drug Delivery Agent</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">778</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2013.10.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.biomaterials.2013.10.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=24148240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yitb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=771-778&author=E.+Zhangauthor=S.+Luoauthor=X.+Tanauthor=C.+Shi&title=Mechanistic+Study+of+IR-780+Dye+as+a+Potential+Tumor+Targeting+and+Drug+Delivery+Agent&doi=10.1016%2Fj.biomaterials.2013.10.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent</span></div><div class="casAuthors">Zhang, Erlong; Luo, Shenglin; Tan, Xu; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">771-778</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">IR-780 iodide, a near-IR fluorescent heptamethine dye, has been recently characterized to exhibit preferential accumulation property in the mitochondria of tumor cells.  In this study, we investigated the possible mechanisms for its tumor selective activity and its potential as a drug delivery carrier.  Results showed that the energy-dependent uptake of IR-780 iodide into the mitochondria of tumor cells was affected by glycolysis and plasma membrane potential.  Moreover, OATP1B3 subtype of org. anion transporter peptides (OATPs) may play a dominant role in the transportation of IR-780 iodide into tumor cells, while cellular endocytosis, mitochondrial membrane potential and the ATP-binding cassette transporters did not show significant influence to its accumulation.  We further evaluated the potential of IR-780 iodide as a drug delivery carrier by covalent conjugation of IR-780 with nitrogen mustard (IR-780NM).  In vivo imaging showed that IR-780NM remained the tumor targeting property, indicating that IR-780 iodide could be potentially applied as a drug delivery agent for cancer targeted imaging and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog7OizKmeZ5bVg90H21EOLACvtfcHk0ljYoaQvBJydYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yitb7O&md5=f53ae1e7857dd901bc1da574806c61e1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2013.10.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2013.10.033%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DMechanistic%2520Study%2520of%2520IR-780%2520Dye%2520as%2520a%2520Potential%2520Tumor%2520Targeting%2520and%2520Drug%2520Delivery%2520Agent%26jtitle%3DBiomaterials%26date%3D2014%26volume%3D35%26spage%3D771%26epage%3D778%26doi%3D10.1016%2Fj.biomaterials.2013.10.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaikari, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kota, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhaveri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groshen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofman, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, J. C.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase A (MAO A) Inhibitors Decrease Glioma Progression</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13842</span>– <span class="NLM_lpage">13853</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.18632%2Foncotarget.7283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=26871599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC28npvF2qsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13842-13853&author=S.+Kushalauthor=W.+Wangauthor=V.+P.+Vaikariauthor=R.+Kotaauthor=K.+Chenauthor=T.-S.+Yehauthor=N.+Jhaveriauthor=S.+L.+Groshenauthor=B.+Z.+Olenyukauthor=T.+C.+Chenauthor=F.+M.+Hofmanauthor=J.+C.+Shih&title=Monoamine+Oxidase+A+%28MAO+A%29+Inhibitors+Decrease+Glioma+Progression&doi=10.18632%2Foncotarget.7283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase A (MAO A) inhibitors decrease glioma progression</span></div><div class="casAuthors">Kushal Swati; Vaikari Vijaya Pooja; Kota Rajesh; Chen Kevin; Yeh Tzu-Shao; Olenyuk Bogdan Z; Shih Jean C; Kushal Swati; Wang Weijun; Vaikari Vijaya Pooja; Kota Rajesh; Chen Kevin; Yeh Tzu-Shao; Chen Thomas C; Hofman Florence M; Shih Jean C; Wang Weijun; Chen Thomas C; Hofman Florence M; Yeh Tzu-Shao; Shih Jean C; Jhaveri Niyati; Hofman Florence M; Groshen Susan L; Shih Jean C</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">13842-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma (GBM) is an aggressive brain tumor which is currently treated with temozolomide (TMZ).  Tumors usually become resistant to TMZ and recur; no effective therapy is then available.  Monoamine Oxidase A (MAO A) oxidizes monoamine neurotransmitters resulting in reactive oxygen species which cause cancer.  This study shows that MAO A expression is increased in human glioma tissues and cell lines.  MAO A inhibitors, clorgyline or the near-infrared-dye MHI-148 conjugated to clorgyline (NMI), were cytotoxic for glioma and decreased invasion in vitro.  Using the intracranial TMZ-resistant glioma model, clorgyline or NMI alone or in combination with low-dose TMZ reduced tumor growth and increased animal survival.  NMI was localized specifically to the tumor.  Immunocytochemistry studies showed that the MAO A inhibitor reduced proliferation, microvessel density and invasion, and increased macrophage infiltration.  In conclusion, we have identified MAO A inhibitors as potential novel stand-alone drugs or as combination therapy with low dose TMZ for drug-resistant gliomas.  NMI can also be used as a non-invasive imaging tool.  Thus has a dual function for both therapy and diagnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrf8QTiCasNgwxfk_AGB-EfW6udTcc2eapbLQFU1-r1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28npvF2qsA%253D%253D&md5=cc8c65fe768793756d82a91e8377b812</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7283%26sid%3Dliteratum%253Aachs%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DVaikari%26aufirst%3DV.%2BP.%26aulast%3DKota%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DYeh%26aufirst%3DT.-S.%26aulast%3DJhaveri%26aufirst%3DN.%26aulast%3DGroshen%26aufirst%3DS.%2BL.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DChen%26aufirst%3DT.%2BC.%26aulast%3DHofman%26aufirst%3DF.%2BM.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DMonoamine%2520Oxidase%2520A%2520%2528MAO%2520A%2529%2520Inhibitors%2520Decrease%2520Glioma%2520Progression%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D13842%26epage%3D13853%26doi%3D10.18632%2Foncotarget.7283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dasari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinaro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, N.</span></span> <span> </span><span class="NLM_article-title">H-Gemcitabine: A New Gemcitabine Prodrug for Treating Cancer</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/bc300095m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc300095m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaqu77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=4-8&author=M.+Dasariauthor=A.+P.+Acharyaauthor=D.+Kimauthor=S.+Leeauthor=S.+Leeauthor=J.+Rheaauthor=R.+Molinaroauthor=N.+Murthy&title=H-Gemcitabine%3A+A+New+Gemcitabine+Prodrug+for+Treating+Cancer&doi=10.1021%2Fbc300095m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">H-Gemcitabine: A New Gemcitabine Prodrug for Treating Cancer</span></div><div class="casAuthors">Dasari, Madhuri; Acharya, Abhinav P.; Kim, Dongin; Lee, Seungjun; Lee, Sungmun; Rhea, Jeanne; Molinaro, Ross; Murthy, Niren</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-8</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this report, we present a new strategy for targeting chemotherapeutics to tumors, based on targeting extracellular DNA.  A gemcitabine prodrug (I) was synthesized, termed H-gemcitabine, which is composed of Hoechst conjugated to gemcitabine.  H-gemcitabine has low toxicity because it is membrane-impermeable; however, it still has high tumor efficacy because of its ability to target gemcitabine to E-DNA in tumors.  We demonstrate here that H-gemcitabine has a wider therapeutic window than free gemcitabine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaarjwWWYWq7Vg90H21EOLACvtfcHk0ljfSEDoHWL5DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaqu77N&md5=326311706a2a58c2ef17af1e340e481f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbc300095m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc300095m%26sid%3Dliteratum%253Aachs%26aulast%3DDasari%26aufirst%3DM.%26aulast%3DAcharya%26aufirst%3DA.%2BP.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DRhea%26aufirst%3DJ.%26aulast%3DMolinaro%26aufirst%3DR.%26aulast%3DMurthy%26aufirst%3DN.%26atitle%3DH-Gemcitabine%253A%2520A%2520New%2520Gemcitabine%2520Prodrug%2520for%2520Treating%2520Cancer%26jtitle%3DBioconjugate%2520Chem.%26date%3D2013%26volume%3D24%26spage%3D4%26epage%3D8%26doi%3D10.1021%2Fbc300095m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee Jae, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">11657</span>– <span class="NLM_lpage">11662</span>, <span class="refDoi"> DOI: 10.1021/ja405372k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405372k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=11657-11662&author=Z.+Yangauthor=H.+Lee+Jaeauthor=H.+M.+Jeonauthor=J.+H.+Hanauthor=N.+Parkauthor=Y.+Heauthor=H.+Leeauthor=K.+S.+Hongauthor=C.+Kangauthor=J.+S.+Kim&title=Folate-Based+Near-Infrared+Fluorescent+Theranostic+Gemcitabine+Delivery&doi=10.1021%2Fja405372k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery</span></div><div class="casAuthors">Yang, Zhigang; Lee, Jae Hong; Jeon, Hyun Mi; Han, Ji Hye; Park, Nayoung; He, Yanxia; Lee, Hyunseung; Hong, Kwan Soo; Kang, Chulhun; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">11657-11662</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of heptamethine cyanine derivs. bearing a carbamate Et disulfide group and gemcitabine, an anticancer drug, have been newly synthesized.  Their disulfide bonds are readily cleaved by various thiols including glutathione, to result in a subsequent decompn. of the carbamate into amine followed by release of the active gemcitabine, which can be monitored by the fluorescence changes.  In the biol. expt., prodrug (I) is preferentially up-taken by folate-pos. KB cells over folate-neg. A549 cells via receptor-mediated endocytosis to release gemcitabine causing cell death and to emit fluorescence in endoplasmic reticulum.  Moreover, it is selectively accumulated in the KB cells which were treated to mice by dorsal s.c. injection.  This drug delivery system is a new theranostic agent, wherein both therapeutic effect and drug uptake can be easily monitored at the subcellular level, by in vivo and in vitro fluorescence imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGxwlND_CfJbVg90H21EOLACvtfcHk0lir18GgXix2CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsrbP&md5=04a9f30059882d60566b5f0aa108afcb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja405372k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405372k%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLee%2BJae%26aufirst%3DH.%26aulast%3DJeon%26aufirst%3DH.%2BM.%26aulast%3DHan%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DK.%2BS.%26aulast%3DKang%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DFolate-Based%2520Near-Infrared%2520Fluorescent%2520Theranostic%2520Gemcitabine%2520Delivery%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D11657%26epage%3D11662%26doi%3D10.1021%2Fja405372k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barile, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emdad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morvaridi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandol, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span> <span> </span><span class="NLM_article-title">Therapy of Pancreatic Cancer via an EphA2 Receptor-Targeted Delivery of Gemcitabine</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">17103</span>– <span class="NLM_lpage">17110</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.18632%2Foncotarget.7931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=26959746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC28jotlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=17103-17110&author=B.+A.+Quinnauthor=S.+Wangauthor=E.+Barileauthor=S.+K.+Dasauthor=L.+Emdadauthor=D.+Sarkarauthor=S.+K.+Deauthor=S.+K.+Morvaridiauthor=J.+L.+Stebbinsauthor=S.+J.+Pandolauthor=P.+B.+Fisherauthor=M.+Pellecchia&title=Therapy+of+Pancreatic+Cancer+via+an+EphA2+Receptor-Targeted+Delivery+of+Gemcitabine&doi=10.18632%2Foncotarget.7931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine</span></div><div class="casAuthors">Quinn Bridget A; Das Swadesh K; Emdad Luni; Sarkar Devanand; Fisher Paul B; Wang Si; Barile Elisa; De Surya K; Stebbins John L; Fisher Paul B; Pellecchia Maurizio; Barile Elisa; De Surya K; Pellecchia Maurizio; Morvaridi Susan Kharagh; Pandol Stephen J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">17103-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">First line treatment for pancreatic cancer consists of surgical resection, if possible, and a subsequent course of chemotherapy using the nucleoside analogue gemcitabine.  In some patients, an active transport mechanism allows gemcitabine to enter efficiently into the tumor cells, resulting in a significant clinical benefit.  However, in most patients, low expression of gemcitabine transporters limits the efficacy of the drug to marginal levels, and patients need frequent administration of the drug at high doses, significantly increasing systemic drug toxicity.  In this article we focus on a novel targeted delivery approach for gemcitabine consisting of conjugating the drug with an EphA2 targeting agent.  We show that the EphA2 receptor is highly expressed in pancreatic cancers, and accordingly, the drug-conjugate is more effective than gemcitabine alone in targeting pancreatic tumors.  Our preliminary observations suggest that this approach may provide a general benefit to pancreatic cancer patients and offers a comprehensive strategy for enhancing delivery of diverse therapeutic agents to a wide range of cancers overexpressing EphA2, thereby potentially reducing toxicity while enhancing therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkle74R4yp-ekdrW1FkXG-fW6udTcc2eaLBBj9-TTXXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jotlGitA%253D%253D&md5=0b5e311729fc3517d90882844ab3d3f2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7931%26sid%3Dliteratum%253Aachs%26aulast%3DQuinn%26aufirst%3DB.%2BA.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBarile%26aufirst%3DE.%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DEmdad%26aufirst%3DL.%26aulast%3DSarkar%26aufirst%3DD.%26aulast%3DDe%26aufirst%3DS.%2BK.%26aulast%3DMorvaridi%26aufirst%3DS.%2BK.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DPandol%26aufirst%3DS.%2BJ.%26aulast%3DFisher%26aufirst%3DP.%2BB.%26aulast%3DPellecchia%26aufirst%3DM.%26atitle%3DTherapy%2520of%2520Pancreatic%2520Cancer%2520via%2520an%2520EphA2%2520Receptor-Targeted%2520Delivery%2520of%2520Gemcitabine%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D17103%26epage%3D17110%26doi%3D10.18632%2Foncotarget.7931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span> <span> </span><span class="NLM_article-title">Structure-inherent Near-infrared Fluorescent Probe Mediates Apoptosis Imaging and Targeted Drug Delivery In Vivo</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2016.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.dyepig.2016.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFymu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=204-212&author=X.+Zhangauthor=N.+Zhaoauthor=B.+Wangauthor=Z.+Tianauthor=Y.+Daiauthor=P.+Ningauthor=D.+Chen&title=Structure-inherent+Near-infrared+Fluorescent+Probe+Mediates+Apoptosis+Imaging+and+Targeted+Drug+Delivery+In+Vivo&doi=10.1016%2Fj.dyepig.2016.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-inherent near-infrared fluorescent probe mediates apoptosis imaging and targeted drug delivery in vivo</span></div><div class="casAuthors">Zhang, Xianghan; Zhao, Na; Wang, Bo; Tian, Zuhong; Dai, Yunpeng; Ning, Pengbo; Chen, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">204-212</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Imaging of tumor apoptosis can provide invaluable information in regards to drug treatment effectiveness, drug development and tumor therapeutic response.  Thus, the development of apoptotic specific and sensitive targeted fluorescence probes is critically needed.  In this work, we developed a novel and simple one-step synthetic method for producing monocarboxylate near-IR cyanine dyes.  The hydrophobic cationic dyes possess advantageous optical properties and good membrane permeability.  One hydrophilic zwitterionic probe is able to both increase specificity and image apoptotic cells owing to its inherent chem. structure.  Furthermore, we conjugated the probe with the antitumor drug gemcitabine for effective apoptosis imaging and therapeutic targeting of gastric tumors in vitro and in vivo.  The novel dye-drug conjugate imaged apoptosis successfully in vitro and in vivo and restricted the growth of SGC7901 s.c. xenograft models.  This strategy may offer the advantages of NIR apoptosis imaging probes for non-invasive tumor imaging and should provide the application for targeted drug delivery and the evaluation of therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtYrK2IzDbcLVg90H21EOLACvtfcHk0liA-h8vrndAiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFymu7bK&md5=b8b1c560c1bdaf35c980f7e323d459bb</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2016.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2016.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DNing%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DD.%26atitle%3DStructure-inherent%2520Near-infrared%2520Fluorescent%2520Probe%2520Mediates%2520Apoptosis%2520Imaging%2520and%2520Targeted%2520Drug%2520Delivery%2520In%2520Vivo%26jtitle%3DDyes%2520Pigm.%26date%3D2017%26volume%3D138%26spage%3D204%26epage%3D212%26doi%3D10.1016%2Fj.dyepig.2016.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usama, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span> <span> </span><span class="NLM_article-title">Site-specific Labeling of Proteins with Near-IR Dyes</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2900</span>, <span class="refDoi"> DOI: 10.3390/molecules23112900</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.3390%2Fmolecules23112900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVWgsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=2900&author=C.-M.+Linauthor=S.+M.+Usamaauthor=K.+Burgess&title=Site-specific+Labeling+of+Proteins+with+Near-IR+Dyes&doi=10.3390%2Fmolecules23112900"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific labeling of proteins with near-IR heptamethine cyanine dyes</span></div><div class="casAuthors">Lin, Chen-Ming; Usama, Syed Muhammad; Burgess, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2900/1-2900/11</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Convenient labeling of proteins is important for observing its function under physiol. conditions.  In tissues particularly, heptamethine cyanine dyes (Cy-7) are valuable because they absorb in the near-IR (NIR) region (750-900 nm) where light penetration is maximal.  In this work, we found Cy-7 dyes with a meso-C1 functionality covalently binding to proteins with free Cys residues under physiol. conditions (aq. environments, at near neutral pH, and 37 °C).  It transpired that the meso-Cl of the dye was displaced by free thiols in protein, while nucleophilic side-chains from amino acids like Tyr, Lys, and Ser did not react.  This finding shows a new possibility for convenient and selective labeling of proteins with NIR fluorescent probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph0WcsC-7-zrVg90H21EOLACvtfcHk0liA-h8vrndAiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVWgsrvF&md5=65d3742978c72536efd068c5e7a48d47</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23112900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23112900%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.-M.%26aulast%3DUsama%26aufirst%3DS.%2BM.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DSite-specific%2520Labeling%2520of%2520Proteins%2520with%2520Near-IR%2520Dyes%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D2900%26doi%3D10.3390%2Fmolecules23112900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usama, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span> <span> </span><span class="NLM_article-title">On the Mechanisms of Update of Tumor-seeking Cyanine Dyes</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">3886</span>– <span class="NLM_lpage">3895</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOnu7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=3886-3895&author=S.+M.+Usamaauthor=C.-M.+Linauthor=K.+Burgess&title=On+the+Mechanisms+of+Update+of+Tumor-seeking+Cyanine+Dyes&doi=10.1021%2Facs.bioconjchem.8b00708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">On the Mechanisms of Uptake of Tumor-Seeking Cyanine Dyes</span></div><div class="casAuthors">Usama, Syed Muhammad; Lin, Chen-Ming; Burgess, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3886-3895</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. entities that localize in tumor tissue are clin. important for targeted delivery of diagnostic, imaging, and therapeutic reagents.  Often these targeting entities are designed for specific receptors (eg EGFR or integrin receptors).  However, there is a subset of cyanine-7 dyes that apparently localize in every type of solid tumor tissue (at least, no exceptions have been reported so far), and they persist there for several days.  Consequently, these dyes can be used for near-IR optical imaging of tumors in animal studies, they can be conjugated with cytotoxic species to give exptl. theranostics, and there is potential for expanding their use into the development of clin. useful derivs.  Data presented in the literature and in this work indicate the half-live of these compds. in serum at 37 °C is of the order of minutes to a few hours, so what accounts for the persistent fluorescence of these dyes in tumor tissue over periods of several days.  Literature, solely based on tissue culture expts. featuring a particular receptor blocker, indicates that uptake of these dyes is mediated by the org. anion transporter proteins (OATPs).  Data presented in this paper agrees with that conclusion for short-term uptake, but significantly expands understanding of the likely reasons for long-term uptake and persistent tumor localization in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoexlK2uA0etLVg90H21EOLACvtfcHk0liipY5mJ8MA6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOnu7bJ&md5=895fbe8c2e3ff50985d09874881ebb11</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00708%26sid%3Dliteratum%253Aachs%26aulast%3DUsama%26aufirst%3DS.%2BM.%26aulast%3DLin%26aufirst%3DC.-M.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DOn%2520the%2520Mechanisms%2520of%2520Update%2520of%2520Tumor-seeking%2520Cyanine%2520Dyes%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D3886%26epage%3D3895%26doi%3D10.1021%2Facs.bioconjchem.8b00708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levitt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitt, M. D.</span></span> <span> </span><span class="NLM_article-title">Human Serum Albumin Homeostasis: a New Look at the Roles of Synthesis, Catabolism, Renal and Gastrointestinal Excretion, and the Clinical Value of Serum Albumin Measurements</span>. <i>Int. J. Gen. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.2147/IJGM.S102819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.2147%2FIJGM.S102819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=27486341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1OrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=229-255&author=D.+G.+Levittauthor=M.+D.+Levitt&title=Human+Serum+Albumin+Homeostasis%3A+a+New+Look+at+the+Roles+of+Synthesis%2C+Catabolism%2C+Renal+and+Gastrointestinal+Excretion%2C+and+the+Clinical+Value+of+Serum+Albumin+Measurements&doi=10.2147%2FIJGM.S102819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements</span></div><div class="casAuthors">Levitt, David G.; Levitt, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of General Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">229-255</span>CODEN:
                <span class="NLM_cas:coden">IJGMBG</span>;
        ISSN:<span class="NLM_cas:issn">1178-7074</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Serum albumin concn. (CP) is a remarkably strong prognostic indicator of morbidity and mortality in both sick and seemingly healthy subjects.  Surprisingly, the specifics of the pathophysiol. underlying the relationship between CP and ill-health are poorly understood.  This review provides a summary that is not previously available in the literature, concerning how synthesis, catabolism, and renal and gastrointestinal clearance of albumin interact to bring about albumin homeostasis, with a focus on the clin. factors that influence this homeostasis.  In normal humans, the albumin turnover time of about 25 days reflects a liver albumin synthesis rate of about 10.5 g/day balanced by renal (≈6%), gastrointestinal (≈10%), and catabolic (≈84%) clearances.  The acute development of hypoalbuminemia with sepsis or trauma results from increased albumin capillary permeability leading to redistribution of albumin from the vascular to interstitial space.  The best understood mechanism of chronic hypoalbuminemia is the decreased albumin synthesis obsd. in liver disease.  Decreased albumin prodn. also accounts for hypoalbuminemia obsd. with a low-protein and normal caloric diet.  However, a calorie- and protein-deficient diet does not reduce albumin synthesis and is not assocd. with hypoalbuminemia, and CP is not a useful marker of malnutrition.  In most disease states other than liver disease, albumin synthesis is normal or increased, and hypoalbuminemia reflects an enhanced rate of albumin turnover resulting either from an increased rate of catabolism (a poorly understood phenomenon) or enhanced loss of albumin into the urine (nephrosis) or intestine (protein-losing enteropathy).  The latter may occur with subtle intestinal pathol. and hence may be more prevalent than commonly appreciated.  Clin., reduced CP appears to be a result rather than a cause of ill-health, and therapy designed to increase CP has limited benefit.  The ubiquitous occurrence of hypoalbuminemia in disease states limits the diagnostic utility of the CP measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKR3oLyDIoObVg90H21EOLACvtfcHk0liipY5mJ8MA6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1OrsL0%253D&md5=d089ab0a8d8b1e6ab698f5f69e84b7d9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2147%2FIJGM.S102819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJGM.S102819%26sid%3Dliteratum%253Aachs%26aulast%3DLevitt%26aufirst%3DD.%2BG.%26aulast%3DLevitt%26aufirst%3DM.%2BD.%26atitle%3DHuman%2520Serum%2520Albumin%2520Homeostasis%253A%2520a%2520New%2520Look%2520at%2520the%2520Roles%2520of%2520Synthesis%252C%2520Catabolism%252C%2520Renal%2520and%2520Gastrointestinal%2520Excretion%252C%2520and%2520the%2520Clinical%2520Value%2520of%2520Serum%2520Albumin%2520Measurements%26jtitle%3DInt.%2520J.%2520Gen.%2520Med.%26date%3D2016%26volume%3D9%26spage%3D229%26epage%3D255%26doi%3D10.2147%2FIJGM.S102819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Simple Bioconjugate Chemistry Serves Great Clinical Advances: Albumin as a Versatile Platform for Diagnosis and Precision Therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1039/C5CS00158G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1039%2FC5CS00158G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=26771036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC28XovVKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=1432-1456&author=Z.+Liuauthor=X.+Chen&title=Simple+Bioconjugate+Chemistry+Serves+Great+Clinical+Advances%3A+Albumin+as+a+Versatile+Platform+for+Diagnosis+and+Precision+Therapy&doi=10.1039%2FC5CS00158G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy</span></div><div class="casAuthors">Liu, Zhibo; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1432-1456</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Albumin is the most abundant circulating protein in plasma and has recently emerged as a versatile protein carrier for drug targeting and for improving the pharmacokinetic profile of peptide or protein based drugs.  Three drug delivery technologies related to albumin have been developed, which include the coupling of low-mol. wt. drugs to exogenous or endogenous albumin, conjugating bioactive proteins by albumin fusion technol. (AFT), and encapsulation of drugs into albumin nanoparticles.  This review article starts with a brief introduction of human serum albumin (HSA), and then summarizes the mainstream chem. strategies of developing HSA binding mols. for coupling with drug mols.  Moreover, we also concisely condense the recent progress of the most important clin. applications of HSA-binding platforms, and specify the current challenges that need to be met for a bright future of HSA-binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX_KUb4v-V6LVg90H21EOLACvtfcHk0liipY5mJ8MA6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovVKkug%253D%253D&md5=6cbd8231b0f3dcdd776d464a835d535e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC5CS00158G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00158G%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DSimple%2520Bioconjugate%2520Chemistry%2520Serves%2520Great%2520Clinical%2520Advances%253A%2520Albumin%2520as%2520a%2520Versatile%2520Platform%2520for%2520Diagnosis%2520and%2520Precision%2520Therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2016%26volume%3D45%26spage%3D1432%26epage%3D1456%26doi%3D10.1039%2FC5CS00158G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frei, E.</span></span> <span> </span><span class="NLM_article-title">Albumin Binding Ligands and Albumin Conjugate Uptake by Cancer Cells</span>. <i>Diabetol. Metab. Syndr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi"> DOI: 10.1186/1758-5996-3-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1186%2F1758-5996-3-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=21676260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Gmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=11&author=E.+Frei&title=Albumin+Binding+Ligands+and+Albumin+Conjugate+Uptake+by+Cancer+Cells&doi=10.1186%2F1758-5996-3-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin binding ligands and albumin conjugate uptake by cancer cells</span></div><div class="casAuthors">Frei, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Diabetology & Metabolic Syndrome</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11</span>CODEN:
                <span class="NLM_cas:coden">DMSIBU</span>;
        ISSN:<span class="NLM_cas:issn">1758-5996</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The scope of this short review is to summarise the knowledge gleaned from the fate of drugs transported by albumin upon contact with the target cancer cell or cells in inflamed tissues.  The authors expertise covers covalently bound drugs and their cellular uptake and release from albumin.  This review therefore aims to deduce what will happen to drugs such as insulin detemir which is considered to bind non-covalently to albumin and may have a fate similar to fatty acids transported by albumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEAGqCuOopDLVg90H21EOLACvtfcHk0lhyWyqix39Xsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Gmt7s%253D&md5=95b808fa029e5a56eded077308199f7f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2F1758-5996-3-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1758-5996-3-11%26sid%3Dliteratum%253Aachs%26aulast%3DFrei%26aufirst%3DE.%26atitle%3DAlbumin%2520Binding%2520Ligands%2520and%2520Albumin%2520Conjugate%2520Uptake%2520by%2520Cancer%2520Cells%26jtitle%3DDiabetol.%2520Metab.%2520Syndr.%26date%3D2011%26volume%3D3%26spage%3D11%26doi%3D10.1186%2F1758-5996-3-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stehle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrenk, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier-Borst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heene, D. L.</span></span> <span> </span><span class="NLM_article-title">The Loading Rate Determines Tumor Targeting Properties of Methotrexate-albumin Conjugates in Rats</span>. <i>Anti-Cancer Drugs</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1097/00001813-199708000-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1097%2F00001813-199708000-00006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=667-685&author=G.+Stehleauthor=H.+Sinnauthor=A.+Wunderauthor=H.+H.+Schrenkauthor=S.+Schuttauthor=W.+Maier-Borstauthor=D.+L.+Heene&title=The+Loading+Rate+Determines+Tumor+Targeting+Properties+of+Methotrexate-albumin+Conjugates+in+Rats&doi=10.1097%2F00001813-199708000-00006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1097%2F00001813-199708000-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001813-199708000-00006%26sid%3Dliteratum%253Aachs%26aulast%3DStehle%26aufirst%3DG.%26aulast%3DSinn%26aufirst%3DH.%26aulast%3DWunder%26aufirst%3DA.%26aulast%3DSchrenk%26aufirst%3DH.%2BH.%26aulast%3DSchutt%26aufirst%3DS.%26aulast%3DMaier-Borst%26aufirst%3DW.%26aulast%3DHeene%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Loading%2520Rate%2520Determines%2520Tumor%2520Targeting%2520Properties%2520of%2520Methotrexate-albumin%2520Conjugates%2520in%2520Rats%26jtitle%3DAnti-Cancer%2520Drugs%26date%3D1997%26volume%3D8%26spage%3D667%26epage%3D685%26doi%3D10.1097%2F00001813-199708000-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canovas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellaye, P.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romieu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, V.</span></span> <span> </span><span class="NLM_article-title">Site-specific Near-infrared Fluorescent Labelling of Proteins on Cysteine Residues with Meso-chloro-substituted Heptamethine Cyanine Dyes</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">8831</span>– <span class="NLM_lpage">8836</span>, <span class="refDoi"> DOI: 10.1039/C8OB02646G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1039%2FC8OB02646G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=30411777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyhsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=8831-8836&author=C.+Canovasauthor=P.-S.+Bellayeauthor=M.+Moreauauthor=A.+Romieuauthor=F.+Denatauthor=V.+Goncalves&title=Site-specific+Near-infrared+Fluorescent+Labelling+of+Proteins+on+Cysteine+Residues+with+Meso-chloro-substituted+Heptamethine+Cyanine+Dyes&doi=10.1039%2FC8OB02646G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Site-specific near-infrared fluorescent labelling of proteins on cysteine residues with meso-chloro-substituted heptamethine cyanine dyes</span></div><div class="casAuthors">Canovas, Coline; Bellaye, Pierre-Simon; Moreau, Mathieu; Romieu, Anthony; Denat, Franck; Goncalves, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8831-8836</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Near-IR (NIR) fluorescence imaging is a promising new medical imaging modality.  Assocd. with a targeting mol., NIR fluorophores can accumulate selectively in tissues of interest and become valuable tools for the diagnosis and therapy of various pathologies.  To facilitate the design of targeted NIR imaging agents, it is important to identify simple and affordable fluorescent probes, allowing rapid labeling of biovectors such as proteins, ideally in a site-specific manner.  Here, we demonstrate that heptamethine cyanine based fluorophores, such as IR-783, that contain a chloro-cyclohexyl moiety within their polymethine chain can react selectively, at neutral pH, with cysteine residues in proteins to give stable, site-specifically labeled conjugates, that emit in the NIR spectral window.  This reaction is exemplified with the labeling of peptides and two protein models: albumin and a Fab' antibody fragment.  The resulting fluorescent proteins are stable and suitable for in vivo NIR imaging applications, as shown on a mice model.  This straightforward one-step procedure, that does not require the prior derivatisation of the fluorophore with a bioconjugatable handle, should facilitate the prodn. and use of near-IR labeled proteins in life sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXzYUbIi6th7Vg90H21EOLACvtfcHk0lhyWyqix39Xsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyhsbrI&md5=cfbda9533268404a37f3d678f52eac07</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC8OB02646G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8OB02646G%26sid%3Dliteratum%253Aachs%26aulast%3DCanovas%26aufirst%3DC.%26aulast%3DBellaye%26aufirst%3DP.-S.%26aulast%3DMoreau%26aufirst%3DM.%26aulast%3DRomieu%26aufirst%3DA.%26aulast%3DDenat%26aufirst%3DF.%26aulast%3DGoncalves%26aufirst%3DV.%26atitle%3DSite-specific%2520Near-infrared%2520Fluorescent%2520Labelling%2520of%2520Proteins%2520on%2520Cysteine%2520Residues%2520with%2520Meso-chloro-substituted%2520Heptamethine%2520Cyanine%2520Dyes%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2018%26volume%3D16%26spage%3D8831%26epage%3D8836%26doi%3D10.1039%2FC8OB02646G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koolen, S. L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witteveen, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langenberg, M. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronemeijer, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ribas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhadji, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slapak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voest, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellens, J. H. M.</span></span> <span> </span><span class="NLM_article-title">Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6071</span>– <span class="NLM_lpage">6082</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-0353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1158%2F1078-0432.CCR-11-0353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=21753156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOitb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6071-6082&author=S.+L.+W.+Koolenauthor=P.+O.+Witteveenauthor=R.+S.+Jansenauthor=M.+H.+G.+Langenbergauthor=R.+H.+Kronemeijerauthor=A.+Nolauthor=I.+Garcia-Ribasauthor=S.+Calliesauthor=K.+A.+Benhadjiauthor=C.+A.+Slapakauthor=J.+H.+Beijnenauthor=E.+E.+Voestauthor=J.+H.+M.+Schellens&title=Phase+I+Study+of+Oral+Gemcitabine+Prodrug+%28LY2334737%29+Alone+and+in+Combination+with+Erlotinib+in+Patients+with+Advanced+Solid+Tumors&doi=10.1158%2F1078-0432.CCR-11-0353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of Oral Gemcitabine Prodrug (LY2334737) Alone and in Combination with Erlotinib in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Koolen, Stijn L. W.; Witteveen, Petronella O.; Jansen, Robert S.; Langenberg, Marlies H. G.; Kronemeijer, Roelien H.; Nol, Annemarie; Garcia-Ribas, Ignacio; Callies, Sophie; Benhadji, Karim A.; Slapak, Christopher A.; Beijnen, Jos H.; Voest, Emile E.; Schellens, Jan H. M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6071-6082</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: LY2334737 is an orally available prodrug of gemcitabine.  The objective of this study was to det. the max. tolerated dose (MTD) and dose limiting toxicities (DLT) of daily administration of LY2334737 with or without erlotinib.  Exptl. Design: Patients with advanced or metastatic cancer were treated with escalating doses of LY2334737 monotherapy or in combination with continuous daily administration of 100 mg erlotinib.  LY2334737 was given once daily for 14 days of a 21-day cycle.  The study was extended with a bioequivalence trial to investigate a novel LY2334737 drug formulation.  RESULTS: A total of 65 patients were treated in this study.  The MTD was 40 mg LY2334737.  Fatigue was the most frequent DLT for LY2334737 monotherapy (4 patients) followed by elevated transaminase levels (2 patients), both obsd. at the 40- to 50-mg dose levels.  Among the 10 patients in the combination arm, 2 had DLTs at the 40-mg dose level.  These were fatigue and elevated liver enzyme levels.  The most common adverse events were fatigue (n = 38), nausea (n = 27), vomiting (n = 24), diarrhea (n = 23), anorexia (n = 20), pyrexia (n = 18), and elevated transaminase levels (n = 14).  The pharmacokinetics showed dose proportional increase in LY2334737 and gemcitabine exposure.  The metabolite 2',2'-difluorodeoxyuridine accumulated with an accumulation index of 4.3 (coeff. of variation: 20%).  In one patient, complete response in prostate-specific antigen was obsd. for 4 cycles, and stable disease was achieved in 22 patients overall.  Pharmacokinetic anal. showed that the 2 investigated LY2334737 drug formulations were bioequivalent.  CONCLUSIONS: LY2334737 displays linear pharmacokinetics and the MTD is 40 mg with or without daily administration of 100 mg erlotinib.  Signs of antitumor activity warrant further development.  Clin Cancer Res; 17(18); 6071-82.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34fxoY2J29LVg90H21EOLACvtfcHk0ljnk4i0mIp21Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOitb3P&md5=0bd39336d09f2e9c0bc4505b3e63332e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0353%26sid%3Dliteratum%253Aachs%26aulast%3DKoolen%26aufirst%3DS.%2BL.%2BW.%26aulast%3DWitteveen%26aufirst%3DP.%2BO.%26aulast%3DJansen%26aufirst%3DR.%2BS.%26aulast%3DLangenberg%26aufirst%3DM.%2BH.%2BG.%26aulast%3DKronemeijer%26aufirst%3DR.%2BH.%26aulast%3DNol%26aufirst%3DA.%26aulast%3DGarcia-Ribas%26aufirst%3DI.%26aulast%3DCallies%26aufirst%3DS.%26aulast%3DBenhadji%26aufirst%3DK.%2BA.%26aulast%3DSlapak%26aufirst%3DC.%2BA.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DVoest%26aufirst%3DE.%2BE.%26aulast%3DSchellens%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DPhase%2520I%2520Study%2520of%2520Oral%2520Gemcitabine%2520Prodrug%2520%2528LY2334737%2529%2520Alone%2520and%2520in%2520Combination%2520with%2520Erlotinib%2520in%2520Patients%2520with%2520Advanced%2520Solid%2520Tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D6071%26epage%3D6082%26doi%3D10.1158%2F1078-0432.CCR-11-0353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, G.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-S.</span></span> <span> </span><span class="NLM_article-title">CD133 Antibody-conjugated Immunoliposomes Encapsulating Gemcitabine for Targeting Glioblastoma Stem Cells</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">3771</span>– <span class="NLM_lpage">3781</span>, <span class="refDoi"> DOI: 10.1039/c4tb00185k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1039%2Fc4tb00185k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVanur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=3771-3781&author=D.+H.+Shinauthor=S.+Xuanauthor=W.-Y.+Kimauthor=G.-U.+Baeauthor=J.-S.+Kim&title=CD133+Antibody-conjugated+Immunoliposomes+Encapsulating+Gemcitabine+for+Targeting+Glioblastoma+Stem+Cells&doi=10.1039%2Fc4tb00185k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">CD133 antibody-conjugated immunoliposomes encapsulating gemcitabine for targeting glioblastoma stem cells</span></div><div class="casAuthors">Shin, Dae Hwan; Xuan, Shuhua; Kim, Woo-Young; Bae, Gyu-Un; Kim, Jin-Seok</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3771-3781</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">CD133+ cells in glioblastoma multiforme (GBM) display glioma stem cell (GSC) properties and have been considered to be the culprit in tumor recurrence, justifying the exploration of potential therapeutic modalities targeting CD133+ cells.  Such strategies require a drug-delivery vehicle, and increasingly, the unique properties of PEGylated liposomes are being exploited for this purpose.  More advanced liposomal delivery studies have suggested conjugation of CD133 antibodies as a suitable method for targeting GSCs.  For targeting studies, GSCs sepd. from U87 GBM cells using a magnetic bead sepn. method were challenged with liposomes encapsulating gemcitabine (GEM) conjugated with a CD133 monoclonal antibody (PEG-lipo-CD133-GEM).  An in vitro study showed that conjugation of CD133 antibody significantly enhanced the cytotoxicity of GEM through endocytosis of CD133 surface markers overexpressed on GSCs.  The anti-tumor effect of PEG-lipo-CD133-GEM was 15 times higher than that of free GEM, presumably reflecting the specific targeting of the CD133 surface marker by PEG-lipo-CD133-GEM and the enhanced stability and cytotoxicity through the PEGylated liposome formulation in xenograft models.  Moreover, monitoring of body wt. changes showed that the use of PEGylated liposomes significantly reduced the toxicity of GEM.  Taken together, our studies demonstrate that PEG-lipo-CD133-GEM shows promise for the treatment of gliomas in vitro and in xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplRF9kSzO7ybVg90H21EOLACvtfcHk0ljnk4i0mIp21Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVanur0%253D&md5=34ba65ddddad0b9c9d16510094a586f9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1039%2Fc4tb00185k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc4tb00185k%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DXuan%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DW.-Y.%26aulast%3DBae%26aufirst%3DG.-U.%26aulast%3DKim%26aufirst%3DJ.-S.%26atitle%3DCD133%2520Antibody-conjugated%2520Immunoliposomes%2520Encapsulating%2520Gemcitabine%2520for%2520Targeting%2520Glioblastoma%2520Stem%2520Cells%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2014%26volume%3D2%26spage%3D3771%26epage%3D3781%26doi%3D10.1039%2Fc4tb00185k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-Targeted Small-Molecule Fluorophores for Dual Modal Cancer Phototherapy</span>. <i>Adv. Funct. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2826</span>– <span class="NLM_lpage">2835</span>, <span class="refDoi"> DOI: 10.1002/adfm.201600159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1002%2Fadfm.201600159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1Cjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2826-2835&author=S.+Luoauthor=X.+Tanauthor=S.+Fangauthor=Y.+Wangauthor=T.+Liuauthor=X.+Wangauthor=Y.+Yuanauthor=H.+Sunauthor=Q.+Qiauthor=C.+Shi&title=Mitochondria-Targeted+Small-Molecule+Fluorophores+for+Dual+Modal+Cancer+Phototherapy&doi=10.1002%2Fadfm.201600159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Small-Molecule Fluorophores for Dual Modal Cancer Phototherapy</span></div><div class="casAuthors">Luo, Shenglin; Tan, Xu; Fang, Shengtao; Wang, Yu; Liu, Tao; Wang, Xin; Yuan, Yi; Sun, Huiqin; Qi, Qingrong; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Functional Materials</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2826-2835</span>CODEN:
                <span class="NLM_cas:coden">AFMDC6</span>;
        ISSN:<span class="NLM_cas:issn">1616-301X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Mitochondria are recognized as the ideal target for cancer treatment because they play a central role in oxidative metab. and apoptosis.  In this work, a mitochondria-targeted near-IR (NIR) photosensitizer (PS) for synchronous cancer photodynamic therapy (PDT) and photothermal therapy (PTT) is synthesized.  This multifunctional small-mol. PS is developed from a variety of synthesized heptamethine cyanine dyes, which are modified with various N-alkyl side chains on the lipophilic cationic heptamethine core.  It is demonstrated to preferentially accumulate in cancer cells by org.-anion transporting polypeptide mediated active transport and retain in mitochondria by its lipophilic cationic property.  As mitochondria are susceptible to hyperthermia and excessive reactive oxygen species, this new PS integrating PTT and PDT treatment exhibits highly efficient phototherapy in multiple cancer cells and animal xenograft models.  Furthermore, this targeted PS with NIR imaging property also enables tumors and their margins clearly visualized, providing the potential for precisely imaging-guided phototherapy and treatment monitoring.  This is the first report that a small-mol. PS integrates both cancer PTT and PDT treatment by targeting mitochondria, significantly increasing the photosensitization.  This work may also present a practicable strategy to develop small-mol.-based cancer theranostic agents for simultaneous cancer targeting, imaging, and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzLHBN3w1PKrVg90H21EOLACvtfcHk0lifnI_nbyCHtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1Cjuro%253D&md5=e883af613349362d09d55b07e56c14dd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fadfm.201600159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadfm.201600159%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DQi%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DMitochondria-Targeted%2520Small-Molecule%2520Fluorophores%2520for%2520Dual%2520Modal%2520Cancer%2520Phototherapy%26jtitle%3DAdv.%2520Funct.%2520Mater.%26date%3D2016%26volume%3D26%26spage%3D2826%26epage%3D2835%26doi%3D10.1002%2Fadfm.201600159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Repurposing Antitubercular Agent Isoniazid for Treatment of Prostate Cancer</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1039/C8BM01189C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1039%2FC8BM01189C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFGnsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&pages=296-306&author=Q.+Lvauthor=D.+Wangauthor=Z.+Yangauthor=J.+Yangauthor=R.+Zhangauthor=X.+Yangauthor=M.+Wangauthor=Y.+Wang&title=Repurposing+Antitubercular+Agent+Isoniazid+for+Treatment+of+Prostate+Cancer&doi=10.1039%2FC8BM01189C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing antitubercular agent isoniazid for treatment of prostate cancer</span></div><div class="casAuthors">Lv, Qingzhi; Wang, Dun; Yang, Zimeng; Yang, Jincheng; Zhang, Ruoshi; Yang, Xiaoguang; Wang, Menglin; Wang, Yongjun</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">296-306</span>CODEN:
                <span class="NLM_cas:coden">BSICCH</span>;
        ISSN:<span class="NLM_cas:issn">2047-4849</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of versatile antitumor agents with tumor-imaging, targeting and therapeutic activity is promising for clin. cancer therapy.  Prostate cancer is still the one of the leading threats to males.  Current therapies have restricted clin. efficiency for patients with advanced and metastatic prostate cancer.  Recent studies demonstrate that monoamine oxidase A (MAOA) levels elevate with prostate cancer aggression and metastasis.  In addn., MAOA inhibitor therapies have been reported as an effective means to reduce the metastasis of prostate cancer and extend mouse survival.  Thus, these findings provide evidence that MAOA is promising for the treatment of metastatic and advanced prostate cancer.  Herein, three isoniazid (INH)-dye conjugates were synthesized by conjugating MAOA inhibitor INH with mitochondria-targeting NIRF heptamethine dyes to improve the therapeutic efficacy of prostate cancer.  These INH-dye conjugates could accumulate in PC-3 cellular mitochondria via org. anion transport peptide (OATP), increase ROS generation, and induce cancer cells apoptosis.  In prostate cancer bearing xenografts, INH-dye conjugates showed significantly improved tumor-homing characteristics, resulting in potent antitumor activity via a redn. in MAOA activity.  These results suggest that INH-dye conjugates have great potential to be used as versatile antitumor agents with prostate cancer targeting, NIR imaging, and potent antitumor efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosA8SyqAULZrVg90H21EOLACvtfcHk0lifnI_nbyCHtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFGnsrjJ&md5=1ebce8e355c89cf562f6434ef2c4958e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2FC8BM01189C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8BM01189C%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DRepurposing%2520Antitubercular%2520Agent%2520Isoniazid%2520for%2520Treatment%2520of%2520Prostate%2520Cancer%26jtitle%3DBiomater.%2520Sci.%26date%3D2019%26volume%3D7%26spage%3D296%26epage%3D306%26doi%3D10.1039%2FC8BM01189C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Usama, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thavornpradit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, K.</span></span> <span> </span><span class="NLM_article-title">Optimized Heptamethine Cyanines for Photodynamic Therapy</span>. <i>ACS Appl. Bio Mater.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1021/acsabm.8b00414</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsabm.8b00414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslWitLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2018&pages=1195-1205&author=S.+M.+Usamaauthor=S.+Thavornpraditauthor=K.+Burgess&title=Optimized+Heptamethine+Cyanines+for+Photodynamic+Therapy&doi=10.1021%2Facsabm.8b00414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Optimized Heptamethine Cyanines for Photodynamic Therapy</span></div><div class="casAuthors">Usama, Syed Muhammad; Thavornpradit, Sopida; Burgess, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Bio Materials</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1195-1205</span>CODEN:
                <span class="NLM_cas:coden">AABMCB</span>;
        ISSN:<span class="NLM_cas:issn">2576-6422</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over 10 near-IR fluorescent sensitizers were prepd. to explore their properties relevant to potential applications in photodynamic therapy (PDT).  Key properties of these compds. are that they can be excited around 800 nm, (i) are hydrophilic, (ii) generate singlet oxygen with acceptable quantum yields, and (iii) are imported into cancer cells via the org. anion transporter proteins (OATPs). (This is crucial to tumor localization.) The N-substituents of these cyanines were varied to adjust their charges and polarities and to accommodate conjugation to other entities (e.g., biomols. or fragments to expand their theranostic modalities).  Thus, it was possible to optimize their photocytotoxicities without compromising their other desirable characteristics for PDT.  Overall, sensitizers like this have superior characteristics relative to clin. approved sensitizers for PDT insofar as they can be excited at greater depths in tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiqLfjWjCtErVg90H21EOLACvtfcHk0lhT75zfgMeEkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslWitLbI&md5=b7e9bd55fee266adb65276e7665edc32</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsabm.8b00414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsabm.8b00414%26sid%3Dliteratum%253Aachs%26aulast%3DUsama%26aufirst%3DS.%2BM.%26aulast%3DThavornpradit%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DOptimized%2520Heptamethine%2520Cyanines%2520for%2520Photodynamic%2520Therapy%26jtitle%3DACS%2520Appl.%2520Bio%2520Mater.%26date%3D2018%26volume%3D1%26spage%3D1195%26epage%3D1205%26doi%3D10.1021%2Facsabm.8b00414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mottram, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddox, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaufils, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, B. R.</span></span> <span> </span><span class="NLM_article-title">A Concise Synthesis of the Pennsylvania Green Fluorophore and Labeling of Intracellular Targets with O6-Benzylguanine Derivatives</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3741</span>– <span class="NLM_lpage">3744</span>, <span class="refDoi"> DOI: 10.1021/ol7015093</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol7015093" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFSmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3741-3744&author=L.+F.+Mottramauthor=E.+Maddoxauthor=M.+Schwabauthor=F.+Beaufilsauthor=B.+R.+Peterson&title=A+Concise+Synthesis+of+the+Pennsylvania+Green+Fluorophore+and+Labeling+of+Intracellular+Targets+with+O6-Benzylguanine+Derivatives&doi=10.1021%2Fol7015093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">A Concise Synthesis of the Pennsylvania Green Fluorophore and Labeling of Intracellular Targets with O6-Benzylguanine Derivatives</span></div><div class="casAuthors">Mottram, Laurie F.; Maddox, Ewa; Schwab, Markus; Beaufils, Florent; Peterson, Blake R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3741-3744</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report improved syntheses of the Pennsylvania Green and 4-carboxy-Pennsylvania Green fluorophores; the latter compd. was prepd. from Me 4-iodo-3-methylbenzoate in a three-pot process (32% overall yield).  Chinese hamster ovary cells expressing O6-alkylguanine-DNA alkyltransferase fusion proteins were treated with Pennsylvania Green and Oregon Green linked to O6-benzylguanine (SNAP-Tag substrates).  Anal. of living cells by confocal microscopy revealed that Pennsylvania Green derivs. exhibit substantially higher cell permeability than analogous Oregon Green-derived mol. probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeObWc6EsrNLVg90H21EOLACvtfcHk0lhT75zfgMeEkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFSmtr0%253D&md5=98c70a3647a53727943264c87eb12458</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol7015093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol7015093%26sid%3Dliteratum%253Aachs%26aulast%3DMottram%26aufirst%3DL.%2BF.%26aulast%3DMaddox%26aufirst%3DE.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DBeaufils%26aufirst%3DF.%26aulast%3DPeterson%26aufirst%3DB.%2BR.%26atitle%3DA%2520Concise%2520Synthesis%2520of%2520the%2520Pennsylvania%2520Green%2520Fluorophore%2520and%2520Labeling%2520of%2520Intracellular%2520Targets%2520with%2520O6-Benzylguanine%2520Derivatives%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D3741%26epage%3D3744%26doi%3D10.1021%2Fol7015093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmryd, I.</span></span> <span> </span><span class="NLM_article-title">Quantifying Colocalization by Correlation: The Pearson Correlation Coefficient Is Superior to the Mander’s Overlap Coefficient</span>. <i>Cytometry, Part A</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1002/cyto.a.20896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1002%2Fcyto.a.20896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=20653013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A280%3ADC%252BC3cnpsV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=733-742&author=J.+Adlerauthor=I.+Parmryd&title=Quantifying+Colocalization+by+Correlation%3A+The+Pearson+Correlation+Coefficient+Is+Superior+to+the+Mander%E2%80%99s+Overlap+Coefficient&doi=10.1002%2Fcyto.a.20896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient</span></div><div class="casAuthors">Adler Jeremy; Parmryd Ingela</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry. Part A : the journal of the International Society for Analytical Cytology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">733-42</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Pearson correlation coefficient (PCC) and the Mander's overlap coefficient (MOC) are used to quantify the degree of colocalization between fluorophores.  The MOC was introduced to overcome perceived problems with the PCC.  The two coefficients are mathematically similar, differing in the use of either the absolute intensities (MOC) or of the deviation from the mean (PCC).  A range of correlated datasets, which extend to the limits of the PCC, only evoked a limited response from the MOC.  The PCC is unaffected by changes to the offset while the MOC increases when the offset is positive.  Both coefficients are independent of gain.  The MOC is a confusing hybrid measurement, that combines correlation with a heavily weighted form of co-occurrence, favors high intensity combinations, downplays combinations in which either or both intensities are low and ignores blank pixels.  The PCC only measures correlation.  A surprising finding was that the addition of a second uncorrelated population can substantially increase the measured correlation, demonstrating the importance of excluding background pixels.  Overall, since the MOC is unresponsive to substantial changes in the data and is hard to interpret, it is neither an alternative to nor a useful substitute for the PCC.  The MOC is not suitable for making measurements of colocalization either by correlation or co-occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEIj-50ALgMgpJitSxOdIlfW6udTcc2eZnqLEvi-sdlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnpsV2luw%253D%253D&md5=4ad5fdfa78023b9110ed68bf9f230a38</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcyto.a.20896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcyto.a.20896%26sid%3Dliteratum%253Aachs%26aulast%3DAdler%26aufirst%3DJ.%26aulast%3DParmryd%26aufirst%3DI.%26atitle%3DQuantifying%2520Colocalization%2520by%2520Correlation%253A%2520The%2520Pearson%2520Correlation%2520Coefficient%2520Is%2520Superior%2520to%2520the%2520Mander%25E2%2580%2599s%2520Overlap%2520Coefficient%26jtitle%3DCytometry%252C%2520Part%2520A%26date%3D2010%26volume%3D77%26spage%3D733%26epage%3D742%26doi%3D10.1002%2Fcyto.a.20896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamocka, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J. H.</span></span> <span> </span><span class="NLM_article-title">A Practical Guide to Evaluating Colocalization in Biological Microscopy</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">C723</span>– <span class="NLM_lpage">C742</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.00462.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1152%2Fajpcell.00462.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=21209361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Orsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2011&pages=C723-C742&author=K.+W.+Dunnauthor=M.+M.+Kamockaauthor=J.+H.+McDonald&title=A+Practical+Guide+to+Evaluating+Colocalization+in+Biological+Microscopy&doi=10.1152%2Fajpcell.00462.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A practical guide to evaluating colocalization in biological microscopy</span></div><div class="casAuthors">Dunn, Kenneth W.; Kamocka, Malgorzata M.; McDonald, John H.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">4, Pt.1</span>),
    <span class="NLM_cas:pages">C723-C742</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">Fluorescence microscopy is one of the most powerful tools for elucidating the cellular functions of proteins and other mols.  In many cases, the function of a mol. can be inferred from its assocn. with specific intracellular compartments or mol. complexes, which is typically detd. by comparing the distribution of a fluorescently labeled version of the mol. with that of a second, complementarily labeled probe.  Although arguably the most common application of fluorescence microscopy in biomedical research, studies evaluating the "colocalization" of two probes are seldom quantified, despite a diversity of image anal. tools that have been specifically developed for that purpose.  Here we provide a guide to analyzing colocalization in cell biol. studies, emphasizing practical application of quant. tools that are now widely available in com. and free image anal. software.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW4EjMG9jdebVg90H21EOLACvtfcHk0ljZKY7QCKi-1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Orsrs%253D&md5=1b6a515733532b20e82a6a8d21cc1448</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00462.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00462.2010%26sid%3Dliteratum%253Aachs%26aulast%3DDunn%26aufirst%3DK.%2BW.%26aulast%3DKamocka%26aufirst%3DM.%2BM.%26aulast%3DMcDonald%26aufirst%3DJ.%2BH.%26atitle%3DA%2520Practical%2520Guide%2520to%2520Evaluating%2520Colocalization%2520in%2520Biological%2520Microscopy%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2011%26volume%3D300%26spage%3DC723%26epage%3DC742%26doi%3D10.1152%2Fajpcell.00462.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span> <span> </span><span class="NLM_article-title">Preferential Accumulation of the Near Iinfrared Heptamethine Dye IR-780 in the Mitochondria of Drug-resistant Lung Cancer Cells</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">4116</span>– <span class="NLM_lpage">4124</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2014.01.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=10.1016%2Fj.biomaterials.2014.01.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=24529902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitlSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=4116-4124&author=Y.+Wangauthor=T.+Liuauthor=E.+Zhangauthor=S.+Luoauthor=X.+Tanauthor=C.+Shi&title=Preferential+Accumulation+of+the+Near+Iinfrared+Heptamethine+Dye+IR-780+in+the+Mitochondria+of+Drug-resistant+Lung+Cancer+Cells&doi=10.1016%2Fj.biomaterials.2014.01.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells</span></div><div class="casAuthors">Wang, Yang; Liu, Tao; Zhang, Erlong; Luo, Shenglin; Tan, Xu; Shi, Chunmeng</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4116-4124</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Personalized oncol. significantly relies on the development of theranostic agents to integrate cancer therapeutics and diagnostics.  Current strategy for development of such multifunctional agents requires multistep chem. conjugation with cancer specific ligands, contrast agents and therapeutic drugs.  In this study, we reported a near IR (NIR) heptamethine indocyanine dye, IR-780, which selectively accumulated in the mitochondria of drug-resistant human lung cancer cells (A549/DR) and significantly inhibited cell growth, self-renewal and migration without the need of any chem. conjugation.  IR-780 was also able to induce A549/DR cell apoptosis by disrupting the mitochondrial function.  Furthermore, IR-780 dye exhibited remarkable tumoricidal activity and inhibited tumor recurrence in mouse syngeneic Lewis lung carcinoma xenograft model.  With the unique properties of targeting, near IR imaging and inhibitive effect to the drug-resistant cancer cells both in vitro and in vivo, IR-780 may represent a potential theranostic agent for tumor recurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBxTST4XZ3g7Vg90H21EOLACvtfcHk0ljZKY7QCKi-1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitlSnsrw%253D&md5=93e2ae9019ad4a5ee66328f634141b3e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2014.01.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2014.01.061%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DC.%26atitle%3DPreferential%2520Accumulation%2520of%2520the%2520Near%2520Iinfrared%2520Heptamethine%2520Dye%2520IR-780%2520in%2520the%2520Mitochondria%2520of%2520Drug-resistant%2520Lung%2520Cancer%2520Cells%26jtitle%3DBiomaterials%26date%3D2014%26volume%3D35%26spage%3D4116%26epage%3D4124%26doi%3D10.1016%2Fj.biomaterials.2014.01.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01147">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_65272"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01147">10.1021/acs.jmedchem.9b01147</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Characterization of all compounds, photophysical properties of compounds <b>1</b>, subcellular localization of compounds <b>1</b> and their parent dyes, stability test of <b>1a</b>, and more in vitro cytotoxicity and in vivo tumor model study details (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_001.pdf">jm9b01147_si_001.pdf (2.54 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01147/suppl_file/jm9b01147_si_002.csv">jm9b01147_si_002.csv (1.4 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01147&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01147%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-20%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01147" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799369be9073c64","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
